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Abstract 
 
Matrix assisted laser desorption/ionisation mass spectrometry (MALDI-MS) is a relatively 
new technique for imaging lipids directly in tissue, with useful applications in disease state 
profiling, bacterial typing and forensics. This thesis describes optimisation and evaluation 
of sample preparation procedures for MALDI-MS and MS imaging of lipids in complex 
samples.  
 
Direct analysis of fresh samples is shown to result in higher ion counts than analysis of 
desiccated tissues but thickness of tissue sections was shown to have a minimal effect on 
imaging results.  Extracts of lipids from rat brain samples were used to optimise matrix 
selection for MALDI-MS of lipids. DHB was found to be the optimum matrix, in accordance 
with literature, for extract analysis; however, superior imaging results were obtained using 
αCHCA. An automated matrix deposition robot is compared to a manual airspray method. 
The robotic method demonstrated enhanced sensitivity, superior image resolution and 
reduced variability between different sample plates compared to traditional manual 
methods. Optimised methods were applied to analysis of formalin fixed tissue. Successful 
imaging of phospholipids in fixed samples is demonstrated for the first time. Lipids in 
formalin fixed samples were found to be predominantly detected as sodium adducts (due 
to high levels of sodium in the buffered formalin). This was exploited to offer enhanced 
structural information afforded by collision induced dissociation (CID) of sodium rather 
than potassium adducts, which is well reported to increase the number of useful product 
ions detected.  
 
Methods for analysis and imaging of non-mammalian lipids by MALDI-MS were 
considered. Members of the Mycobacterium tuberculosis complex (MTBC) are important 
human pathogens. The cell wall of mycobacteria contains a number of lipids, which 
contribute largely to the virulence of pathogenic species. Preliminary research showed 
relatively poor sensitivity for these complex lipids but improved results were obtained by 
direct analysis of TLC plates. A binary matrix solvent system was developed offering 
considerably improved sensitivity. Successful detection of numerous lipids species 
involved in virulence, along with several previously unreported molecules is presented. 
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which is at m/z 1530 and represents the major homologue of PGL. The cluster of 
peaks seen at the higher mass range m/z 1677-1756 are believed to be cell 
envelope associated lipids with a similar structure, but are yet to be identified. 
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1. Introduction 
 
1.1 Basic Principles of the MALDI Technique  
 
MALDI (matrix-assisted laser desorption/ionisation) is a soft ionisation technique 
introduced by Karas and Hillenkamp[1] and Tanaka[2] simultaneously in the late 1980’s. 
The method involves the use of a matrix compound, usually a low molecular weight 
organic acid, which is mixed in molar excess with the analyte/s of interest to facilitate in 
desorption/ionisation. For optimum results a molar ratio of 1:1000 to 1:10000 
(analyte:matrix) are often recommended. The simplest and most commonly used sample 
preparation method is the dried droplet[1]. In this method the analyte and matrix are 
mixed in (ideally) the same solvent system and 0.25-1 µl of this mixture is deposited onto 
a stainless steel MALDI target plate. Upon evaporation of the solvent a co-crystallised 
structure of matrix/analyte is formed. This is then placed in the MALDI ion source and 
interrogated with a pulsed UV or IR laser. Energy transfer into the co-crystallised structure 
results in the desorption of both the matrix and analyte species from the surface, and the 
formation of the ‘MALDI plume’, which contains gas phase (de)protonated and cationised 
species of matrix and analyte. Charged species are extracted into the mass analyser 
using a known electrical field, traditionally a time-of-flight instrument, where they are 
separated and detected according to their mass-charge ratio (m/z). A simplified overview 
of the MALDI process is presented in figure 1. 
 
Investigations presented in this thesis focused on UV-MALDI, thus only aspects related to 
this will be discussed in detail.  
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Figure 1. Simplified overview of the MALDI technique. Matrix:analyte crystal on the 
MALDI target plate are irradiated with a pulsed laser, this causes rapid heating of the 
matrix molecules, resulting in energy transfer into the analyte molecules and local 
sublimation/ablation of the solid material. Gas-phase protonation occurs in the expanding 
MALDI plume. Charged species are then extracted into the mass spectrometer. 
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1.1.2 MALDI Matrices 
 
Since the MALDI technique was pioneered, numerous molecules have been tried and 
tested for their suitability as a MALDI matrix[3]. However, of the numbers tried and tested 
relatively few of these proved successful. Generally speaking, a MALDI matrix is usually a 
low molecular weight organic acid that has two important functions: (1) absorption of 
energy from the laser beam and transferring it into excitation energy, and (2) isolation of 
the analyte molecules from one another, thus holding analyte aggregation to a minimum. 
A successful MALDI matrix also requires the following characteristics:  
 
 High molar absorptivity at the lasers wavelength 
- Removes the need to tune the laser to the wavelength of the analyte 
and protects the analyte from the laser energy, thereby minimising 
fragmentation. 
 
 Solubility in the solvent compatible with the analyte. 
- For enhanced analyte incorporation into the matrix crystals 
 
 Vacuum stability 
- To ensure the matrix does not sublime in the high pressure of the 
MALDI source 
 
 The ability to promote ionisation by acting as a proton donor and receptor. 
 
In recent years matrices have been grouped or categorised depending on the 
compounds/molecules they ionise. Table 1 lists the common MALDI matrices, their 
structure and applications.  
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Compound Structure Applications 
α-cyano-4-hydroxycinnamic 
acid (αCHCA) 
O
OHHO
NC
 
Peptides [4, 5] 
Oligonucleotides [6] 
Pharmaceuticals [7-9] 
Lipids [10] 
2,5-dihydroxy benzoic acid 
(DHB) 
OH
HO
O
OH
 
Peptides [11] 
Lipids [12-14] 
Carbohydrates [15-
17] 
Oligonucleotides [18, 
19] 
3,5-dimethoxy-4-
hydroxycinnamic acid 
(sinapinic acid, SA) 
H3CO
O
OHHO
H3CO
 
Proteins [20-22] 
Peptides [23] 
Picolinic acid (PA) 
N
O
OH 
Oligonucleotides [24] 
3-hydroxy-picolinic acid (3-
HPA) 
N
O
OH
OH
 
Oligonucleotides [18, 
25-27] 
2,4,5-
trihydroxyacetophonone 
(THAP) 
OH
OHHO
O
 
Oligonucleotides [28-
30] 
Lipids [31, 32] 
Carbohydrates [15, 
17, 33] 
 
Table 1.  Common MALDI matrices, their structure and applications. 
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There are a number of sample preparation methods that have been published since the 
original dried droplet method[1]; this is largely due to the poor spot-to-spot reproducibility 
associated with this method. As the solvent evaporates from the sample spot the 
formation of analyte-doped matrix crystals is inhomogeneous, resulting in crystals of 
varying shapes and sizes, that may either contain high concentrations of analyte 
molecules, or low to no analyte molecules. These effects also influence the quality of the 
mass spectra acquired, regarding mass resolution and signal intensity[34]. Techniques 
presented to improve crystal homogeneity and thus reproducibility include; the two-layer 
method[35], crushed crystal method[36], seeding method[37], fast evaporation 
method[38], electrospray deposition of the mixed matrix:analyte solution [39] and 
sublimation of the dried matrix material[40]. In the two-layer method the matrix is first 
deposited onto the target plate and allowed to crystallise, this is then followed by 
deposition of the sample onto the target plate[35]. The crushed crystal method involves 
crushing of formed matrix crystals to use as a ‘template’ for further matrix:analyte crystal 
growth[36]. The seeding method is similar to the two-layer method, a low concentration of 
matrix solution is first deposited onto the target and allowed to dry, a higher concentration 
of matrix solution mixed 1:1 (v/v) with the analyte is then applied on top of the first spot in 
the same manner as the dried droplet method[37]. The fast evaporation technique is 
again similar to the two-step method, with this method a high concentration of matrix is 
deposited onto the target plated in a highly volatile organic solvent, the rapid spread and 
evaporation of the solvent results in smaller crystals, the analyte solution is then applied 
after the matrix crystals have formed[38]. A pre-mixed solution of matrix:analyte is 
sprayed over the target surface for electrospray deposition, resulting in a thin layer of 
matrix:analyte crystals[39]. For sublimation the analyte is first applied to the target plate, 
followed by sublimation of the matrix solid[40]. All of the aforementioned methods have 
been shown to increase crystal homogeneity and reproducibility, or enhance detection 
sensitivity and spectral quality compared to the dried droplet method. 
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Sample preparation concerning matrix:analyte deposition onto the target plate is just one 
factor that can affect both the reproducibility and the quality of the mass spectrum 
acquired. The solvent composition of the matrix and sample (if different) solution can also 
greatly affect reproducibility and spectral quality; this is discussed further in chapter 5. 
 
1.1.3. Lasers 
 
MALDI-MS has successfully employed a variety of UV and IR lasers. These are shown in 
table 2.  The energy deposition between the two wavelengths differs, with UV-MALDI; the 
matrix compound absorbs the lasers energy, whereas energy deposition in IR-MALDI 
occurs through excitation of the functional groups of the matrices. UV-MALDI is the most 
widely used of the two techniques; however, IR-MALDI does offer some advantages. 
Metastable fragmentation has been shown to be much lower in IR-MALDI compared to 
UV, thus would be a better choice for the analysis of very labile biomolecules. Spectral 
reproducibility is also superior in IR-MALDI compared to UV-MALDI this is mainly due to 
the type of matrices used for each. IR-MALDI utilises liquid matrices whereas UV-MALDI 
uses matrix:analyte co-crystals which can have a high degree of heterogeneity, however, 
liquid matrices have also been used in UV-MALDI analysis[41].  
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Ultraviolet Lasers (UV) Frequency quadrupled Nd:YAG, 266 nm [1] 
Nitrogen (N2), 337 nm [42, 43] 
Frequency tripled Nd:YAG, 355 nm [42-44] 
Nd:YVO4, 355 nm [45] 
Infrared Lasers (IR) Er:YSGG, 2.79 µm [46] 
Er:YAG, 2.94 µm [47] 
CO2, 10 µm [46] 
Wavelength-tuneable free-electron laser (FEL) [48] 
 
Table 2. Lasers employed for both UV and IR MALDI. 
 
Original MALDI experiments were carried out using quadrupled Nd:YAG lasers 
(266nm)[1]. These were soon replaced with the less expensive and smaller nitrogen 
lasers, which until relatively recently, were the most widely used and published. The 
introduction of solid state lasers, particularly the diode-pumped frequency-tripled Nd:YAG 
laser (355nm) offered an alternative to the nitrogen laser[44]. Nd:YAG lasers have two 
major advantages, they offer high-throughput or more sensitive analysis in MALDI 
imaging studies, due to achievable repetition rates of 1000 Hz, compared to the nitrogen 
laser which is limited to 50 Hz. The Nd:YAG laser also offers a longer life span compared 
to the nitrogen laser. The nitrogen laser has been shown to ionise certain 
molecules/sample preparation procedures more efficiently than the Nd:YAG laser. Holle 
et al. 2006 has published a good paper comparing the UV-lasers to date.  
Laser fluence, beam or spot diameter, and the type and length of the optical fibres used 
have all been shown to greatly influence ion signals in MALDI-MS investigations[43, 49-
51]. 
 
 
8 
 
1.1.4 Desorption/Ionisation 
 
The desorption/ionisation process in MALDI is incredibly complex and involves a 
magnitude of physical and chemical events, these processes have been the focus of 
many research groups[49, 50, 52-73]. To fully outline or discuss all the theoretical, 
molecular dynamic and experimental models presented to date, is out of the scope of this 
thesis, thus the main/key points for desorption/ionisation will be presented only.  
 
1.1.4.1 Desorption 
 
Upon irradiation by the laser, the phase transition of the bulk matrix-analyte material from 
solid to gas is rapid, the resulting MALDI plume expands out taking many microseconds 
to expand to a collision-free environment, if it does at all[54, 67]. The two main models for 
desorption are the thermal spike and the pressure pulse models, which have been 
discussed in an excellent review by Dreisewerd (2003)[49]. Desorption is affected by a 
number of sample parameters, matrix absorption, sample surface characteristics, and 
most importantly, laser fluence[49]. The laser fluence defines whether desorption occurs, 
or ablation of the bulk matrix:analyte material[73]. Desorption in the form of 
evaporation/sublimation, resulting in individual gas particles, is observed at low laser 
fluence. At low laser fluence phase transition is observed as a smooth evaporation of the 
bulk material from the surface. This process, according to literature, rarely happens in 
MALDI, thus desorption is not really a suitable word to describe this part of the 
technique[49, 67].  At higher laser fluencies, ablation of the bulk material from the surface 
occurs, causing what is known as ‘phase explosion’, this results in the ejection of gas 
particles and clusters from the upper layers of the matrix-analyte crystals. This reportedly 
is a more common occurrence during the MALDI processes, thus ablation is more 
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suitable to describe this part of the MALDI process[49, 54, 58, 67]. The laser fluence also 
impacts the velocity of the expanding plume, as demonstrated by Knochenmuss and 
Zhigilei (2009)[62]. 
 
1.1.4.2 Ionisation 
 
Much research has focused on the specific mechanisms of the MALDI ionisation process, 
whilst numerous theories and models have been put forward, there are now two generally 
agreed and accepted models, the Two-Step model[60] and the Lucky Survivor model[71]. 
The two stages of the Two-Step model involve primary matrix ionisation, and secondary 
analyte ionisation. Secondary ionisation mechanisms have been widely accepted for 
some time as they are believed to follow basic condensed phase ‘plume’ kinetic and 
thermodynamic rules[60, 64, 72]. Primary ionisation is still an area of much discussion, 
the theory of the Lucky Survivor model developed from the idea of pre-formed analyte 
ions, this was a method originally presented to describe primary ionisation. The model of 
primary ionisation that has attracted the most interest and has increasingly become 
accepted is the two-photon energy ‘pooling’ model. Only these models will be discussed. 
 
 
1.1.4.2.1 Primary Ionisation-The Energy Pooling Model 
 
Many models/theories have been put forward to explain the mechanisms of primary 
ionisation; they have been discussed in an excellent review by Knochenmass[60], and will 
not be discussed here. The two-photon energy pooling model, is also known as the gas 
phase protonation model[58, 60-62, 65, 67]. The theory for this method is based on 
energy pooling between excited neighbouring matrix molecules within the solid state 
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crystals, this energy pooling is essential for the following reason. Typical MALDI lasers 
are operated at 337 and 355 nm for the N2 and Nd:YAG lasers respectively, with laser 
photon energies of 3.6 eV for nitrogen and 3.3 eV for Nd:YAG[72]. These energies are 
lower than those required for the resonant two photon absorption of many MALDI 
matrices[72]. For photoionisation of matrix molecules to occur, 2-3 photons are 
necessary, thus interaction of the electronic states of two excited neighbouring molecules, 
the energy ‘pooling’ process, enables this.  These excitations are not said to be fixed, they 
can ‘wander’ or ‘hop’ around, thus at typical laser fluencies, these excitations frequently 
collide and are ionised[60, 67]. It has also been postulated that matrix ionisation potentials 
(IPs) may also be lower in the solid phase of the crystals and/or thermal energy impact 
may contribute to the gas phase protonation model[67]. This model can demonstrate 
many of the features observed experimentally for MALDI-MS. One such feature is the 
matrix suppression and analyte suppression effects, the depletion of the primarily formed 
matrix ions by analyte ions, when present at high concentrations results in the presence 
of incredibly low or no  matrix ions in the mass spectrum[60, 63, 67]. The opposite is seen 
for analyte suppression effects. 
 
 
1.1.4.2.2 Secondary Ionisation 
 
Secondary ionisation occurs in the expanding plume, the three key reactions for the 
production of analyte ions have been reported as[60, 72]: 
 
Proton transfer:  
‐ Positive ion mode – mH+ + A ----> m + AH+ 
‐ Negative ion mode – (m-H)- + A ----> m + (A-H)- 
11 
 
Cation transfer: 
‐ Positive ion mode – mNa+ + A ----> m + ANa+ 
Electron transfer: 
‐ Positive ion mode – m+ + A ----> m + A+ 
‐ Negative ion mode – m- + A ----> m + A- 
 
 
1.1.4.2.3 The Lucky Survivor Model 
 
The ‘lucky survivor’ model is based on the theory of ejected clusters of preformed analyte 
ions from the solid state[55, 56, 71, 74]. Evidence for this was presented by Kruger et al. 
(2001), who observed pH indicator molecules retaining their colour, and thus charge 
state, within acidic, neutral and basic matrix crystals[69]. These results indicate proteins 
and other analyte molecules may also retain their charge state upon co-crystallisation.  
This model assumes, for instance, that peptides carrying multiple positive charge sites, 
are incorporated in a partially solvated form, and kept separate from their counterions, 
which would include matrix anions.  Once in the expanding plume of clusters, these 
peptides are then believed to undergo neutralisation of all charges except the excess 
charge (only remaining) by proton transfer with counterions such as matrix/solvent 
molecules[55, 56, 69]. Hence the term ‘lucky survivors’, these singly charges species are 
thought to be the surviving molecules of neutralisation processes [74]. This model can 
explain the presence of only/mainly singly formed ions in MALDI mass spectra, in addition 
to this, this model can be applied to both IR and UV MALDI[56, 74].  
 
A recent research article published by Jaskolla and Karas (2011)[74] provided evidence, 
for the first time, that verifies both ionisation models. The extent or ratio of which model 
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was predominant depended on a number of experimental factors, and analyte and matrix 
characteristics, including; laser fluence, matrix and analyte proton affinity, analyte 
composition and size, and the protonated-to-neutral analyte ratio embedded in the matrix 
crystal. 
It would be naive to believe that for such a multitude of complex reactions, that these two 
models are solely responsible for ionisation in MALDI, but to date they are the best 
described and most experimentally researched models.  
 
 
1.1.5 Mass Analysers 
 
Mass analysers are used to separate and detect pre-formed ions according to their mass-
to-charge (m/z) ratio. Generally speaking they fall into two distinct categories: 1) scanning 
or sector instruments that continuously analyse, include quadrupole and magnetic sector 
instruments, and 2) pulsed instruments which include time-of-flight, ion cyclotron 
resonance and ion trap analysers.  Scanning instruments only allow for the separation 
and detection of one m/z value at a time, whereas pulsed instruments allow for the 
simultaneous measurement of pulsed ion packets, giving the m/z values of all ions 
transmitted[75-80]. 
MALDI was traditionally used as an ion source for time-of-flight (TOF) mass analysers. 
This was largely due to the nature of the ion source, producing pulsed ion packets which 
were suitably measured and analysed using a TOF analyser[77].  
 
There has been a constant drive within the mass spectrometry community to produce 
instruments with greater resolving power, sensitivity and tandem MS capabilities 
(MS/MS)[81-84]. Mass resolution is seen as the dimensionless ratio of the mass peak 
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divided by its width, and is taken as the full width at half maximum intensity (FWHM). 
Tandem MS (MS/MS) instruments (two or more mass spectrometers placed together) 
have been developed to allow for structural information and identification of molecules of 
interest.   
 
Work herein is carried out on a hybrid quadruple time-of-flight (QqTOF) mass 
spectrometer; therefore this will be discussed in detail. A QqTOF instrument combines the 
high accuracy and sensitivity of a TOF reflectron analyser, with the stability of the triple 
quadrupole mass analyser, and its ability to select a particular ion of interest for tandem 
analysis[85]. In order to fully understand the mechanisms of the QqTOF instrument, it will 
be necessary to first look at them individually.  
 
 
1.1.5.1 Quadrupole Mass Analysers 
 
First described by Paul and Steinwegen in 1953, quadrupole mass analysers consist of 
four cylindrical rods used to separate ions according to their trajectories in oscillating 
electric fields[86]. The mass analyser electrodes or rods must have exactly hyperbolic 
profiles to achieve maximum transmission and resolution of the oscillating ions about the 
positional axis[87]. Ions are transmitted according to these oscillations and depend 
entirely upon the radio frequency (r.f.) and direct current (d.c.) voltages that are applied to 
the electrodes. The electrodes of the analyser are connected in opposing pairs, with a 
differing r.f voltage being applied to each pair, combined with a superimposed d.c voltage.  
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The application of the potentials to the rods is as follows: 
 
Equation 1.  Φ0 = +(U – V cosωt) and –(U – V cosωt) 
 
Where Φ0 represents the potential applied to the rods, ω is the angular frequency (in rad 
s-1) = 2πν, ν is the frequency of r.f. field, U is the d.c. potential, and V is the ‘zero to peak’ 
amplitude of the r.f. voltage[88, 89].  
 
Variation of the electrical parameters for a specific ion of interest allows its trajectory 
through to the mass detector. All the other ions with a different m/z value to the selected 
ion/ion of interest are deflected by the electrical field and collide with the electrodes, which 
in turn neutralises them [86-88]. Hence they follow an unstable trajectory and are never 
detected. This means that only one m/z value can be transmitted to the detector at a time, 
thus quadrupole analysers are often termed mass filters. 
 
Under constant operating conditions ion trajectories in a quadrupole mass analyser are 
determined by the Mathieu equation: 
 
Equation 2. a = 8eU/mω2ro2 q = 4eV/ mω2ro2 
 
In which e is the charge of an electron, m is the m/z ratio of the ion, Vcos(ωt) is the 
applied r.f. voltage between the opposite rods, U is the d.c. voltage, and ro is the radius of 
the quadrupole field, which remains constant for a given instrument[90].  
Quadrupole mass analysers offer the advantage of fast scanning times along with high 
ion transmission efficiency. However, they are limited to unit mass resolution, are unable 
to carry out a full-scan across a wide mass range and have an upper mass limit of m/z 
4000. 
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Figure 1.2.  Illustration of a quadrupole mass analyser showing the source, focusing 
lenses, quadrupole rods and the detector. Transmitted ions oscillate in the resulting 
quadrupolar field, ions with an unstable trajectory (nonresonant) are filtered out. Figure 
taken from www.huygensgcms.gsfc.nasa.gov (accessed July 2011). 
 
 
1.1.5.2 Time-of-Flight Mass Analysers 
 
TOF mass spectrometry was first proposed by nuclear physicist William E. Stephens in 
1946. In the 1950s that the instrument was adapted for use in biomolecular analysis and 
was commercially produced[91, 92]. Time-of-flight mass analysers are probably the 
simplest analysers in design; they separate ions in time as they travel down a field-free 
flight tube. Short ion packets are produced by a pulsed ion source, which are then 
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accelerated to a constant energy by the application of a known electric field. As all ions 
experience the same electric potential, they all have the same kinetic energy on entrance 
to the flight tube[93]. The velocity of an ion and thus the time it takes to travel the distance 
of the flight tube depends upon its m/z ratio. Equation 3 shows the acceleration of an ion 
before it leaves the source, by conversion electric potential energy into kinetic energy. 
 
Equation 3  𝐸" = $%&' = 𝑞𝑉* = 𝑧𝑒𝑉* = 𝐸-. 
 
Equation 3 shows the conversion of an ions electric potential energy Eel into kinetic energy EK. An ion with a mass m and total charge q=ze is accelerated by a potential vs. 
 
Equation 3 can be rearranged to give the velocity (v) of the ion leaving the source; this is 
shown in equation 4. 
 
Equation 4 𝑣 = (2𝑧𝑒𝑉*/𝑚)5/' 
The ion travels to the detector at a constant velocity, the time it takes for the ion to reach 
the detector can be calculated by equation 5. 
 
Equation 5 𝑡 = 7% 
Where t = time and L is the distance the ion travels, which will be the length of the flight 
tube. 
 
The m/z of the ion can thus be calculated by: 
 
Equation 6 𝑡' = $8 9 7&'-:;< 
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As smaller masses are lighter they will traverse the field-free drift tube faster due to their 
higher velocities, with larger molecules taking longer. The velocity of a singly charged ion 
is inversely proportional to the square root of its mass-to-charge ratio[94]. 
 
TOF instruments offer the following advantages: 
 Very high sensitivity 
 Minimal ion loss due to increased transmission efficiency 
 Complete mass spectrum of all ions transmitted 
 Theoretical unlimited mass range 
 
Linear instruments are associated with poor mass resolution for the following reasons[94]: 
 Spatial width of the initial ion packed produced (spatial distribution) 
 Variation of the initial kinetic energy of the ions (kinetic energy distribution) 
 Temporal spread over which the ions are formed (time distribution) 
 
A number of instrument developments have resulted in improvements to the original TOF 
design and has solved some of these mass resolution issues. These include using an ion 
mirror as a reflectron to increase the length of the flight tube, and delayed extraction (DE) 
of the ion packets[91, 95]. 
 
Reflectron TOF analysers minimise the effects of the initial spread in kinetic energy. Ions 
are in effect decelerated, stopped and reaccelerated in a static electric field (ion mirror) 
before they reach the detector[95]. Ions with a higher kinetic energy be retarded and 
repelled compared to ions with less kinetic energy. This results in high and low energy 
ions that share the same m/z arriving at the detector at the same time, thus increasing the 
resolution of the instrument[94-96]. 
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The method of delayed extraction is based on the theory of “time lag energy focusing”, 
which was described by Wiley and Mclaren in 1955[91] to reduce the kinetic energy 
spread among ions sharing the same m/z ration[91]. A time delay is introduced between 
ion formation and ion extraction into the instrument. Ions are formed in a weak electric 
field and then extracted after a time specific delay by the application of a high voltage 
pulse[97-99].  
 
 
1.1.5.3 Quadrupole Time-of-Flight Mass Spectrometer 
 
A quadrupole time-of-flight mass spectrometer (QqTOF) is a hybrid instrument. Q refers 
to the mass resolving quadrupole, q refers to an r.f-only quadrupole or hexapole and TOF 
refers to a time of flight mass analyser as previously discussed. The instrument can be 
regarded as the replacement of Q3 in a triple quadrupole instrument with a TOF mass 
analyser, as shown in figure 1.1.5.3 [100].  
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Figure 1.3.  Representation of a QqTOF mass spectrometer. Image taken from the 
Hardware Overview for the QStar mass spectrometer supplied by Applied Biosystems.  
 
Q0 is an r.f-only quadrupole used for collisional cooling of the ions to suppress 
fragmentation, and focusing the ion into Q1[101]. The rf voltage of Q0 is a fraction of the rf 
voltage applied to Q1 to ensure optimal ion transfer through the quadrupoles. Q1 can be 
operated in the r.f-only mode for MS analysis, in this mode ions are transmitted through 
the quadrupoles and separated and detected in the TOF chamber (TOF analysis). Q1 can 
also be operated in the mass selective mode for MS/MS analysis, for this mode of 
analysis a resolving DC voltage is applied to the electrodes to select or resolve the ion of 
interest. Q2 is also an r.f-only quadrupole, but is also the collision cell of the instrument. In 
Ion Detector 
Ion Accelerator 
Q2 
Q1 
 
 Q0 
Ion Mirror 
(reflectron) TOF Chamber 
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MS/MS mode, Q1 functions as a mass selector for the ion of interest, which is then 
transmitted into the collision cell (Q2) for fragmentation. Fragmentation usually occurs 
within the first few collisions with a neutral gas, nitrogen or argon and the resultant 
fragments are transmitted into the TOF section for analysis[85]. 
 
QqTOF instruments offer the advantage of high sensitivity, mass resolution and mass 
accuracy for full scan measurements and tandem analysis modes. These are attributed to 
the features of the TOF section of the instrument. The disadvantages to this instrument 
are associated with the loss of numerous functions a QqQ mass spectrometer has. These 
include single ion monitoring and multiple reaction monitoring, the inability to perform 
neutral loss and parent ion scans. The need for a pulsed ion source also limits the duty 
cycle of the instrument and there is also a limited dynamic range not usually seen with a 
TOF instrument[100]. 
 
 
1.2 Overview of the MALDI Imaging Technique 
 
Caprioli and co-workers pioneered the MALDI mass spectrometric imaging (MALDI-MSI) 
technique in 1997, in which they demonstrated imaging of proteins in tissue[102].  
The basic MALDI technique applies, in which a matrix is required to co-crystallise with the 
anaylte/s of interest. For imaging investigations, organs/tissues of interest are sectioned 
using a cryostat, usually at a thickness between 5 and 20µm. The sectioned tissue is then 
transferred onto a MALDI stainless steel sample plate, glass slide or other solid 
substrates, and allowed to dry onto the plate prior to matrix application. Matrix deposition 
for imaging experiments is more commonly carried out using an artistic airbrush; this is 
discussed in more detail in chapter 3. Briefly, the matrix solution is deposited over the 
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target plate and tissue area in the form of a fine mist, with an aim to cover the entire 
tissue section with a homogenous coating. The sample is then ready for MALDI-MSI 
analysis. Within the ion source the sample plate moves in x and y dimensions, under a 
fixed laser.  A pre-determined data acquisition grid pattern controls the movement of the 
sample plate within these dimensions. The number of laser shots or rasters per grid co-
ordinate is set prior to the start of the experiment, with a fixed distance between each grid 
spot. The distance selected is dependent upon the diameter of the laser spot, the 
stepping distance capability of the sample plate motor and the image resolution required. 
These are generally set between 50-300 µm stepping distances, with a smaller distance 
giving higher resolution. All processes are controlled by specialised computer software. 
Individual m/z values are determined at each raster location, giving rise to a mass 
spectrum of compounds at each location. The acquired data files are then converted or 
transferred to an image processing application programme. Each laser spot or individual 
spectrum now becomes a pixel. Imaging applications allow the selection of the m/z or 
mass spectrum of the analyte/s of interest and enables visualisation of its distribution over 
the defined area of interest. Pixel intensity (given in colour in many cases) of the analyte/s 
of interest thus corresponds to ion intensity. Images can also be overlaid such that a 
protein, lipid or drug compound in a selected area of tissue can be placed over an optical 
image of that tissue, indicating its anatomical position.  The workflow from sample 
preparation to image and spectral analysis is shown in figure 1.4. 
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Figure 1.4  MALDI-MSI workflow from sample preparation to analysis. 
 
Fixed
Laser
Pre-determined data 
acquisition pattern
Data conversion and 
processing
 +TOF MS: 562.976 min from Sample 1 (13.583, 22.691, 24.409, ...
a=3.59399643374711460e-004, t0=-2.33778614031616600e+001...
Max. 645.0 counts.
660 680 700 720 740 760 780 800 820 840 860 880 900
m/z, Da
0
100
200
300
400
500
600
In
te
ns
ity
, c
ou
nt
s
798.535
772.521
799.545
782.570739.472 800.555
713.458 769.562 826.580
801.570723.501 740.472714.457 810.615 848.562
Data Reviewing
Each m/z can be 
selected and its 
distribution over the 
tissue section 
displayed
23 
 
1.2.1 Imaging and profiling of Proteins by MALDI-MS 
 
The following section reviews the key research articles, including the pioneering article, 
that where important in establishing MALDI imaging as a viable technique. 
The first application of MALDI-MSI (Caprioli, 1997) was used in the analysis of tissue via 
direct and indirect methods[102]. For the indirect methods the tissue was blotted onto 
specially prepared carbon coated membranes or with C18 coated resin beads. All imaging 
experiments were carried out on a MALDI-TOF-MS instrument, equipped with delayed 
extraction (DE) and nitrogen laser (337mn). The group successfully imaged and localised 
insulin in a section of rat pancreatic tissue, mapped hormone peptides from rat pituitary 
tissue and a small protein bound on the surface of human endothelial cells. By comparing 
the results of different matrix application methods, the group also found that optimum 
results were achieve by electrospraying the matrix onto the tissue. This prevented analyte 
migration (to an extent) thus allowing the compounds investigated to be mapped to 
specific locations within the tissue sections analysed. However, care must be taken when 
interpreting these results as two completely different matrices and solvent systems were 
used for each method. Therefore it is not known whether the method of matrix deposition 
or the matrix of choice was responsible for the results achieved by electrospray 
deposition. The pioneering authors also commented on the need for 
methods/instrumentation and software to improve the spatial resolution of the images 
achieved in this first paper.  
Stoeckli and co-workers (2001) used MALDI-TOF-MS to investigate human brain tumour 
xenograph sections[103]. The group distinguished subgroups of gliomas from each other 
as well as distinguishing between two tumours that shared the same histological features 
but had different origins. The results lack a histological stained section for comparison, 
making it difficult to visualise the distribution of these proteins within the tumour and non 
tumour sections/tissue areas. 
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Stoeckli and co-workers (2002) used MALDI-MSI to investigate brain sections from 
transgenic mice models of Alzheimer’s disease[104]. This investigation was carried out on 
a DE MALDI-TOF instrument equipped with an Nd:YAG laser. The group successfully 
imaged and localised plaques that contained increasing concentrations of amyloid β (Aβ) 
peptides, as well as differentiating between the different Aβ isoforms present. These 
peptides are central to the pathogenesis of Alzheimer’s disease. The acquired images 
from this investigation strongly correlated with immunohistochemical (IHC) results 
obtained on a section of the same brain tissue. Although the group demonstrated the 
specificity of MALDI-MSI in terms of imaging peptides and being able to do this 
simultaneously in a single imaging run, the spatial resolution of the images obtained here 
are poor. This is mainly due to the choice of method for matrix application. As stated by 
the authors, the slow crystal drying process that accompanies this method resulted in 
crystal sizes of up to 200 µm in some cases. This would drastically affect the achievable 
resolution as this is affected by laser diameter and matrix crystal size. Despite the laser 
irradiation being set at 100 µm increments, a crystal size above this, as is occurring here 
would inhibit the ability of the resolution to reach that level. There was also crystal 
migration during the matrix drying process which would cause analyte migration, thus 
affecting the specificity with respect to mapping analyte distribution within tissue. 
 
 
1.3 Lipidomics 
 
The term ‘lipidomics’ began appearing in literature in 2003 and is seen as a subsection of 
metabolomics[105]. Lipidomics, much like genomics and proteomics, is said to be the 
systems-biology analysis of lipids and their interacting moieties[106]. The study of lipids 
has seen a rapid increase in interest over recent years. This is owed in part to the 
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understanding of their involvement in physiological and pathological processes, and in 
part to the development of analytical tools and instrumentation that enable rapid high-
throughput analysis. The development of soft ionisation techniques, MALDI and ESI has 
greatly contributed to the vast amount of knowledge we now have on these 
molecules[107-119]. Prior to ESI and MALDI, techniques included, fluorescence-based 
assays, anti-PL antibodies, TLC, HPLC, NMR and GC/MS, whilst these techniques are 
useful they are non-specific and/or extremely time consuming, due to the extensive 
separation process which was often necessary before analysis[120-124]. 
 
Every living cell, be it eukaryotic or prokaryotic, is enclosed by a protective plasma 
membrane containing phospholipids, proteins, carbohydrates and cholesterol. The main 
constituents of plasma membranes are phospholipids (PLs), also called 
glycerophospholipids (GPLs). 
Bacteria, in addition to having a plasma membrane, also have protective outer cell wall 
containing a number of unique lipids, including highly complex methyl-branched, and/or 
cyclopropane containing fatty acids[125-128]. The cell wall lipids in bacteria have been 
shown to be involved in virulence and resistance to antibiotics by providing incredibly low 
fluidity[125-129]. Of particular interest are cell wall lipids from the genus Mycobacterium, 
for two reasons, firstly the species from this genus comprise the Mycobacterium 
tuberculosis complex, and secondly, these cell wall lipids are highly unique to the 
Mycobacterium genus, they are not observed in any other bacterium, and contribute 
greatly to the virulence and intracellular survival of the slow-growing pathogenic 
Mycobacterium[127, 130-139]. 
This thesis is separated into two parts, the first three experimental chapters describe 
routes to optimised sample preparation for MALDI-MS of PLs, the final two experimental 
chapters describe efforts made to analyse slow-growing pathogenic mycobacterial cell 
wall lipids from complex solutions.  
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1.4 Glycerophospholipids 
 
Glycerophospholipids are amphiphilic in nature and contain a polar head group attached 
to non-polar acyl chains. The polar head group, which defines the subgroup or class of 
the lipid, contains a phosphate group esterified to the sn-3 of a glycerol backbone[116]. 
The main head group classes are phosphatidylcholine, phosphatidylethanolamines, 
phosphatidylserines, phosphatidylinositols, and phosphatidylglycerol[140]. The glycerol 
backbone is acylated or alkylated with long-chain fatty acids (FAs), typically 14-24 
carbons in length at the sn-1 and sn-2 positions[141]. The sn-1 position of the glycerol 
backbone usually has a saturated or monounsaturated FA esterified, whereas 
polyunsaturated FAs (PUFAs), typically 2-6 double bonds, are usually located at the sn-2 
position[141]. The structural diversity that exists due to the different combinations of fatty 
acids with the different head groups gives rise to hundreds of different molecule species. 
The different structures of GPL head groups are presented in figure 1.5 
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Figure 1.5.  Structures of the different classes of Glycerophospholipids according to their 
polar head group, drawn in green, with the glycerol backbone in blue, R1 and R2 
represent acyl chains. 
 
A comprehensive classification system for lipids was published in 2005 by Fahy et al to 
establish a universal nomenclature for lipids[142]. From this glycerophospholipids are 
recognised by their polar head group and type and location of their fatty acid residues. For 
instance, a choline containing head group will be termed a glycerophosphocholine, or 
simply phosphatidylcholine, if sn-1 and sn-2 contained palmitic acid (hexadecanoic acid) 
and arachidonic acid (5Z,8Z,11Z,14Z-eicosatetraenoic acid) respectively, would have a 
systemic name of 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-
phosphocholine, commonly called PC(16:0/20:4(5Z,8Z,11Z,14Z)), which can then be 
further abbreviated to PC 36:4.  The structure of this lipid is presented in figure 1.6, GPLs 
should always be drawn with the head group on the right[142]. 
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Figure 1.6. Structure of 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
3-phosphocholine, commonly known as PC 36:4. 
 
GLPs are abundant in cellular systems and the main constituents of cellular membranes. 
The fluid mosaic model for cell membranes was proposed in 1972 by Singer and 
Nicholson, in which the phospholipids are distributed on either side of the membrane in an 
asymmetrical manner, organised as a bilayer[143]. GLPs were previously thought to 
serve merely as membrane barriers and reservoirs for biological energy. It is now known 
that they are involved in numerous physiological processes, including membrane 
trafficking and cell signalling[141]. PUFAs are hydrolysed from membrane GPLs and are 
further metabolised into numerous biologically active molecules[108]. Figure 1.7 depicts 
the fluid mosaic model of cell membranes, with a simplified overview of lipid involvement 
in physiological processes. 
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Figure 1.7 Schematic representation of the fluid mosaic model of cell membranes, 
adapted from[143], addition information collected from[108, 144-146]. 
 
With the involvement of lipids in numerous physiological processes it is unsurprising that 
lipid distribution has also been shown to be altered in a number of pathological conditions. 
These include, diabetes, Alzheimer’s, cancer, heart disease, and numerous metabolic 
diseases, and the list is still growing [108, 144-154]. It is yet to be understood as to 
whether these changes occur prior to, or are the cause of, initial disease states. 
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1.4.1 Analysis of Glycerophospholipids by MALDI-MSI 
 
Sample preparation and Instrument Evaluation 
 
One of the first lipid imaging papers was by Garrett and co-workers (2007)[155], who 
analysed phospholipids in 10 µm rat brain sections to assess the feasibility of a number of 
MALDI parameters, and a new intermediate-pressure MALDI linear ion-trap mass 
spectrometer (MALDI LTQ-MS). High resolution images were produced of PC (18:0, 18:1) 
m/z 810, [M+Na]+, on both conductive and non-conductive microscope slides, and PC 
36:4, m/z 804, [M+Na]+ and PC 38:6,  m/z 828, [M+Na]+. An important feature of this 
article is the ability to show and separate isobaric species by tandem MS analysis. This is 
shown in by the images presented, which showed the differential distribution of product 
ions recorded from the fragmentation of the ion at m/z 828. Three different spatial 
distributions were produced, meaning three different species were fragmented at m/z 828, 
if only one species was present the same image, would be present for all product ions 
produced. The ability to perform MS3 enabled structural identification of the lipids. Lipid 
species were identified as PC (16:0, 22:6) [M+Na]+, PE (18:0, 20:4) [M-H+Na+K]+ and PS 
(16:0, 18:1) showing the benefit of this instrument platform for PL analysis. 
 
The use of MALDI-Ion-mobility time-of-flight mass spectrometry (IM-TOF-MS) in imaging 
investigations of PLs from rat brain sections was presented for the first time by Jackson et 
al. (2007)[156]. This instrument separated ions according to their mobility, based on gas-
phase density of ions, prior to TOF analysis. Images illustrating the distribution of m/z 
798.6, assigned (PC 34:1 + K), m/z 826.6 assigned (PC 36:1 + K), and m/z 844.6, 
assigned (PC 38:6 +K) were presented, demonstrating the differential distribution of lipids 
in grey and white matter regions of the brain.  
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In 2008 Shimma and co workers used PLs as a way of assessing another new instrument 
platform, a MALDI quadrupole-ion-trap time-of-flight (QIT-TOF) instrument[157]. Images 
of two PCs at m/z 798.5 and 826.7 were recorded in positive ion mode and two species at 
m/z 885.5 and 904.7 in negative ion mode. The MS3 spectra for the positive ion mode 
species allowed for the identification of phosphocholine head group fragments, alkali-
metal adducts and proper structural identification of the fatty acid chains. PC 16:0/18:1 
and PC 18:0/18:1 was structurally identified for m/z 798 and 826 respectively; the former 
displayed an omnipresent distribution in the brain, and the latter showed higher intensity 
within white matter regions. Upon fragmentation the ions recorded in negative mode at 
m/z 885 and 904 were found to be PI 18:0/20:4 and ST d18:1/24h:1 respectively. The 
image at m/z 904 showed clear anatomical specificity for white matter regions, whereas 
the ion at m/z 885 displayed an omnipresent distribution. Images presented are of rather 
poor quality, as the authors commented on the whole area scanned and not the resolution 
it is unknown whether the image quality is due to intentionally low resolution images being 
acquired.  
Prior to these investigations the majority of MALDI imaging studies were carried out using 
MALDI-TOF, MALDI-TOF/TOF and MALDI QqTOF mass spectrometers[7, 158-163]. 
 
MALDI-LTQ-MSI of a specific phospholipid was used to assess a new matrix deposition 
method[164]. PC 36:1 at m/z 810, representing [M+Na]+, was used to compare a new 
automated inkjet printer to the commonly used airbrush and electrospray deposition 
methods. Three images of this PC were presented, one for each method for comparison 
of image resolution afforded by all, images representing inkjet and airbrush deposition 
demonstrated a higher intensity of this lipid within the white matter regions of the brain. 
Electrospray deposition resulted in images of poor resolution; the inkjet printer deposition 
resulted in higher quality images, and increased reproducibility. 
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A MALDI-QqTOF-MS study showing PC images was published by Murphy et al. (2007), 
with the aim of assessing a new method of matrix deposition. This time the method was 
sublimation, and comparisons were made to electrospray deposition. Species detected 
included PC 32:0, at m/z 734, PC 34:1 at m/z 760, both representing the protonated 
molecule, PC 34:1 at m/z 798 for the sodium adduct, and PC 36:1, m/z 826, representing 
the potassium adduct. The images presented displayed the potassium adduct of PC 36:1 
at m/z 826, slightly outlining grey matter features such as the corpus callosum.  
 
Another imaging study using phospholipid distribution in brain as a way of assessing 
matrix deposition methods rapidly followed the former paper[165]. This was carried out by 
Wang and co-workers (2008) who compared the use of a TLC reagent sprayer, collision 
nebuliser and an artistic airbrush for matrix deposition followed by MALDI-TOF-MS 
analysis. Images of phosphatidylinositols and sulfatides were acquired in negative ion 
reflectron mode, while phosphatidylcholines were acquired in positive ion, reflectron 
mode. The group identified a total of 11 lipid species in negative ion mode and 6 in 
positive. Positive ion mode images were of PC 32:0, m/z 772, [M + K]+ PC 36:1, m/z 826, 
[M + K]+ and PC 34:1, m/z 760, [M + H]+ showed a grey, white and omnipresent 
distribution respectively. Negative ion mode images of PI 38:4, followed the grey matter 
contours of the brain such as the cerebral cortex and the hippocampus, whereas ST 24:1 
and ST 24:1 (OH) followed white matter regions of the brain, such as the corpus 
callosum. Airbrush deposition was found to generate at more homogenous matrix 
distribution with enhanced analyte extraction and co-crystallisation compared to the other 
two methods evaluated. 
 
Phospholipids were imaged directly from 12 µm sagittal mouse brain sections for the 
assessment of a newly developed dry matrix application protocol using MALDI-TOF/TOF-
MS[166]. DHB was finely ground and deposited onto the tissue section through a 20 µm 
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stainless steel sieve; results were compared to those obtained using a thin layer 
chromatography (TLC) reagent spray gun for matrix application. Phospholipid patterns in 
mouse brain cerebellum were determined by overlaying the extracted lipid images onto an 
adjacent haematoxylin and eosin stained optical image. The overlaid image showed the 
localization of m/z 872, PC 40:6, in the cerebellar cortex, m/z 826, PC 36:1 and m/z 810, 
PC 38:4 in the cerebellar nucleus and m/z 844, PC 38:6 in the granule cell layer.  
 
The use of alkali metal salts in mass spectrometric analysis has been proven to aid in 
either the reduction of complexity of the mass spectra for lipid analysis or in the case of 
lithium, in enabling enhanced PL fragmentation for identification by MS/MS[112, 167]. 
Alkali metal salts were first shown to be of use in the analysis of polymers by MALDI-
MS[168, 169], eventually leading to MALDI profiling and imaging investigations[165, 170]. 
In 2009 Sugiura et al. published an investigation into the use of alkali metal additives in 
matrix solutions, to enable the selective ionisation of GLPs directly from tissue, using 
MALDI TOF/TOF mass spectrometry[171]. Mass spectra of lipid species acquired directly 
from tissue are complex due to the presence of multiple adducts ([M+H]+, [M+Na]+ and 
[M+K]+), leading to overlapping m/z values for several lipid species. The group showed 
that the addition of 10 mM of potassium acetate simplified the resulting mass spectra by 
shifting the ionised PCs to a single ion, the [M+K]+ ion. They also showed the addition of 
sodium acetate did not have the same effect as multiple adducts were still present. The 
authors concluded that K+ formed stronger adducts than Na+, however this may not be the 
case. There are high concentrations of sodium and potassium already present in organ 
systems, which is why these adducts are often observed when analysing PLs directly 
from tissue sections. Therefore the results seen may be due to a higher concentration of 
potassium already being present in the tissue analysed, meaning a higher concentration 
of K+ is readily available. Images of PC 32:0, m/z 772, PC 34:2, m/z 796, PC 34:1, m/z 
798, PC 36:4, m/z 820, PC 38:6, m/z 844, and PC 38:4, m/z 848, all representing [M+K]+ 
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were presented, displaying differential distributions across the cortex, medulla and pelvis 
renalis regions of a kidney section. CID experiments were conducted out using lithium 
additives to enable structural identification. The group then went on to analyse the 
distribution of PUFA containing PLs during growth; this part of the research paper is 
discussed in the physiological studies presented below. 
 
Shanta et al. (2011) have recently reported the combination of DHB and CHCA as a 
binary matrix for enhanced analysis and imaging of lipids by MALDI TOF/TOF-MS, with 
the addition of both TFA and piperidine (an acid and a base) they gave the matrix ionic 
properties[172]. Combining equal amounts of DHB and CHCA, 1:4 ratio of TFA:PIP the 
group carried out both positive and negative ion made MSI studies on the same 12 um 
section of rat brain, resulting in the detection of over 100 peaks relating to lipid species, 
including PC, SM, PA, PE, PI and ST. Multiple ion forms of the same lipid species are 
detected during MSI analysis, thus this number is by no means the total number of 
individual species detected. The binary matrix proved more sensitive when comparing to 
DHB or CHCA used alone. For the 3 commonly detected lipid species in positive ion 
mode, m/z 798, [PC 34:1+K]+,  m/z 734, [PC 32:0+H]+,  m/z 772, [PC 32:0+K]+, and m/z 
826, [PC 36:1+K]+, the binary matrix showed a three-fold increase in signal intensity 
compared to the individual matrices. For analysis in negative ion mode the binary matrix 
detected more peaks and showed increased intensities for ions at m/z 784, 806, 878, 906 
and 920, which were identified as PS 36:3, ST 18:0, ST OH-20:0, ST OH-40:1, ST OH-
42:1 and ST 44:0 respectively. The differential distribution of numerous lipid species 
across the brain were presented after principal component analysis (PCA) had been 
carried out. 
 
A study by Cerruti and co-workers (2011) evaluated five different lithium salts, citrate, 
acetate, trifluoroacetate, iodide and chloride,  for their suitability for MSI analysis, with 
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respect to crystal formation, detection sensitivity of lithium adducts and image quality[10]. 
Results were compared to one another and CHCA without additive. Lithium acetate 
produced large elongated crystals that although was the most sensitive, in terms of 
yielding the highest proportions of lithium lipid adducts, produced images of extremely 
poor quality, thus was deemed unsuitable for MSI. Lithium citrate was also unsuitable for 
MALDI-MSI as crystals produced with this additive were that of large irregular plaques, 
that required increased laser fluencies for obtaining only weak signals. Lithium chloride, 
iodide and trifluoroacetate all produced crystals of small size with good homogeneity over 
the tissue, however, lithium chloride adducts did not exceed 65 % of the ions formed. 
Lithium trifluoroacetate was shown to give a three-fold increase in sensitivity compared to 
lithium iodide. Lithium trifluoroacetate was also shown to give a two-fold increase in 
sensitivity of PC 32:0 and PC 34:1 compared to αCHCA alone, these lipids were chosen 
because they are commonly observed in MALDI-MS and display different distributions in 
the cerebellum. Images presented using αCHCA as the matrix solution were of m/z 734, 
[PC 32:0+H]+, m/z 760, [PC 34:1+H]+, m/z 731, [SM 18:0+H]+, displaying grey matter 
distributions, whereas m/z 806, [PE 38:4+K]+ or [PC 38:6+H]+, m/z 812,  [PC 38:3+H]+, 
[PE 38:1+K]+, or [PE 38:4+2Na-H]+, m/z 816.6, [PE 42:8+H]+, and m/z 834, [PE 
38:1+Na+K–H]+, displayed white matter distributions. The same images were produced 
for lithium iodide and lithium trifluoroacetate, showing more resolved images for the latter 
two, however, it should be noted that the images presented for αCHCA without additive 
are of extremely poor quality. It is suggested in this thesis that the poor quality results 
presented by this group using αCHCA without additive, may be due to acetonitrile being 
used as the solvent system. Images presented in chapter 3 of this thesis, which used the 
same matrix compound and deposition method, but different solvent system presents high 
quality molecular images of PLs. 
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The majority of lipid MS imaging experiments, regarding sample preparation, have been 
carried out on brain tissue sections, more recently a report has been published detailing 
efforts made to analyse PLs from lung tissue. 
The sectioning of lung tissue for analysis is problematic due to its spongy nature, frozen 
non-inflated lungs result in sections with compromised morphology[173]. Histological 
preparation of lung tissue employs agarose inflation followed by FFPE or OCT-embedding 
for sectioning. These preparations are not suited to MALDI-MS and MSI investigations of 
lipids due to two factors; the processing of tissue for paraffin embedding, and then 
removal after sectioning involves grades of alcohol, in which lipids are soluble and thus 
washed away, whilst OCT contains benzalkonium salt as a preservative, which is known 
to cause ion suppression of analytes and thus spectral interference during the MALDI 
process. Berry et al. (2011) modified the OCT cryoembedding agent with a mixture of 10 
% PVA 6-98 and 8 % PPG 200 and evaluated its use in MALDI QqTOF-MSI 
investigations[173]. The results obtained from the analysis of tissue inflated with and 
embedded in the modified OCT (mOCT) were compared to FFPE and OCT-embedded 
preparations and lung lipid extracts. As expected MALDI-MSI analysis of FFPE produced 
no signals representing PLs. The analysis of agarose-inflated OCT-embedded tissue 
detected the presence of a few PL species, with images showing some definition of the 
lipid airway, however the signals for these lipids were low and thus was the image quality 
was poor. Numerous PL species were detected from mOCT-embedded tissue sections, 
including the commonly observed ions at m/z 706, 734, 760, 782 and 810. In addition to 
this, pulmonary morphology of the lung section was conserved, with far superior image 
quality, as evidenced by comparison to a stained section. MSI images revealed several 
lipids were distinctly located within specific lung regions, for instance, m/z 782, 806 and 
810 were found to be highly abundant along the edge of the putative airways, whilst m/z 
725 was found to have higher signal intensity at the edge of pulmonary blood vessels. 
Further MS/MS investigations identified these as PC (16:0/20:4), for m/z 782, PC 
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(16:0/22:5), for m/z 806 and PC (18:0/20:4), for m/z 810, the ion at m/z 725 was assigned 
SM d18:1/16:0. This is the first study demonstrating increasing amounts of PUFA 
containing PLs within specific distributions of pulmonary tissue. Little is known about the 
change in arachidonic acid (AA) and decosahaexanoic acid(DHA) containing lipids during 
lung disease and environmental toxicants; methods presented in this work provides a 
possible route to investigate such changes. 
 
 
Physiological Changes 
 
PUFAs have been proven to be involved in numerous physiological processes, and have 
high abundance in the CNS. A study by Suguira and co-workers (2009) used MALDI-QIT-
TOF MSI, with the addition of potassium acetate to the matrix system, as described 
above, to show the specific distribution of PUFA containing GPLs within distinct 
anatomical regions of the rat brain[171]. Specifically, the distribution of arachidonic acid 
(AA) and decosahexaenoic acid (DHA) containing GPLs were investigated. Principle 
component analysis was used to investigate whether there are changes observed in the 
distribution of these lipid species with increasing age. Three trends in distribution of GPLs 
were observed, all of which presented as MS images. The first scores were for spectra 
that displayed higher counts in the infant brains (1 and 12 days old) compared to the adult 
brains (7 and 96 weeks old), and a PC that showed increasing intensity in white matter 
regions of the brain with increasing age.  Specifically, PC (14:0/16:0), m/z 744 (cerebral 
cortex distribution), and PC (16:0/16:1), m/z 770 (omnipresent distribution), showed high 
intensity in the 1 day old brain, which decreased with age, showing lower intensity in the 
12 day old, followed by no or low counts observed in the 7 and 96 week old brains. 
Conversely PC (18:0/18:1), m/z 826 displays low signal intensity in the 1 day old brain, 
which increases in intensity with age, showing high abundance in the white matter regions 
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of the 7 and 96 week old brains. The second trend represented the accumulation of AA-
PCs during the formation of the hippocampus, cerebral cortex, corpus striatum and the 
granular layer of the cerebellum. The images produced of this PCA showed PC 
(16:0/24:4), m/z 820, and PC (18:0/20:4), m/z 848 were only faintly observed within the 
hippocampus in the infant brains but were clearly defined in the adult brains. The third 
and final trend reported the accumulation of DHA-PCs in the cerebellar cortex. The PCs 
attributed to this were PC (16:0/22:6), m/z 844 and PC (18:0/22:6), m/z 872, which 
increased in intensity with the developing brain. PC (18:0/22:6) was said to be contained 
in the soma and dendrites of the Purkinje cells and was detected in the 1 day old brain at 
the surface of the cerebellum, an area where immature Purkinje cells are located. Due to 
the addition of potassium into the matrix solvent system this group reported these ions as 
[M+K]+. This report highlights the importance of MALDI-MSI in spatially mapping the 
distribution of PCs containing two biologically active and important PUFAs. In addition, the 
report gives insight into how the distributions of PUFA containing PCs change with age. 
 
Kobayashi and co-workers (2010) have recently published a report imaging PLs in the 
placental villus. The group detected and imaged numerous PLs, however, the focus of the 
report was on two specific ions due to them showing distinct differential distribution within 
the tissue[174]. The ions at m/z 785.6 and 804.7 were identified as sphingomyelin 
(d18:1/16:0) and PC (16:0/20:4), both being detected as the sodium adduct [M+Na]+. SM 
(d18:1/16:0) was found to be predominantly located in the stem villi, but not in the terminal 
villi, whereas PC (16:0/20:4) showed the opposite distribution. Terminal villi are 
responsible for hormone secretion and nutrient transportation, thus the identification of the 
distribution of PLs containing AA within this region may be of importance. AA metabolism 
into eicosanoids is believed to play a key part in normal/abnormal growth, and 
vasodilation/constriction of vessels in the placental villus, thus mapping the distribution of 
these lipids may provide key insight into both physiological and pathological changes. 
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Difference in the composition of PCs between placentas from normally grown and growth-
restricted newborns have been shown, however, this is the first study mapping differential 
distribution of PCs within such tissues. 
The liver has a remarkable capacity to regenerate; Miyamura et al. (2011) used MALDI-
TOF-MS imaging to investigation the difference in lipid composition/distribution in rodents 
that had received a partial hepactomy (PH), the experimental model used to investigate 
liver regeneration[175]. MALDI-MS analysis of mice liver tissue, acquired 0, 6, 12 or 24 h 
post-operative showed differences in lipid distribution compared to sham (control) post-
operative tissue. This investigation demonstrated an increase in 6 PC species, including 
PC 34:1, PC 34:2, PC 36:0, PC 36:2, PC 36:5 and PC 38:6, along with a decrease in LPC 
16:0, PC 40:6 and PC 40:8 in the regenerating liver compared to the control. Care needs 
to be taken with the interpretation of these results, as images produced and the table 
generated, showing the differences in lipid composition, were based on m/z values 
representing either [M+H]+, [M+Na]+ or [M+K]+. The report does not take into 
consideration the sum of these ions for a given lipid species, and then compare this 
across the samples, thus results are not a true representation of PL composition, the 
differences observed may be due to different levels of salts in the samples. It should also 
be noted that there are no recognisable anatomical features in the MALDI-MS images 
presented.  
 
 
Pathological Changes 
 
In a study by Shimma and co workers (2007), images of tumour and non tumour areas of 
colon cancer liver metastases were compared[176]. Whilst numerous lipid species where 
detected, the authors constructed three images focusing on two differentially distributed 
ions; the first was of a lipid at m/z 725 showing higher accumulation within the cancerous 
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area. The second was of a lipid at m/z 616 which showed higher ion counts in the normal 
area and the third image was an overlay of the former two. The authors also stated these 
lipid species were of equal distribution in the stroma area of the biopsy sample, 
demonstrated by the overlay image of the two. Tandem MS analysis and the use of the 
database Lipid Search suggested the ion observed at m/z 725 was that of the sodium 
adduct of SM 16:0. This study demonstrates the feasibility of MALDI-MS imaging as a 
viable tool for the comparative analysis of lipid distribution between physiological and 
pathological specimens. The reader should note that this particular study appeared to 
only analyse one biopsy sample, thus reproducibility is not shown.  
 
Immunoglobin IgA is the most common glomerular disease worldwide. Kaneko et al. 
(2011), using a MALDI-QIT-TOF mass analyser,  successfully identified eight dominant 
peaks that were present in the kidneys of HIGA mice, the widely used animal model of 
this disease, but absent from controls[177].  These were reported as, m/z 792, 814 and 
830, assigned to PC O-16:0/22:6, representing the protonated molecule and the sodium 
and potassium adduct respectively. The peak at m/z 840 was assigned to PC O-
18:0/22:4, [M+Na]+, and m/z 854, 852, 880 and 882, were unidentified due to insufficient 
fragment peaks; however, the authors believed they were related structures. It must be 
noted however, that the images produced from the control samples show signal intensity 
outside the tissue area, which at times equals that found in the tissue area. In addition to 
this, the stained sections presented are either of poor quality or presented badly as 
anatomical features are unrecognisable, it is difficult to see if the section for the control 
includes the cortex, medulla and pelvic areas.  The group also analysed urine samples in 
parallel and demonstrated the lipids observed in the kidneys of HIGA mice were secreted 
in the urine of both healthy and disease models. Unilateral urethral obstruction (UUO), 
which causes artificial urinary stag, was carried out on control mice. Kidneys from these 
experiments were said to mimic the results obtained from the HIGA disease model. This 
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is not the case, the distribution of m/z 792, 814, 830, 840, 854, 856, 880, and 882 are 
mainly confined within what appears to be the medullar region of the HIGA kidneys, 
whereas the images produced of these values in the kidneys of the UUO mice show an 
omnipresent distribution, and again there is evidence of increased signal intensity outside 
of the tissue area.  
 
The investigation of PL distribution in rat models of ischemic brain injury, induced by 
middle cerebral artery occlusion (MACO), was carried out using a MALDI-QqTOF mass 
spectrometer[178].  Koizumi et al. (2010) compared images and mass spectra of the 
injured and normal hemisphere. The group focused on the differential distribution and 
signal intensities of three ions at m/z 760, identified and [PC 34:1+K]+, m/z 798 identified 
as [PC34:1+K]+ and m/z 496 identified as [LPC 16:0+H]+. Images, spectra and statistical 
analysis presented by the group show a reduction in signal intensity for m/z 760 and 798 
for PC 34:1, and an increase in signal intensity for m/z 496, for LPC 16:0, in the ischemic 
area compared to the normal brain regions. They concluded there is a reduction of PC 
34:1 in the ischemic area, and an increased in LPC 16:0, possibly resulting from the 
biodegradation of PC by lipases to release LPC. What the group fail to comment on, or 
indeed investigate, is the signal intensity representing [PC 34:1+Na]+, which, in the 
spectrum presented from the ischemic area, shows a large increase in signal intensity 
compared the spectrum taken from the normal area. As is the case of other PCs detected 
in this spectrum, there is a noticeable difference in the ratios of [M+K]+ and [M+Na]+ 
across the two sample areas. There is not believed to be a difference in the intensity of 
this PC across the two areas.  
 
The differences in the ratio of PL sodium to potassium adduct formation in brain injury 
models was later reported by Hankin et al. (2011)[179]. The analysis of fluid percussion 
injury (FPI) using MALDI-QqTOF-MSI identified key changes in lipid distribution and metal 
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adduct formation. Highly abundant phospholipids commonly detected in brain tissue were 
detected during this MALDI-MSI investigation; however there was a distinct difference in 
adduct formation within the region of injury. There was a clearly visible increase in Na 
adduct formation for common lipid species, which directly correlated to a decrease in K 
formation. The authors demonstrated this by presenting images of m/z 782 [PC34:1+Na]+, 
which showed high signal intensity within the injured region of the brain and lower 
intensity across normal brain anatomy, and m/z 798 [PC34:1+K]+,  which displayed to 
opposite distribution. This finding was observed across all sections analysed for the FPI 
model, the authors attributed this difference to the loss of the Na/K ATPase pump/activity 
and cell death.  
 
 
1.5 Mycobacterium 
 
The Mycobacterium genus comprises many species responsible for disease in humans, 
the most problematic and widely known being Mycobacterium tuberculosis (M.tb), the 
aetiological agent of tuberculosis (TB). Once thought to be a disease that was on the 
verge of eradication, the World Health Organisation (WHO) statistics show that TB kills 
nearly 2 million people annually, with 9 million new cases each year, 1.5 million of these 
among people living with HIV, and over half a million are multidrug-resistant (MDR-TB) 
strains. The resurgence of the disease is thought to be due to inadequate compliance with 
drug treatment along with the appearance of drug- and multidrug-resistant strains, and 
immunocompromised individuals. In 2006 the WHO launched the new Stop TB Strategy 
with a global plan to eliminate TB 2006-2015, which consists of six main components, the 
sixth being – “enable and promote research, by which improved practices and elimination 
depend on new diagnostics, drugs and vaccines”[180]. 
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1.5.1 Cell Envelope Components 
 
The Mycobacterium cell envelope structure has been extensively studied as the 
components play a central role in the growth, survival and thus pathogenicity of disease-
causing Mycobacterium species. The cell envelope is unique compared to other Gram-
positive bacterium and non-Mycobacterium.  It contains an unusually high number of 
lipids, which comprise up to 60 % of the bacterial cell wall dry weight, and are responsible 
for the extremely hydrophobic nature of the cell envelope. Structurally, from  the plasma 
membrane to the surface, the mycobacterium cell envelope contains a cell wall core 
composed of 3 covalently bound macromolecules; peptidoglycan, which is covalently 
bound to arabinogalactan via a linker unit; and the mycolic acids (MAs), which are 
esterified to the arabinose termini of the arabinogalactan[181]. Collectively these 
macromolecules have been termed the mycolyl-arabinogalactan-peptidoglycan (mAGP) 
complex, which is, in turn, capped by a layer of non-covalently bound lipids and 
glycolipids. The outer-most component of the cell envelope is a capsule of 
polysaccharides, proteins and lipids[182]. The most intensively studied of the 
mycobacterial cell envelope lipids to date, are the mycolic acids. Over half a century of 
research has proven their structural and functional importance: they are responsible for 
the highly hydrophobic and extremely low fluidity of the cell, making the cell impermeable 
to many detergents, toxins and pharmaceuticals, and their involvement in virulence has 
shown they are key to the success of Mycobacterium as intracellular pathogens[125, 183-
189].  
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1.5.1.2 Mycolic Acids 
 
MAs are signature lipids of mycobacterium due to their unique structure; they are 
extremely long-chain α-alkyl-branched, β-hydroxylated fatty acids, which vary according to 
their chain length (C60-C90) and functional group[125, 184, 190-192]. M.tb and some 
strains of M. bovis produce three types of MAs, the alpha-mycolates and oxygenated 
methoxy- and keto-mycolates, with the functional group being at the distal position of the 
merocolate chain. The MAs of M.tb and other slow-growing pathogenic Mycobacterium 
are cyclopropanated, with the alpha-mycolates containing two cis or trans cyclopropane 
rings (di-cyclopropanated), and the oxygenated MAs have a methoxy- or ketone- group 
and a proximal cis or trans cyclopropane ring[134, 188, 193-195]. In addition to the free 
MAs and those bound to the arabinogalactan, mycolic acids are also present in the cell 
envelope as sugar esters known as trehalose monomycolates and dimycolates, TMM and 
TDM respectively. These larger non-covalently bound lipids form part of the outer leaflet 
of the lipid bilayer, and contribute highly to the pathogenicity of mycobacteria[133, 196, 
197]. The biosynthesis of MAs is the target of several first line anti-microbial drugs, such 
as isoniazid, which acts on several enzymes involved in their biosynthesis[185, 198].  
 
 
1.5.1.3 Non-Covalently Bound Lipids – PDIMs, PGLs and MMGs 
 
In addition to the covalently bound MAs, several non-covalently bound lipids have been 
shown to contribute to the permeability barrier of the Mycobacterium cell envelope, and 
are thus also involved in virulence. Of these, two structurally related families of lipids 
which are predominantly found in slow-growing pathogenic mycobacterium have been 
identified. These are the phthiocerol dimycocerosates, PDIMs or DIMs for short and 
phenolphthiocerol dimycolates, also called phenoglycolipids or PGLs[128]. PDIMs are 
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composed of a mixture of long-chain β-diols esterified by multimethyl-branched fatty acids 
called mycocerosoc acids. The major PDIM produced by M.tb is termed PDIM A or DIM 
A. Minor structural variants of these lipids are also present, termed PDIM B or DIM B[199, 
200]. PGLs have a chemical structure similar to that of PDIMs, with a lipid core formed by 
long-chain β-diols, the structural difference is that this phthiocerol chain is ω-terminated 
by an aromatic nucleus (phenolphthiocerol), which is glycosylated[132, 201]. In M.tb the 
major form of PGL is termed PGL-tb, in M. bovis it is termed PGL-1. PDIMs and PGLs 
constitute part of the outer membrane component of the envelope; their FAs are believed 
to interact with the covalently bound MAs, with their sugar moiety interacting with the 
capsule. Mutant knock-out models have shown PDIMs are required for the multiplication 
of M.tb during the acute phase of TB infection in both the lung and spleen of mouse 
models[128]. Although these lipids are structurally similar and are observed together, not 
all strains of M.tb synthesise PGLs, this is due to a natural frame shift mutation in the 
pks15/1 gene. These lipids are thought to be involved in the hyper-virulence of certain 
M.tb strains[132]. MAs are organised with other lipids, including PGLs, PDIMs, 
monomycolated glycerol (MMG), sphingomyelin (SM), and triacylglycerides (TAGs) to 
form an outer barrier with extremely low fluidity, that confer very low permeability to 
mycobacteria.  
 
 
1.5.2 MALDI-MS of Mycobacterium Cell Wall Lipids 
 
The analysis of mycolic acids using  MALDI-TOF-MS was carried out for the first time by 
Laval et al. (2001)[193], who successfully analysed various types of purified mycolates 
from a number of representative Mycobacterial species and showed that chain lengths 
corresponded to the growth rate of strains, i.e rapid- and slow-growers. For analysis the 
group converted the extracted MAs into methyl esters with an ethereal solution of 
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diazomethane prior to TLC separation into MAME subgroups, and MALDI-TOF analysis. 
Mycolic acids are non-polar molecules, their methyl esters (MAMEs) ionise more readily 
than the free acids, thus enhancing detection of these species, which is the reason 
methylation is carried out. This investigation evaluated seven matrix solutions for their 
suitability in MALDI-MS analysis of MAMEs and found DHB 10 mg/mL in 
methanol:chloroform (1:1,v/v) gave the best results. From the analysis of the extracts from 
M. tuberculosis H37Rv the group detected four clear α-MAMEs, at m/z 1146, 1174, 1202, 
and 1230, which they designated carbon chain lengths C76, C78, C80, and C82 respectively. 
Four methoxy-MAMES were also detected at m/z 1262, 1290, 1318 and 1346, assigned 
C83, C85, C87, C89. The keto-MAMEs detected from this species were, m/z 1246, 1274, 
1288, 1302, 1316, and 1330, designated C82, C84, C85, C86, C87, and C88. All peaks 
detected in this study were designated [M+Na]+ ions. The group then went on to detail the 
differences observed in MAME composition between rapid- and slow-growing 
Mycobacterium. The most important part of this study however, was the proof of viability 
of MALDI-MS as a technique that can analyse complex FA mixtures from pathogenic 
species, and comparing results to those obtained from mutant strains, devoid of certain 
mycolate biosynthesis. The group detected alpha-methoxy- and keto-MAMEs from a 
mixture, detecting the same species as was observed in the analysis of single mycolate 
extracts. Results obtained from the analysis of a mutant model, showed this species to be 
devoid of both methoxy- and keto-MAMEs, compared its parent strain; this was evidenced 
by a mass spectrum containing one series of peaks from m/z 1118 to 1250. This 
investigation was important as it demonstrated, for the first time, the feasibility of MALDI-
MS as a tools to provide accurate molecular mass information, and a more direct and 
rapid route for the analysis of MAs.  
 
During the same year Watanabe and co-workers[195] used MALDI-TOF-MS alongside 
NMR, the former revealing the chain length with the latter revealing the type and location 
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of the double bonds, along with the cyclopropane ring content of MAs from 24 
representatives of the Mycobacterium genus. This was an exhaustive study comparing 
differences in mycolate type, double bond location, configuration and degree of 
cyclopropane content, not only between a number of species in the MTBC, but also at 
different growth stages of cultivation. Much of this report however, is concerned with NMR 
results obtained. MALDI-MS was used as a confirmatory tool; results presented by the 
group were for the detection of alpha- and methoxy-MAMEs from M. tuberculosis H37Ra, 
an attenuated strain, which demonstrated distinct differences in mycolate profiles 
compared to virulent strains. All peaks presented by the authors represented [M+Na]+,  α-
MAMEs were detected at m/z 1133, 1161, 1173, 1189, 1201, 1217, 1229, and 1257, 
methoxy-MAMEs were detected at m/z 1235, 1263, 1275, 1291, 1303, 1319, 1331, and 
1359. 
 
A comprehensive analysis of MA subclass and molecular species composition of M. bovis 
BCG Tokyo 172 has used MALDI-TOF-MS for the determination of the molecular weight 
of the species detected[194]. After initial extraction of the lipids from the bacterial cells the 
group methylated the MAs, MAMEs were then separated into alpha-, methoxy- and keto- 
subgroups by HPTLC. Each subgroup was then further separated by AgNO3 coated silica 
gel TLC and designated, α1, α2, methoxy 1-6 (m1-6) and keto 1-5 (k1-5). MALDI-MS 
analysis of α1 detected peaks at m/z 1117-1229 which the group assigned carbon chain 
lengths of C74, C76, C78,C80, and C82 respectively, the major homologue is shown in bold. 
Peaks detected from α2 were observed at m/z 1131, 1159, 1187, and 1215, which the 
group assigned as C75, C77, C79, and C81. MALDI-MS data presented by the group for the 
detection of the methoxy sub-subgroups were as follows; m1, m/z 1233, 1261, 1289, 
1317, and 1345, assigned C81, C83, C85, C87, and C89 homologues; m2, m/z 1275, 1303, 
and 1331, assigned C84, C86, and C88; m3, m/z 1233, 1261, 1289, and 1317, assigned C81, 
C83, C85, and C87; m4, m/z 1217, 1245, 1273, 1301, and 1329, assigned C80, C82, C84, 
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C86,and C88; m5, m/z 1233, 1247, 1261, 1275, 1289, 1303, 1331,  and 1345, assigned C81 
through to C89; finally, m6, m/z 1259, 1287, 1315, and 1343, assigned C83, C85, C87, and 
C89. Similarly, MALDI-MS data for keto- sub-subgroups were presented as follows; k1, m/z 
1217, 1245, 1273, 1301, and 1329, assigned C80, C82, C84, C86,and C88; k2, m/z 1259, 
1287, 1315, and 1343, assigned C83, C85, C87, and C89; k3, m/z 1217, 1245, 1273, and 
1301; k4, m/z 1203, 1231, 1259, 1287, and 1315; k5, m/z 1271, 1299, and 1327. With the 
aid of fast atom bombardment-MS and NMR analysis the group were able to structurally 
identify each species detected.  
 
MALDI-TOF MS has since been applied to the analysis of the MA content of MA 
containing glycolipids, including TMM[196] and TDM[133, 197], with both the free acids 
and the whole glycolipids being analysed from a number of mycobacterium species.  
MALDI-TOF-MS was used in the analysis of mycolic acid content of TDM from nine 
species of Mycobacterium, five slow-growing virulent strains and four rapid-growing non-
virulent strains. Analysis was again using MAMEs and all species were detected as 
[M+Na]+. The group presented results detected from the analysis of MAMEs after alkali 
hydrolysis from TDMs. MALDI mass spectral data presented by the authors showed, M. tb 
H37Rv and Aoyama B strains to have similar MAME profiles. Peaks detected 
representing α-MAMEs were at m/z 1145-1285 for C76-C86, methoxy-MAMEs were at m/z 
1219-1387 for C80-C92, and keto-MAMEs were detected at m/z 1203-1387 for C79-C92. The 
peak profiles observed for the M. bovis BCG Tokyo 172 were detected at m/z 1145-1257 
(28 u difference) for α-MAMEs with carbon chain lengths C76-C84, methoxy-MAMEs were 
detected by the group at m/z 1233-1359 for C81-C90, and keto-MAMEs at, m/z 1217-1343 
for C80-C89. The MALDI-MS results presented by the authors for the analysis of M. bovis 
BCG Connaught differed from those present for the other pathogenic strains due to this 
strain not being able to synthesis methoxy-MAMEs. Peaks for α-MAMEs were detected at 
m/z 1117-1257 assigned C74-C84 by the authors, and keto-MAMEs were detected at m/z 
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1175-1371, assigned C77-C91 by the authors. The MALDI mass spectra presented for the 
analysis of TDMs from these species is highly complex due to the numerous 
combinations of possible MAs within their structure. Using the compositional m/z acquired 
from the analysis of the hydrolysed MAs, coupled with the m/z obtained from their parent 
TDMs the authors deduced possible MA structures of TDMs for each respective species. 
This is the first report of such a study, and provides useful information of the structure-
virulence relationship of TDMs in pathogenic Mycobacterium. 
 
Other cell envelope lipid species, including PDIMs and PGLs, have been structurally 
investigated using MALDI-TOF MS in combination with NMR to identify lipid species 
involved in growth and virulence[132, 199-201].  
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1.6 Aims and Objectives 
 
MALDI-MS and MSI investigations has widespread application across many research areas, but is 
limited by poor sensitivity and reproducibility in many instances. This can be partially addressed 
through optimisation of sample preparation methods. Investigations into sample preparation are 
aimed at increasing sensitivity, resolution, reproducibility, and techniques that enable MSI to be 
used alongside clinical pathology procedures to investigate disease processes.  
The choice of matrix compound, a range of section thickness and storage parameters will be 
considered. There is little research in this area for lipid analysis to date; results from these 
investigations will be presented in chapter 2. Optimised matrix deposition methods aimed at 
enhancing sensitivity, mass and spatial resolution, increasing throughput times and reducing 
variability will be presented in chapter 3. This chapter will compare a robotic matrix deposition 
method to a manual airspray method. The analysis of archival tissue is highly desirable to study 
disease pathology. MALDI imaging of lipids from formalin fixed tissue, as prepared by clinical 
pathology laboratories is investigated. To the best of the author’s knowledge, this has never been 
carried out before; results from this study form chapter 4 of this thesis.  
The analysis and imaging of non-polar lipids by MALDI-MS proves to be somewhat difficult, due 
to their nature. MALDI-MS analysis and imaging of non-polar cell wall lipids from the 
Mycobacterium tuberculosis complex will be considered. The investigation of a variety of samples, 
including complex lymph and blood extracts, full lymph nodes and TLC plates, for MALDI-MS 
analysis and imaging of these lipids will be presented in chapter 5. Methods that enhance MALDI-
MS sensitivity in the detection of non-polar lipids, particularly with regard to cell wall components 
of the Mycobacterium tuberculosis complex, are needed. Development and optimisation of matrix 
solvent systems is one way this can be achieved. The screening or evaluation of numerous solvent 
systems, with the aim of developing an optimised system, will be carried out. Comparisons will be 
made to those currently used in literature for these and other non-polar lipids, applications to 
complex bacterial extracts will be considered, results from this study will be presented in chapter 6.  
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2. An Investigation into the Effects of Sample Storage Parameters 
and Section Thickness for MALDI-MSI 
 
 
2.1 Introduction 
 
It is widely accepted that sample preparation is key to the success of a MALDI-MSI 
investigation; affecting both sensitivity and spectral and image quality[202, 203]. As 
sample preparation greatly influences the quality of results, every step of the preparation 
process must be carefully and correctly carried out in order to maintain as much spatial 
and chemical information as feasibly possible[204]. The choice of matrix compound and 
solvent system are crucial, and this is always the first procedure to be evaluated for 
MALDI-MS and MSI investigations[205-211]. As discussed in chapter one, the most 
suitable solvent system is one in which both the matrix and analyte/s are soluble. The 
matrix compound of choice is largely dependent on the type of molecules/analyte/s of 
choice, common MALDI matrices and their compound applications have been discussed 
in chapter 1. There is great diversity that exists not only between organs/tissues of 
interest, but also between molecules/species of interest from within these samples, and 
so no two experiments are the same[160, 212-224]. In general investigators optimise their 
experiments by varying sample preparation parameters before analysis of specific 
analyte/s of interest are investigated. Numerous reviews have been published with 
recommended guidelines for sample preparation procedures, such as range of tissue 
section thickness; section embedding; storage and storage temperatures, however these 
vary from investigator to investigator[21, 202-204, 218, 225]. It is generally accepted that 
tissue sections between thicknesses of 5-20 µm are suitable for MALDI-MSI experiments, 
with respect to extractable analytes and resulting spectral and image quality, with 10-20 
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µm being reported as optimal[204, 218]. Many investigators also desiccate samples for 
varying time periods after tissue sectioning, but prior to matrix deposition, this is to 
dehydrate the tissue sections[202, 203, 226, 227]. To the best of the author’s knowledge 
no investigation has been reported on a comparison of the effects of sample storage or 
preparation prior to matrix deposition, such as to desiccate or not, and the length of time 
samples are in the desiccator. There have been two investigations published to date 
assessing sample thickness. The first investigated the effects of sample thickness on the 
sensitivity and signal and image quality of proteins detected from tissue[227]. The second 
assessed the effects of section thickness on laser profiling depth, and thus detection 
sensitivity and signal quality for both large and small compounds[228]. The two studies 
produced conflicting results. 
 
In this chapter αCHCA and DHB, two commonly used matrices for the investigation of 
small molecules[165, 210, 229-231], were evaluated for the analysis of previously 
reported GPL species[13, 14, 155, 156, 165, 171, 196, 205, 230-233]. Initial investigations 
used rat brain lipid extracts to assess which matrix produced the best overall results. They 
were then both assessed for their suitability for MALDI-MSI studies. The selected matrix 
was then used in MALDI-MS imaging of GPLs to investigate the effects of varying sample 
thickness, between 5-50 µm. The effect of sample desiccation prior to MALDI matrix 
application is concluded. 
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2.2 Experimental 
 
2.2.1 Materials 
Alpha-cyano-4-hydroxy cinnamic acid (α-CHCA), 2, 5-dihydroxybenzoic acid (DHB) and 
trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich (Dorset, UK).  Methanol and 
chloroform were purchased from Fisher Scientific (Loughborough, UK). Whole control rat 
brains were supplied by Covance, (Harrogate, UK). 
 
2.2.2 Matrix Evaluation for GPL Investigations 
Whole brain lipid extracts were prepared using the Folch[234] method and stored at -20C 
until analysis. For analysis, 1 µL of extract was deposited onto a stainless steel MALDI 
target plate and allowed to air dry at room temperature, 1 µL of either αCHCA 10 mg/mL 
or DHB 12.5 mg/mL (80% MeOH, 0.1% TFA) was deposited on top of the extract.  
 
Serial sagittal rat brain sections were taken at 12 µm on a Leica CM 1800 cryostat, and 
transferred to stainless steel MALDI target plates prior to matrix deposition and analysis. 
 
2.2.3 Sample Storage and Section Thickness 
MALDI plates were prepared with serial sagittal sections of rat brain tissue; sectioned at 
12 and 40 µm on a Leica CM 1800 cryostat. Plate A was immediately sprayed (10 min 
after sectioning, to allow temperature equilibration) with matrix and analysed. Plate B was 
stored for 24 h at -20°C, on removal from the freezer the sections were left for 10 min to 
allow temperature equilibrium before matrix deposition and analysis. Plate C was placed 
in a desiccator for 1 h, and Plate D was stored in a desiccator for 24 h prior to matrix 
application and analysis.  
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In further investigation on the effects of tissue thickness the cerebellum of rat brain tissue 
was bisected along the midline of the sagittal plane, and embedded on a cryostat chuck 
using water-ice slush. Serial sections at 5, 10, 14, 20, 25, 30, 35, 40, 45 and 50 µm were 
taken and transferred to a stainless steel MALDI target plate for analysis. Matrix 
deposition was carried out as described below. 
 
2.2.4 Matrix Deposition for MALDI-MSI 
Matrix deposition was via an artistic airbrush (Badger Airbrush Ltd, UK), the MALDI target 
insert was held in a fume hood using a clamp,  25 mg/mL αCHCA matrix material solution, 
(prepared in 80% methanol (0.1% TFA)) was deposited over each plate in cycles, 
allowing time to dry between each cycle. Deposition was carried out from a distance of 
15-20 cm, the plate was rotated 90° between each cycle to ensure an even distribution, 
deposition was deemed optimal when 9 mL had been deposited. 
 
2.2.5 MALDI-MS 
Analysis of the lipid brain extract was carried out using an Applied Biosystems (Toronto, 
Canada) hybrid quadrupole time-of-flight (QqTOF) instrument (Qstar XL). The instrument 
was fitted with an orthogonal MALDI ion source and a nitrogen laser (337nm), operated at 
20 % available power with a repetition rate of 20Hz. The instrument was operated in the 
positive ion reflectron mode, recording all signals between m/z 50-1000. Data collection 
was via an automated pre-determined pattern analysis over the sample spot, using a Q1 
scan time of 1 s, summing 15 scans per spectrum obtained. Mass spectral data was 
analysed using Analyst software supplied by Applied Biosystems. 
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2.2.6 MALDI-MSI 
MALDI mass spectrometric analysis was carried out using a QqTOF (Qstar XL – Applied 
Biosystems, Toronto, Canada) mass spectrometer fitted with an orthogonal MALDI ion 
source. The nitrogen laser (337nm) energy was operated at 20% available power for 
CHCA and 30% for DHB, with a repetition rate of 20 Hz. MALDI-QqTOF mass spectra 
were collected at 150 µm intervals, with a laser dwell time of 2 s at each location. A dwell 
time of 2 s is optimal before the matrix is completely ablated and the signal is lost. The 
resulting two-dimensional ion density maps were generated using the TissueView 
software, after conversion of the raw data into the format required using the ‘wiff to 
analyse’ script, provided by applied biosystems. 
 
In the subsequent analysis of tissue section thickness, sections of cerebella were 
analysed using QqTOF  (Qstar Elite – Applied Biosystems, Toronto, Canada), operated in 
positive ion reflectron mode. Instrument parameters had been previously optimised for the 
analysis of PCs from rat brain, data was acquired between the mass range m/z 50-1000. 
The Nd:YAG (355nm) laser was operated at 20 % available power (2.1 µJ), with a 
repetition rate of 500 Hz. The target plate stepping distance was set to 100 µm for both 
the x and y dimension using the imaging acquisition software. Data were acquired using 
the ‘dynamic pixel’ setting, which involves the laser being moved within the 100 µm2 pixel 
area and resultant data being summed to give an accumulated mass spectrum over one 
second for each pixel area. The resulting two-dimensional ion density maps were 
generated using the TissueView software, after conversion of the raw data into the format 
required using the ‘wiff to analyse’ script, provided by Applied Biosystems. 
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2.3 Results and Discussion 
 
2.3.1 Matrix Evaluation for MALDI-MS and MSI Analysis of Lipids 
 
To evaluate the most suitable matrix compound to use for MALDI-MS investigations of 
lipid species from tissue, αCHCA and DHB were used as matrix compounds in analysis of 
brain lipid extract. Each matrix was assessed on spectral quality, species present and ion 
counts/sensitivity. The spectral complexity differs remarkably for the two different matrices 
assessed, as shown by the overlay spectrum presented in figure 2.1. There are a much 
higher number of peaks present in the mass spectrum for αCHCA (red trace) compared to 
DHB (blue trace). This is believed to be due to αCHCA forming a higher number of matrix 
clusters or associated peaks compared to DHB. In addition to this αCHCA is what is 
termed a ‘hot’ matrix, in that is causes a higher degree of analyte fragmentation compared 
to ‘cold’ matrices such as DHB[49, 70, 72]. This is visible in the spectrum presented in 
figure 1, when focusing on the mass range between m/z 300-650, m/z within this range 
represent the neutral losses of PC head groups and fatty acids from GPLs and SMs[235]. 
The ion counts for the lipid fragments are much lower for DHB (labelled blue peaks) 
compared to αCHCA (red peaks), for which ion counts for m/z 478 and 504 go into the 
thousands. DHB appears to show a two-fold increase in ion counts for common lipid 
species, which is demonstrated by the mass spectra presented in figure 2.2.  When 
observing the two most common species detected from rat brain sections, PC 32:0 and 
PC 34:1 at m/z 734 and 760 representing [M+H]+, m/z 756 and 782 for [M+Na]+, and m/z 
772 and 798 representing [M+K]+ for these lipids, the increase is clearly visible when 
using DHB. The ion counts for PC 32:0 at m/z 734 were 225 counts for αCHCA and 609 
counts for DHB from the spectra present in figure 2.2. The same trend was observed for 
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the protonated ion of PC 34:1 at m/z 760, where the ion counts using αCHCA as the 
matrix were 505 counts compared to 1124 counts for DHB. 
 
 
 
 
Figure 2.1. MALDI mass spectral overlay of brain lipid extract for αCHCA (red trace) and 
DHB (blue trace). A large difference in spectral complexity is visible due to the high 
number of αCHCA peaks, shown in red. Conversely, DHB shows not only reduced 
spectral complexity but also produced higher ion counts for lipids species of interest as 
shown by the labelled blue peaks m/z 700-900.  
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Figure 2.2. MALDI mass spectra of brain lipid extract acquired using αCHCA (top 
spectrum) and DHB (bottom spectrum). The increased spectral complexity observed with 
αCHCA is clearly visible. There appears to be a two-fold increase in ion counts for lipid 
species of interest using DHB as the matrix system compared to αCHCA. 
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The analysis of the lipid extract was repeated five times and the mean ion counts for 
several lipid species were recorded. The mean ion counts for the [M+H]+ of three different 
lipid species, PC 32:0, PC 34:1 and PC 36:1, for αCHCA and DHB is presented in figure 
2.3. For all lipid species DHB proved to be the most sensitive matrix compound to use. 
This matrix produced over a three-fold increase in ion counts for PC 32:0 and PC 36:1 
and over a two-fold increase in ion counts for PC 34:1. Brain tissue contains high 
concentrations of sodium and potassium, thought to be due to the Na+/K+ ATPase (also 
known as the sodium/potassium pump)[179, 236], this increases spectral complexity 
when analysing lipids from brain tissue, as the [M+H]+, [M+Na]+ and [M+K]+ adducts are 
commonly detected in MALDI-MS analysis. To evaluate total ion yields from single 
molecules, all ions for a given lipid species were summed, the results are presented in the 
graph in figure 2.4. Review of the sum of ion counts for [M+H]+, [M+Na]+ and [M+K]+ 
revealed the same trends were observed as for the [M+H]+, with DHB giving over a two-
fold increase in counts for PC 34:1 and over a three-fold increase for PC 32:0 and 36:1. 
These results show the improvement is not linear across all species, preferential 
ionisation of certain lipid species if apparent, this could be attributed to the different matrix 
used, however, it could also be a laser affect, as DHB requires a higher laser power for 
optimal ionisation.  Previously reported lipid species detected from the lipid extracts using 
both matrices are presented in table 3. 
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Figure 2.3. MALDI-MS data from the analysis of brain lipid extract using αCHCA and DHB 
as the matrices. The selected m/z values represent the [M+H]+ for PC 32:0, PC 34:1 and 
PC 36:1 from left to right respectively. Values presented are the mean ion counts ± SD 
taken from 5 repeat analyses. For all species DHB produced the highest ion counts. 
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Figure 2.4. MALDI-MS data summing the mean ion counts (n=5) for the [M+H]+, [M+Na]+ 
and [M+K]+ ions for PC 32:0, PC 34:1 and PC 36:1. DHB shows over a two-fold increase 
in signal intensity in analysis of dried droplet lipid extracts. 
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Species [M+H]+ [M+Na]+ [M+K]+ References 
SM 18:0 731 753 769  [14, 165, 166, 232] 
SM 20:0 759 781 797  [232] 
PC 32:1 732 754 770  [205, 231] 
PC 32:0 734 756 772 
 [14, 165, 166, 205, 231, 
232] 
PC 34:1 760 782 798  [165, 166, 205, 231, 232] 
PC 34:0 762 784 800  [14, 232] 
PC 36:4 782 804 820  [165, 166, 205, 231] 
PC 36:3 784 806 822  [205, 231] 
PC 36:2 786 808 824  [205, 231] 
PC 36:1 788 810 826  [165, 166, 231, 232] 
PC 38:6 806 828 844  [165, 166, 231] 
PC 38:5 808 830 846  [205, 231] 
PC 38:4 810 832 849  [205, 231] 
PC 38:3 812 834 851  [205] 
PE 36:2 744 766 782  [205] 
PE 36:1 746 768 784  [205] 
PE 38:4 768 790 806  [14] 
PE 40:6 792 814 830  [205] 
 
Table 3. List of m/z of SM, PC and PE species detected using both αCHCA and DHB as 
the matrix compounds, along with their previously published record. Isobaric ions are 
colour coded. 
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Analysis of solutions on a spot plate and analysis of tissue in an imaging experiment are 
very different, tissue sections are highly complex compared to solutions and sufficient 
extraction of the analyte/s can be difficult. A key factor when considering a matrix 
compound for MALDI-MSI investigations is crystal size and morphology and homogeneity, 
as these factors affect resolution, and spectral/image quality. Although DHB proved to be 
the most suitable matrix for spot analysis of lipid extracts, both matrices must be 
evaluated for their suitability for MALDI-MS imaging studies of lipids.  
Contrary to results from the analysis of lipid extracts from spot samples, the direct 
analysis of rat brains using DHB at the matrix did not produce any recordable analyte 
ions. The optimisation of DHB for imaging studies was thus unsuccessful; DHB crystals 
appear white when deposited over the MALDI target plate, which made it quite difficult to 
evaluate how much material was being deposited on the tissue. The formation of DHB 
crystals within the airbrush column and at the tip caused repeated blockages and 
spluttering of the gun. DHB is known to form large needle like crystals, the size of the 
matrix crystals influence the image resolution, if they are larger than the laser spot size 
then resolution is compromised[41, 164, 237]. The results obtained using αCHCA as the 
matrix system were of high quality, image resolution was clear and defined for airbrush 
deposition, high numbers of lipid species were detected (all corresponding to those 
previously published and those detected from the extract). The facile detection of lipid 
species using αCHCA resulted in high ion counts, and the lateral distribution of PLs 
across the brain section showed clear anatomical differentiation for a number of species. 
The crystal size and morphology using αCHCA is that of small rounded crystals, 
establishing good coverage on the sample surface and greatly increased homogeneity 
compared to DHB. These results, combined with the much lower laser power needed for 
desorption/ionisation, lead to the decision of αCHCA being the most suitable matrix to 
take forward for all imaging studies of lipids from tissue sections. For these reasons DHB 
was not optimised further. A direct comparison of image resolution achieved with the two 
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matrices has recently been published, much more highly resolved images are observed 
for αCHCA[172].  
 
 
2.3.2 Sample Preparation and Thickness 
 
Images of m/z 772 (potassium adduct of PC 32:0) presented in figure 2.5 clearly show 
well defined anatomical regions that correspond to those previously published for the 
MALDI-MSI analysis of this lipid[165]. This lipid is highly abundant in rat brain, readily 
ionises in positive ion mode, and its anatomical distribution has been published[12, 14, 
156, 164-166, 205, 230-232, 238], which is why this m/z was chosen to compare data 
obtained from the analysis of the different sample preparation methods. Initial results 
demonstrated that analysis of 40 µm sections of fresh-frozen tissue yielded marginally 
higher ion counts than those observed in analysis of sections prepared at 12 µm (figure 
2.5, plates A and B). Little difference was found between the 12 and 40 µm sections that 
were desiccated, as demonstrated by the relatively similar ion intensity across the tissues 
for these plates, presented in figure 2.5, plates C and D.  
In order to achieve high ion counts for a given analyte, the analyte must be incorporated 
sufficiently within the matrix crystals (co-crystallisation) during the crystal drying process. 
A slower crystal drying time increases this process but also increases crystal size which in 
turn decreases image resolution[34, 239]. If the crystals dry too fast the analyte/s have 
less time to migrate into the crystals and sensitivity is often compromised[238, 239]. 
Images from the sample prepared immediately after sectioning and the sample stored in 
the freezer display a much higher signal compared to the desiccated samples, as shown 
by the pixel intensity in figure 2.5. This may be attributed to the desiccated samples being 
much dryer upon matrix deposition compared to the samples that were prepared for 
analysis after sectioning/removal from the freezer. In these samples the solvent system 
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used for the deposition of matrix material may have evaporated much faster than in the 
fresh samples, reducing the time available for the analyte/s to incorporate into the matrix 
crystals. The images also illustrated slightly higher ion counts are observed in the sample 
desiccated for 24 h compared to the sample desiccated for 1 h.  
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Figure 2.5. MALDI-MS images of m/z 772 [PC32:0+K]+. Plate A sprayed immediately, 
plate B frozen for 24 h, plate C desiccated for 1 h and plate D desiccated for 24 h. In all 
cases the 40 µm section is on the left and the 12 µm section on the right. The sample 
prepared immediately after sectioning (A) and the sample stored in the freezer for 24 h 
(B) display the highest signal intensities, with similar pixel intensities seen for both. These 
are significantly higher than the samples that were desiccated (C and D).  
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To further assess the effects of sample preparation single point spectra were taken from 
10 different anatomical regions of the cerebral cortex for each sample preparation 
method. The mean ion counts of two commonly detected lipids species, PC 32:0 and PC 
34:1 were calculated to investigate the difference in signal intensity, results are presented 
in figure 2.6. The sample prepared immediately after sectioning displayed a two-fold 
increase in ion counts compared to both of the samples that were desiccated prior to 
matrix deposition. The sample stored in the freezer for 24 hrs prior to matrix deposition 
showed higher ion counts than both of the desiccated samples, but lower ion counts than 
the freshly prepared plate. The lower signal intensity may be signs of slight degradation, 
even after 24 h, which would not normally be noticeable because the signal quality is still 
good. The sample desiccated for 24 h prior to matrix deposition displayed marginally 
higher ion counts than the sample desiccated for 1 h; the difference is not high enough to 
be significant. 
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Figure 2.6. MALDI-MS single point spectral data taken from 10 different anatomical 
regions of the cerebral cortex for each sample preparation method. The mean ion counts 
± SD for PC 32:0, m/z 772 and PC 34:1, m/z 798 are displayed, both are [M+K]+. Lower 
ion counts are seen in the desiccated samples. 
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It should be noted that the matrix selection and concentration remained fixed for a given 
experiment, but matrix deposition for each experiment or plate was carried out 
individually. The comparison of ion intensities for section thickness across a given sample 
plate therefore remained constant. There may however be slight differences in the 
amount of matrix applied to each plate, as deposition was carried out manually and thus 
difficult to reproduce. To investigate whether the effects observed with the different 
sample preparation methods were a result of varying amounts of matrix being deposited 
onto the plates, and not the storage conditions, single point spectra were analysed from 
ten different regions on each plate (off tissue). As αCHCA forms many clusters in addition 
to the protonated, dehydrated ion and sodium and potassium adducts, all matrix peaks 
above 10 % relative intensity were summed. The sample desiccated for 1 hour prior to 
matrix deposition displayed the highest mean ion counts (n=10) for matrix ions on the 
plate; followed by the samples prepared immediately after sectioning/removal from the 
freezer; with the sample desiccated for 24 h displaying the lowest, as presented in figure 
2.7. There is a three-fold increase in summed matrix ions for the sample prepared 
immediately after sectioning and the sample prepared after removal from the freezer 
compared to the sample desiccated for 24 h prior to matrix deposition. The sample 
desiccated for 1 h prior to matrix deposition showed a four-fold increase in summed 
matrix ions compared to the sample desiccated for 24 h. This finding was not expected as 
this sample preparation method displayed the lowest ion counts across all lipid species, 
as more matrix was deposited, higher analyte signals might be expected. The low ion 
counts seen with the sample desiccated for 1 h could be due to analyte suppression 
effects caused by high concentrations of matrix ions. The matrix ion counts from this 
sample, however, were not much higher than those from the sample prepared after 
sectioning, and the sample prepared after storage in the freezer for 24 h prior to matrix 
deposition, thus similar analyte/s signals would have been expected. The latter two 
preparation methods displayed similar matrix ion counts and relatively similar lipid ion 
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counts. The sample desiccated for 24 h displayed much lower matrix ions on the plate 
compared to all other preparation methods, indicating less was deposited onto this plate. 
If a low a concentration of matrix was deposited on this plate it would lead to inefficient 
extraction and incorporation of the analyte molecules into the matrix crystals, which in turn 
would greatly affect signal quality. An interesting observation however, is that the ion 
counts for lipid species of interest are higher in this sample than the sample desiccated 
for 1 h, which appears to have had the highest amount of matrix deposited on the plate. 
The poor results observed with the samples that were desiccated prior to matrix 
deposition could thus be attributed to different amounts of matrix being deposited on each 
plate. It is rather difficult to achieve the same amount each time when depositing the 
matrix manually via airbrush deposition, hence the need for fully automated systems.  
 
Crystal formation on stainless steel target plates and tissue surfaces are very different, for 
this reason matrix ion intensity on tissue was assessed. The most abundant matrix ion 
detected on tissue is observed at m/z 265, representing [M+2K-2H]+∙, the protonated 
species is detected with low intensity, if it is detected at all on tissue, thus m/z 265 was 
used for comparison. The mean ion counts taken from single point spectral data from ten 
different anatomical locations were again used here. Interestingly the results do not 
correlate to the amount of matrix deposited on each plate, as seen by comparing the data 
presented in figure 2.8 for matrix on tissue, to the data in figure 2.7 for matrix off tissue. 
The sample desiccated for one hour, which appeared to have the highest amount of 
matrix deposited over the plate, display the lowest ion counts for matrix on tissue. Results 
presented here correspond to those observed for analyte detection in each sample 
preparation method. Collectively these results suggest that desiccating samples prior to 
matrix deposition affects the surface properties of the tissue, resulting in reduced analyte 
extraction compared to samples that had not been desiccated. Results observed may 
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also be due to matrix crystals forming differently on each sample, with poorer analyte 
incorporation and co-crystalisation in the desiccated samples. 
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Figure 2.7. MALDI-MS single point spectral data taken from 10 different regions on the 
plate (away from tissue areas), for each sample preparation method. Every matrix peak 
above 10 % of the relative intensity was summed and the mean ion counts from this 
displayed. The sample desiccated for 1 h appears to have a the highest concentration of 
matrix deposited, the freshly prepared and the sample stored in a freezer for 24 h have a 
similar amount, with the sample desiccated for 24 h showing the lowest matrix ion counts 
on the MALDI target plate. 
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Figure 2.8. MALDI-MS single point spectral data taken from 10 different anatomical 
regions of the cerebral cortex for each sample preparation method. The mean ion counts 
± SD of a matrix ion at m/z 265 are displayed. Lower ion counts are seen in the 
desiccated samples. 
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2.3.3 Sample Thickness 
 
Next a more detailed study into sample thickness was carried out. The aim of this 
experiment was to investigate a wider range of thicknesses than in the previous 
experiment, to evaluate an Nd:YAG laser and a newer more sensitive QqTOF instrument. 
Two lipids were chosen that displayed a differential distribution over the cerebella grey 
and white matter regions. The distribution of PC 32:0, m/z 772 clearly highlights the outer 
molecular and inner granular layers (grey matter regions) of the cerebellar cortex. There 
was little difference observed in signal intensity for the 5-40 µm sections, the sections 
taken at 45 and 50 µm show slightly higher signal intensities, with 50 m showing the 
highest overall, as demonstrated in figure 2. 9 (left image). The images of PC 34:0, m/z 
784, show this lipid following the contours of white matter regions, including the arbour 
vitae, fourth ventricle and Purkinje cells which run through the junction of the inner 
granular layer of the cerebellum. Images presented show a similar trend to those 
observed with PC 32:0, in that there is little difference in signal intensity for section 5-40 
µm, with 45 and 50 µm sections showing slightly higher signal intensities, as shown in 
figure 2.9 (right image). This trend was observed for every m/z investigated. 
Single point spectra were taken from 10 different anatomical regions of the cerebellum, 5 
from white matter regions (arbour vitae and fourth ventricle), and 5 from grey matter 
regions (molecular and granular layers). Mean ion counts of m/z 772 and 784 were 
recorded for each of the sample thicknesses, results not shown. Although not entirely 
accurate as these are single point spectra and thus a degree of variability exists, results 
do correspond with those observed in figure 2.5, in that there is little difference in signal 
intensity for most section thicknesses, with the 50 µm section showing higher ion counts 
across the sample. No difference was observed in the detection efficiency, with respect to 
the number of lipid species observed in both the mass spectra and resulting 2D images 
from each of the sample thicknesses. 
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Results here are not in agreement with a previously published paper by Sugiura and co-
workers (2006)[227], who found thinner tissue sections produced greater ion counts, and 
improved spectral quality with a higher number of proteins being identified. The group 
determined 2 µm sections to be more efficient and anything above 10-20 µm having 
drastically reduced ion counts and greater spectral interference from tissue related 
molecules, as well as a decrease in S/N ratio. It must be noted that sectioning at a 
thickness of 2 µm by cryomicrotomy (as described by this group) is quite difficult to 
achieve, this is rather thin for a frozen section and the parameter settings are not an exact 
measurement. The group concluded that the charging effect on tissue sections increased 
with thicker sections, as well as greater interference from biological compounds, including 
salts, lipids and other proteins that are not washed away efficiently during the washing 
stages of sample preparation, due to the section thickness. This in turn resulted in a loss 
of ionisation, efficiency of detection and thus reduced spectral quality. It must be noted 
that the study in this chapter did not use pre-washing steps and the analysis was carried 
out for highly abundant small molecular weight compounds rather than large molecular 
weight compounds such as proteins, as presented by Sugiura et al (2006)[227]. 
Results found here are in agreement with a study published by Crossman and co-workers 
(2006)[228], who carried out experiments on profiling depths in MALDI analysis. The 
group successfully ionised both large (protein, cytochrome c) and small (drug, prozasin) 
molecular weight molecules from liver sections covered by two 20 µm control brain 
sections. This demonstrated that laser profiling depth of MALDI analysis is greater than 
40 µm. This group postulated that profiling depth is dependent on the size and velocity of 
matrix droplets during deposition, cell density of the tissue under interrogation, and 
dissociation efficiency of the analyte from its binding tissue. These theories can be used 
to explain why the results obtained here do not correspond to those previously published 
in the former study. The concentration of matrix used here is higher, as is the number of 
deposition cycles compared to the method used in the Sugiura paper, which may account 
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for some of the variation seen. Rather than charging effects and biological interferences 
being responsible for decreased spectral quality and ion counts seen in thicker sections; 
decreased penetration of matrix and solvent into the tissue leading to insufficient 
extraction of the analyte/s could well be responsible.  
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Figure 2.9. MALDI-MS images showing the differential distribution of PC 32:0, m/z 772 
[M+K]+ (left image), and PC 34:0, m/z 784 [M+Na]+ (right image) across cerebellar 
sections. Sections range from 5-50 µm as indicated by the schematic below the images. 
Little difference is observed in the signal across the tissue for the sections ranging 5-40 
m, indicated by similar pixel intensity distribution across the sections. The cerebellum 
sectioned at 45 and 50 µm show a higher signal is detected from these sections.  
 
 
 
 
 
 
Values represent the placement 
of tissues on the MALDI plate 
and their section thickness. 
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The use of two different instrument platforms, the Qstar XL (commercially available in 
2002) and the Qstar Elite (commercially available in 2006) along with the configuration of 
two different lasers lends the opportunity to assess the difference in sensitivity afforded by 
both. Although a direct comparison cannot be made with regard to the lasers, as they 
were operated on different instrument platforms, the nitrogen on the XL and the Nd:YAG 
on the Elite, some information can be gained. The Qstar Elite is a newer version of the 
XL, with a reported 10 times increase in sensitivity (manufacturer information), which is 
clearly visible when comparing the images produced from the distribution of m/z 772 
across the tissue sections for the cerebella section thicknesses, figure 2.9 and the sample 
preparation plates in figure 2.5. There is a fifty-fold increase in the intensity scale 
representing the former compared to the latter, however the images produced do vary in 
colour intensity, thus this is not an accurate measurement. Five single point spectra were 
taken from grey matter regions of the cerebella and five from the white, from the plate 
analysed on the Elite and the sample plate prepared immediate and analysed on the XL, 
all spectra were taken from the 40 m sections. The mean ion counts from the two lipid 
species used for the comparison of sample thickness were again used here, for two 
reasons, firstly they display a differential distribution across the brain, and secondly 
because they are detected at different abundances. The lipid at m/z 772 is detected with 
high abundance, whereas m/z 784 is detected with a much lower abundance. The mean 
ion counts for these species showed a 15 fold increase for m/z 772 and a 30 fold increase 
for m/z 784, as presented in figure 10. For all lipid species detected a large increase in 
sensitivity was observed for the Elite compared to the XL.  The images acquired using the 
Elite were also at a lower resolution compared to the XL, 100 µm2 compared to 150 µm2, 
lower resolution is known to have a negative effect on spectral quality, this was not 
observed here. The laser dwell time for the nitrogen laser on the XL was also double that 
of the Nd:YAG on the Elite, thus such a large difference in sensitivity would not have been 
expected. The manufacturers state the Elite is 10 times more sensitive than the XL, 
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results here show a much greater increase in sensitivity, even at a lower resolution and 
shorter dwell time. The high rep laser could well be responsible for this for the greater 
increase in sensitivity observed, however, this cannot be said with certainty as the 
different lasers were operated on different platforms. It should also be noted that again 
the amount of matrix on each plate could vary as deposition was manually by airbrush, 
this would affect the results. Nonetheless, the superior sensitivity of the newer instrument 
platform and laser configuration is highlighted in this work.  
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Figure 2.10.  Single point spectral data (n=5) from cerebella grey matter regions, m/z 772 
and cerebella white matter regions, m/z 784. Data was acquired on two different 
instrument platforms, using two different lasers.  
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2.4 Conclusion 
 
This thesis chapter highlights the importance of matrix evaluation and optimisation for 
both solution/spot analysis and imaging studies. It has been demonstrated that although a 
given matrix may prove more suitable for the MALDI-MS analysis of complex solutions, 
this result does not necessarily carry over to imaging studies. Whilst DHB provided over 
two-fold improvement in sensitivity for the analysis of lipids from brain extracts and has 
been applied to numerous lipid imaging investigations, αCHCA was shown to be more 
suitable for MALDI-MSI in this laboratory. The mass spectra obtained with αCHCA were 
high quality and well defined images of lipids were obtained, matrix coverage over tissue 
sections was complete, and it was far easier to achieve a homogenous distribution. 
Furthermore, the lower laser power required for facile detection of lipid species using 
αCHCA is beneficial.  
Results presented in this chapter show that tissue preparation and storage prior to matrix 
deposition greatly affects the quality of MALDI-MS image data. Tissue sections that had 
been dehydrated showed much lower ion intensities compared to those that had not. 
Fresh tissue may absorb the matrix more effectively thus allowing greater and more 
efficient co-crystallisation on its surface therefore giving better resolution and imaging 
results. Alternately the application of matrix onto a fresh sample may decrease the solvent 
evaporation time, which in turn would decrease the crystal drying process allowing more 
time for the analyte/s to be incorporated into the matrix crystals[206, 239]. These results 
agree with those postulated by Crossman et al. (2006)[228], that experimental conditions 
that decrease matrix solvent evaporation may increase analyte extraction efficiency, and 
in turn increase sensitivity of analysis. There was a difference in the amount of matrix 
deposited on each plate, this is a known issue associated with manual deposition 
methods, which highlights the need for automated matrix deposition methods, to decrease 
the variability and thus increase the reproducibility of MALDI-MSI investigations, and this 
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is a current focus of many research groups[12, 164, 166, 238, 240] and manufacturing 
companies[241-243]. The difference observed between the amounts deposited on each 
plate, although thought to impact the results, are not believed to be solely responsible for 
the large variation in signal intensity.  The difference in matrix ion counts for the sample 
desiccated for 1 h, and the samples prepared after sectioning, is not thought to be 
significant enough to be responsible for such drastic variations in signal intensity. This 
was further evidence by comparing matrix ions on tissue, in which the sample plate 
desiccated for 1 h displayed the lowest ion counts on tissue despite displaying the highest 
counts off tissue. The different sample preparation procedures are believed to play a large 
role in the differences seen in image quality. 
The initial investigation into sample thickness showed 40 µm sections had a marginal 
increase in ion counts compared to the 12 µm sections. As these results conflicted those 
previously published for the investigation into sample thickness for MALDI-MSI[227], a 
more in-depth investigation was carried out using a wider range of thicknesses. The 
analysis of sections of cerebellum ranging from 5-50 µm further supported the evidence of 
thicker sections giving slightly higher signal intensities. The increase in ion counts was 
however, only detectable in the thicker sections of 45 and 50 µm, the results obtained for 
the 5-40 µm were comparable. Although only two lipid species were chosen to 
demonstrate these findings it should be noted that the same results were observed for all 
species analysed. These findings are in conflict to those reported by Sugiura et al. 
(2006)[227]; there may be several reasons for this. The concentration of matrix used in 
their study was rather low for an imaging experiment, sinapinic acid (SA) was used at 
12.5 mg/mL, this may have been too low a concentration for sufficient matrix:analyte co-
crystalisation, which would greatly affect sensitivity and signal quality. In a review of 
sample preparation Schwartz et al. (2003)[21] reported SA at 30 mg/mL showed the 
highest number of ion signals and best resolution compared to both 20 and 10 mg/mL 
solutions. The number of matrix deposition cycles used is also of concern in this paper, 
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although the amount deposited with each cycle is unknown (as many authors do not 
report the amount deposited), 4 cycles seems incredibly low for an imaging study, most 
authors report 15-20 cycles per deposition[214, 228, 244]. Four cycles at a concentration 
of 12.5 mg/mL may have resulted in inefficient extraction of analytes, particularly in the 
thicker samples, and poor crystal coverage over the tissue sections. The study carried out 
by Crossman et al. (2006)[228], showed sufficient extraction, desorption/ionisation and 
good signal intensity of small and large molecules from beneath 40 µm sections. This 
group did use a similar concentration of SPA, however, matrix deposition was carried out 
over 15 cycles. This may account for the differences reported between the two papers 
and those observed here. This indicates matrix application and not sample thickness 
greatly affects the sensitivity and quality of a MALDI-MSI study.  
Whilst the 50 µm section did show increased ion counts, the tissue integrity on the plate 
was rather poor. Sections over 30 µm in thickness showed evidence of sample drying and 
crusting off the target plate, a process which would be sped up under the vacuum 
environment of the orthogonal MALDI source used here. Sections thinner than 10 µm 
tend to be quite fragile and thus can split or rip when being manipulated, particularly if 
being handled by someone inexperienced. As there was little difference observed in the 
sections ranging from 5-30 µm, a section thickness of 10-12 µm is recommended, 
sections at this thickness show good sensitivity and thus resulting spectral quality, in 
addition to being easy to handle on the cryostat anti-roll plate, this thickness produces 
sections with good integrity.  
The use of two different instrument platforms showed the Qstar Elite to be a much more 
sensitive instrument, which was expected as this is an upgrade of the Qstar XL. The large 
increase in signal intensity observed with the Elite, however, greatly exceeded what was 
expected according to manufacturers information. Applied Biosystems reports an ten 
times increase in sensitivity for the Elite compared to the XL, much higher increases were 
seen here, up thirty times for some analytes. The difference in sensitivity observed could 
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thus be attributed to the use of the high rep laser; without comparing the lasers on the 
same platform this cannot be said with 100 percent certainty. There are a number of clear 
advantages to using the high rep laser, including much faster analysis times, longer laser 
life span, and the smaller laser spot diameter enhances the spatial resolution for MALDI-
MSI applications. 
 
Whilst MALDI-MSI is proven as a viable tool for the analysis of lipids in both normal and 
disease states, method development and sample preparation protocols are still very 
young. Work presented here has shown how sample preparation is vital to a successful 
MALDI-MSI experiment. Future work will involve the evaluation of sample preparation 
methods that could be applied to pathological specimens/problems. This is with an aim to 
use MALDI-MSI as a complimentary technique to traditional clinical methods in cellular 
pathology departments, such as histology and immunohisitochemistry. Automated matrix 
deposition methods are needed to ensure inter- and intra-laboratory reproducibility. 
Automated methods would reduce the problems associated with manual deposition as the 
amount deposited on the target plate is carefully controlled. Future work will aim to 
evaluate automated matrix deposition methods and apply them to MALDI-MSI 
investigations of samples prepared for histology. 
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3. A Comparison of Automated and Manual Matrix Deposition 
Methods for Imaging of Tissues by MALDI-MS 
 
3.1 Introduction 
 
An important aspect of all imaging studies is the method for matrix deposition, as this 
greatly influences the MALDI-MS image quality in terms of mass resolution, detection 
sensitivity, spatial resolution of resulting images and the reproducibility of results[21, 40, 
52, 166, 245]. It is known that a smaller crystal size and a homogenous layer over tissue 
sections lead to greater reproducibility and higher spatial resolution of images[164, 246]. 
Matrix deposition has to be carefully controlled, as an insufficient deposition will result in 
minimal analyte signals, with poor resolution thus resulting in images of poor quality. 
Conversely, a matrix deposition that is too wet will lead to analyte migration and result in 
images representing molecules that are highly delocalised from their original tissue 
region, leading to inaccurate results[41, 240]. In addition to these two problems there are 
also issues associated with an uneven matrix deposition, as this would result in local 
variations in extraction and thus desorption/ionisation[245]. These so called ‘sweet spots’ 
would have higher signal intensities than the surrounding tissue even though the 
distribution or concentration of the analyte within this area is the same. In recent years a 
number of studies have reported the use and credibility of numerous matrix deposition 
methods, all of these were touched upon in chapter 1, and can be divided into two main 
techniques, spotting and spraying. All methods to date have advantages and 
disadvantages.  
Spraying techniques include the airbrush[155], electrospray nebulisers[247], oscillating 
capillary nebuliser (OCN)[164], TLC reagent sprayers[165] the commercially available 
vibrational sprayer[248] and the automated TM-sprayer. Spraying deposition methods are 
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the most commonly used to date, owing to their speed of sample preparation, small 
crystal size and homogeneity, and ease of use. That said, they are not without their own 
problems. Electrospray nebulisers and TLC reagent sprayers produce good crystal 
homogeneity but have problems with reproducibility and the droplets drying in transit, 
meaning the crystals are formed before they reach the tissue, resulting in poor analyte 
signals[240, 249].  The OCN produces results comparable to the manual airbrush 
method, in that it achieves good homogenous matrix coverage, small crystal size, with 
high analyte signals, and once optimised deposition is relatively fast. The OCN also offers 
the advantage of being an automated system, once the flow rate and deposition distance 
has been optimised, the sample plate moves under the nozzle in pre-determined 
diameters, meaning all matrix is deposited onto the plate in a fully automated and 
controlled manner[164, 250]. The vibrational sprayer (ImagePrep, Bruker Daltonics), is a 
commercially available automated device which utilises a piezo-electric spray head. The 
system evaluates matrix coverage using an optical scattering-light sensor to measure 
matrix thickness at off tissue positions[242]. Although reported to produce a homogenous 
layer that is reproducible, achieving high resolution images, the ImagePrep device has 
recently been reported as producing a matrix coverage that is far from homogenous, 
having issues with ‘sweet spots’[244]. In addition to this, because of the optical sensor 
used to measure matrix deposition, this device is limited to the application of glass sides, 
which is not compatible with many instrument platforms. Another commercially available 
spray device is the TM-sprayer (HTX Technologies), which uses a heated capillary 
pneumatic spray. The temperature, flow rate and deposition cycles must be previously 
optimised. The sample stage moves under the spray device in a predetermined pattern, at 
a predetermined distance from the nozzle, meaning this device is fully automated and 
thus thought to be more reproducible than manual spraying devices. The TM-sprayer 
sample stage is also adapted to fit many types of MALDI targets; as such it is not limited 
to one vendor or one platform[241].  
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To date, the most widely used and accepted matrix deposition method remains the artistic 
airgun. This method provides a homogenous layer of crystals, with small crystal size and 
complete tissue coverage, as well as yielding high ion counts. It is easy to operate and 
cost effective as well as producing fast sample turnaround times, of around 20 minutes. 
Matrix deposition with the artistic airgun is not without its own issues. Over wetting of the 
tissue during application can cause analyte delocalisation, conversely a deposition too dry 
will result in poor analyst signals. The matrix crystal homogeneity, concentration and 
amount deposited, are all operator dependent and therefore vary from investigator to 
investigator, resulting in inter- and intra-laboratory variation.  Chapter 2 highlighted the 
reproducibility problems associated with this method. 
 
This chapter will assess a new automated spraying method for matrix deposition, the TM-
sprayer (HTX Technologies, North Carolina, USA). The results obtained from this method 
will be compared to the widely used and accepted artistic airbrush method, which 
produces high ion counts and high spatial resolution images. Investigations will focus on 
spectral and image quality, mass and spatial resolution, and detection sensitivity. As the 
distribution of numerous phospholipid species in the rat brain is already known[41, 155, 
165, 166, 171, 230-232], and already used in the assessment of matrix deposition 
methods[12, 164, 166], they will also be used here.  
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3.2. Experimental 
 
3.2.1 Materials 
Alpha-cyano-4-hydroxy cinnamic acid (α-CHCA) and trifluoracetic acid (TFA) were 
purchased from Sigma-Aldrich (Dorset, UK).  Methanol was purchased from Fisher 
Scientific (Loughborough, UK). Whole control rat brains were supplied by Covance, 
(Harrogate, UK). The automated matrix TM-sprayer was supplied on loan by Leap 
Technologies, Inc (North Carolina, USA). 
 
3.2.2 Tissue Preparation 
A whole rat brain, wet weight 1.916 g was homogenised in 3 mL of distilled water, giving a 
40 % homogenate. This was frozen at -80°C for 24 h. Upon removal from the freezer the 
homogenate was allowed to defrost and using a pipette small amounts were added to a 
cryostat chuck. This was carried out in such a way as to build a sufficient enough amount 
to be sectioned. Serial sections of homogenates were then taken at 20 µm on a Leica 
cryostat, transferred to a stainless steel MALDI target plate.  
 
A whole rat brain was removed from the -80°C freezer and transferred to the -20°C 
cryostat chamber and allowed to equilibrate. The rat brain was then bisected and half was 
mounted onto a cryostat chuck, using water-ice slush. Serial sagittal sections of the brain 
were taken at 12 µm and thaw mounted onto stainless steel MALDI target plates. The 
MALDI plates were placed in a -80°C freezer until analysis.  
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3.2.3 Matrix Application 
The automated matrix TM-sprayer was supplied on loan by HTX Technologies, LLC. For 
deposition using the TM-sprayer, several plates were coated in 5 mg/mL αCHCA matrix 
material, prepared in 80% methanol (0.1% TFA). Plates were sprayed at 150°C, 10 psi, a 
flow rate of 0.25 mL/min with a stage velocity of 500 mm/min, as optimised for this matrix 
and solvent system. Each target insert was sprayed with 4 or 8 cycles. 
For airbrush deposition (Badger Airbrush Ltd, UK), the MALDI target insert was held in a 
fume hood using a clamp,  25 mg/mL αCHCA matrix material solution, (prepared in 80% 
methanol (0.1% TFA)) was deposited over each plate in cycles, allowing time to dry 
between each cycle. Deposition was carried out from a distance of 15-20 cm, the plate 
was rotated 90° between each cycle to ensure an even distribution, deposition was 
deemed optimal when 9 mLs had been deposited. 
 
3.2.4 Instrumentation 
The homogenate samples were analysed using an Applied Biosystems (Toronto, Canada) 
hybrid quadrupole time-of-flight (QqTOF) instrument (Qstar XL). The instrument was fitted 
with an orthogonal MALDI ion source and a nitrogen laser (337nm), operated at 20 % 
available power with a repetition rate of 20Hz. The instrument was operated in the 
positive ion reflectron mode, recording all signals between m/z 50-1000. Data collection 
was via an automated pre-determined pattern analysis over the tissue, using a Q1 scan 
time of 1 second, summing 9 scans per spectrum obtained. Mass spectral data was 
analysed using Analyst software supplied by Applied Biosystems. 
 
For imaging investigations MALDI mass spectrometric analysis was carried out using an 
Applied Biosystems (Toronto, Canada) hybrid quadrupole time-of-flight (QqTOF) 
instrument (Qstar Elite), operated in positive ion reflectron mode. Instrument parameters 
had been previously optimised for the analysis of PCs from rat brain, data was acquired 
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between the mass range m/z 50-1000. The Nd:YAG (355nm) laser was operated at 20 % 
available power (2.1 µJ), with a repetition rate of 500 Hz. The target plate stepping 
distance was set to 100 µm for both the x and y dimension using the imaging acquisition 
software. Data were acquired using the ‘dynamic pixel’ setting, which involves the laser 
being moved within the 100 µm2 pixel area and resultant data being summed to give an 
accumulated mass spectrum over one second for each pixel area. The resulting two-
dimensional ion density maps were generated using the TissueView software, after 
conversion of the raw data into the format required using the ‘wiff to analyse’ script, 
provided by applied biosystems. 
 
 
3.3 Results and Discussion 
 
3.3.1 Optimisation of the TM-Sprayer 
 
Matrix deposition via airbrush application is a widespread commonly used technique that 
has been discussed in detail elsewhere. It will therefore only be discussed as a 
comparison to the automated Leap TM-sprayer. The TM-sprayer has a number of 
parameters that can be adjusted for a given matrix and solvent system to ensure a fine 
even distribution of matrix crystals. These parameters include; adjustable nozzle height; 
the block temperature; matrix deposition rate; air pressure; stage speed and offset/line 
spacing of deposition. The precision robot that controls the x-y sample stage has a variety 
of spray pattern designs that can be applied for deposition. All parameters were controlled 
by a Microsoft WindowsTM interface that was relatively easy to operate. Due to time 
constraints and to reduce the time taken for optimisation, the nozzle height was kept at 
distance of 40 mm from the sample plate, and the stage velocity was kept at 500 mm/min, 
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all other parameters where optimised around these. Initial optimisation used single line 
deposition methods to establish parameters that appeared to deposit the matrix without 
being too wet or too dry. Over wetting was seen as spluttering along, and increasing out 
from the edges of the deposition line. A deposition was considered too dry if the matrix 
colouring on the plate was very light, or the deposition showed no signs of wetness upon 
contact with the plate.  The psi, flow rate and temperature were varied until a smooth 
densely coloured line was achieved along the MALDI target plate. A flow rate above 0.25 
mL/min resulted in deposition lines with increased diameter, when coupled with a lower 
temperature this often caused spluttering and blocking of the capillary nozzle. A psi and 
flow rate too low resulted in insufficient levels of matrix deposition on the plate. The 
optimal psi and flow rate was determined to be 10 psi and 0.25 mL/min.  The optimal 
temperature was then determined from these parameters, starting at 80 C the 
temperature was increased in increments 10 C, until matrix deposition appeared as an 
even, smooth line on the plate. It was critical for the matrix to appear wet on deposition, 
for optimal analyte extraction, but with rapid solvent evaporation, as to minimise analyte 
delocalisation. This was optimised as 150 C. The vertical line spacing between 
depositions was set to 3 mm, this was determined to be the thickness of the deposition 
line. The line offset stepping distance between each full deposition cycle was then set to 
25 mm, on observation it was noted the outer areas of deposition lines had a slightly 
thinner matrix deposition, thus a slight overlap was chosen to ensure these areas had 
similar amounts deposited. Deposition of matrix via the TM-sprayer produced what 
appeared to be a thick dense film of bronze coloured matrix, evenly distributed over the 
target plate and tissue area. Once optimised matrix deposition was carried out in minutes 
for each plate. 
Airbrush deposition produced finely dispersed droplets, which are built up in an almost 
‘seeding’ technique; resulting in a near homogenous distribution of minute crystals over 
the target plate. Deposition using the airbrush usually takes around 20 min per plate. The 
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entire matrix is deposited directly onto the plate with the TM-sprayer, whereas with 
airbrush application, it is impossible to accurately calculate how much matrix gets 
deposited onto the plate, and thus the tissue surface. 
 
 
3.3.2 Comparison of Deposition Methods for MALDI-MS 
 
Tissue homogenates were used for the optimisation of the TM-sprayer. Homogenates 
were chosen as they enable analysis of a sample with the same properties of tissue, but 
with even analyte distribution throughout. This ensures differences that may occur are not 
due to variations of analyte distribution within the tissue sections, such as regional 
changes of PLs within the different anatomical compartments of the brain, but are a true 
representation of the different matrix deposition methods. Firstly the number of robotic 
deposition cycles was optimised for the TM-sprayer, this involved a comparison of 4 and 8 
repeated cycles. These automated methods were compared to the previously optimised 
airbrush deposition method. Similar peaks were detected in MALDI-MS analysis of tissue 
homogenates prepared by each deposition method; however the ion intensities were 
extremely different, as shown in figure 3.1.  The base peak was the same for all spectra 
acquired at m/z 265, however, at over 7000 counts for the airbrush deposition method, 
this peak was over three-fold higher for the TM-sprayer 4 cycle method, and two-fold 
higher for the 8 cycle method. The base peak at m/z 265 and the peak at m/z 221, are 
matrix salt adduct peaks that are usually observed above all other matrix peaks on tissue. 
These peaks are thought to be predominantly observed from brain tissue due to the high 
concentration of salts found within the brain. The difference in signal intensity observed 
for these peaks is believed to be due to the different concentration of αCHCA used for 
each method, 25 mg/mL for airbrush deposition, compared to 5 mg/mL for deposition by 
the TM-sprayer. The high signal intensity for m/z 265 observed with the airbrush method 
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dominates the spectra and masks many of the lipid species detected, as shown in the top 
spectrum of figure one. The region between m/z 650-900 had to be enlarged within this 
spectrum for these species to be clearly visible. The commonly reported lipid species that 
usually dominate this region of mass spectra when analysing brain tissue[41, 155, 165, 
166, 171, 230-232], are not the most abundantly observed here. For example, m/z 772, 
798 and 826, representing [M+K]+ for PC 32:0, PC 34:1 and PC 36:1, are all present but 
their intensities were incredibly low with airbrush deposition, at 30, 69 and 32 counts. 
These species were detected with much higher signal intensity for the TM-sprayer, for 
both deposition cycle methods, as shown in figure 3.1. The 4 cycle method produced a 
seven-fold increase for m/z 772, over a six-fold increase for m/z 798 and over a three-fold 
increase for m/z 826 compared to airbrush deposition method. The TM-sprayer applying 8 
deposition cycles, showed over a thirteen-fold increase for both m/z 772and 798, and 
over a nine-fold increase for m/z 826 compared to the airbrush method.  
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Figure 3.1. MALDI mass spectra of rat brain homogenate acquired using the manual 
airbrush (top spectrum), automated TM-sprayer, 4 cycles (middle spectrum), and 
automated TM-sprayer, 8 cycles (bottom spectrum). The difference in ion intensity for the 
base peak and lipids of interest, between m/z 700-900 is clearly visible. 
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As previously mentioned, the region of interest for lipid analysis, m/z 700-900, shows a 
very different lipid profile for the analysis of brain homogenates, compared to those 
usually observed in MALDI-MS analysis of whole rat brain sections.  The most abundant 
peaks within this region of the mass spectrum are predominantly odd numbered m/z, 
rather than the commonly observed even numbered species reported in chapter 2 and 
literature[41, 155, 165, 166, 171, 230-232]. These peaks are believed to be fragment 
peaks of the commonly observed species, resulting from the neutral loss (NL) of 
trimethylamine from the phosphocholine head group. Trimethylamine (N(CH3)3) has a 
mass of 59 u, thus m/z 713, 739 and 767 are [M+K-N(CH3)3]+ for the three commonly 
observed lipids, PC 32:0, PC 34:1 and PC 36:1. This fragmentation pathway is more 
commonly observed in the analysis of brain tissue by SIMS[251]. The difference in signal 
intensities for these peaks, for the different matrix deposition methods, follows the same 
trend as when observing the intact molecules, with the TM-sprayer 8 cycle deposition 
method giving the highest signal intensities.  The increase in signal intensities however, is 
smaller when reviewing these peaks, with a six-fold increase for m/z 713 and 739, and a 
five-fold increase for m/z 767, for the TM-sprayer 8 cycle method compared to the 
airbrush method. Due to the presence of multiple ions for a given lipid species, it is 
necessary to monitor the sum of all ions for a more accurate assessment of the difference 
in sensitivity for each method. The summation of ion counts for a specific lipid species, for 
example, the sum of [M+H]+, [M+Na]+, [M+K]+ and [M+K-N(CH3)3]+, for PC 32:0, showed 
the same difference in signal intensity was observed, as when reviewing the fragment 
peaks, [M+K-N(CH3)3]+. The TM-sprayer, using 8 deposition cycles proved far more 
sensitive than both the 4 cycle deposition and the manual airbrush, regarding spectral 
quality, detection sensitivity and mass resolution, which is clearly demonstrated by the 
green trace in the overlay spectrum presented in figure 3.2. The peaks at m/z 713, 739, 
798 and 826 have been enlarged, the peak height and shape for airbrush deposition is of 
extremely low quality as shown by the blue trace. The peak height is greatly increased for 
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the TM-sprayer 4 cycle method, as shown by the red trace, however the resolution for the 
peak at m/z 826 is still rather poor, as demonstrated by the peak shape. For all other 
investigations the TM-sprayer 8 cycle method was used, as this gave better overall results 
compared to the 4 cycle deposition method. 
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Figure 3.2. MALDI mass spectral overlay acquired from a rat brain homogenate for the 
airbrush deposition method (blue trace), TM-sprayer 4 cycle deposition (red trace) and the 
TM-sprayer 8 cycle deposition (green trace). The difference in spectral quality is clearly 
visible when observing the enlarged peaks at m/z 713 for [PC32:0+K-N(CH3)3]+, m/z 739 
representing [PC34:1+K-N(CH3)3]+, m/z 798 for [PC34:1+K]+, and m/z 826 representing 
[PC36:1+K]+. 
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3.3.3 Evaluation of Reproducibility 
 
To assess or compare the reproducibility of the TM-sprayer against the airbrush method, 
three MALDI plates were prepared for each method and analysed as described in the 
matrix deposition and instrumentation (imaging) section of the method. Single point 
spectra were analysed from ten different locations on each plate for each method, 
comparisons were made for inter- and intra-plate variability. Due to the high abundance of 
matrix peaks along with their high signal intensities, all peaks with a signal above 100 
counts were summed. For the investigation of laser spot-to-spot reproducibility, or inter-
plate variability, the summed ions at each location for an individual plate were compared 
for each method. The mean of the summed ions for each plate was then calculated 
(n=10) to investigate the plate-to-plate variability for each method.  The irreproducibility 
issues associated with the manual airbrush deposition method are known, and were 
highlighted in chapter 2.  The investigation of the spot-to-spot reproducibility across each 
plate, for each method, showed both methods suffer with variability. The data obtained 
from the analysis of plates 2 and 3 for airbrush deposition show areas of high and low ion 
counts, as show in figure 3.3, demonstrating so called ‘sweet spot’ areas, and areas of 
low matrix deposition. The results from plate 1 for this method show a high reduction in 
the variability of ion counts at each location on the plate.  
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Figure 3.3. MALDI-MSI single point spectral data taken from 10 different regions on the 
MALDI target plate, for airbrush deposition. All matrix peaks above 100 counts were 
summed for each location. Results show quite high spot-to-spot variability for plates 2 and 
3, inter-plate variability is greatly reduced for plate 1. 
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Similar results were obtained from the spectra from plates 1 and 3 for TM-sprayer 
deposition, these plates also showed high spot-to-spot variability; this is particularly 
evident in the data presented for plate 1 in figure 3.4. There is an incredibly high spike in 
ion counts at location 4 of plate 1, indicative of a higher concentration of matrix within this 
area; again this is the ‘sweetspot’ effect. The review of plate 2 from this deposition 
method shows reduced variability of ion counts between each location on the plate.  
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Figure 3.4. MALDI-MSI single point spectral data taken from 10 different regions on the 
MALDI target plate, for the TM-sprayer deposition method. All matrix peaks above 100 
counts were summed for each location. Results show quite high spot-to-spot variability for 
plates 1 and 3, inter-plate variability is greatly reduced for plate 2.  
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On observation it would appear that plate 1 for airbrush deposition shows a higher degree 
of spot-to-spot reproducibility across the plate compared to plate 2 for TM-sprayer 
deposition, figures 3.3 and 3.4 respectively. This is not the case, it appears this ways 
because of the high intra-plate variability for the airbrush method, the scale difference 
caused by the large range between ion counts across the plates, gives plate 1 the 
appearance of a near homogenous matrix distribution, apparent by near equal columns 
representing each location. Comparison of coefficient of variation (CV) for plate 1, 
airbrush deposition, and plate 2, TM-sprayer, showed the latter to be more reproducible 
across the plate. The CV for plate 1, airbrush deposition was 36 %, compared to 18 % for 
plate 2 TM-sprayer. Interestingly, plate 3 using airbrush deposition had the lowest CV of 
the 3 plates analysed for this method, at 24 %, this, however, is still higher than that 
achieved with the TM-sprayer. 
 
The Intra-plate reproducibility for each method was assessed by summing the ions taken 
from the single point spectral analysis, and calculating the mean from the 10 locations. 
The TM-sprayer was shown to be far more reproducible across plates than deposition by 
airbrush, as shown by figure 3.5. The coefficient of variation (CV) between the plates for 
the automated TM-sprayer was 18 %, whereas the CV for the manual airbrush method 
was 53 %, thus the TM-sprayer shows over a two-fold reduction in variability compared to 
the widely used airbrush method.  
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Figure 3.5. MALDI-MS single point spectral data taken from 10 different regions on the 
plate, for 3 different plates. Every matrix peak above 100 counts was summed and the 
mean ion counts ± SD (n=10) displayed. There is less variance between the amounts of 
matrix deposited using the TM-sprayer (blue columns) compared to the airbrush method 
(red columns).  
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3.3.4 Comparison of Deposition Methods for MALDI-MSI 
 
The comparison of matrix deposition methods thus far has shown spectral quality, 
regarding detection sensitivity, S/N, mass resolution and reproducibility, were enhanced 
with the TM-sprayer. The next investigation sought to assess whether these results were 
translated to imaging studies, producing the same spectral and thus image quality, with 
high image spatial resolution, without causing analyte delocalisation. The images of 
sagittal rat brain sections acquired using the TM-sprayer and airbrush deposition methods 
are presented in figure 3.6 and show mutual distributions. Images of m/z 772 representing 
[PC 32:0+K]+, clearly follow the contours of grey matter regions of the brain, as found in 
chapter 1 and literature[12, 165, 166, 171], demonstrating little or no analyte 
delocalisation has occurred. The image presented for airbrush deposition shows well 
defined brain anatomy, however, the appearance is rather grainy, as is commonly 
observed with this method. Conversely, the image presented using the TM-sprayer shows 
well defined anatomy, without the grainy appearance that was seen with airbrush 
deposition, this image is smooth, displaying a much improved resolution. The signal 
intensity is again higher for the TM-sprayer compared to the airbrush method, as shown 
by the intensity bars for each image. The image of m/z 772 for airbrush deposition 
displays an area of higher signal intensity around the tissue; this has previously been 
observed in MALDI imaging experiments and is known as the ‘halo’ effect. It is thought to 
be associated with tissue shrinking during sample preparation or once in the vacuum of 
the MALDI source. Images of m/z 826 show higher signal intensities within white matter 
regions of the brain, which is in agreement to the previously reported distribution of this 
lipid by MALDI-MSI[165, 166, 171]. Images are again more highly resolved, and the signal 
intensity is higher for the TM-sprayer compared to airbrush deposition. Spatial resolution 
is controlled or limited by a number of factors, including the size of the laser spot, the size 
of the matrix crystals and the coverage of matrix on the tissue[248-250]. As the laser was 
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the same for both applications the higher resolution images seen with the TM sprayer is 
attributed to the method used for the matrix application, and thus the formation of crystals 
and crystal size on the tissue. That is that the TM sprayer produced finer crystals. This 
could be due to a number of factors, including the lower concentration used, the 
controlled pressure and flow rate, the velocity of the sample stage during deposition and 
finally, the temperature used during deposition. These are all key factors affecting the way 
the matrix is deposited on the tissue surface.   
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Figure 3.6. MALDI-MS images of m/z 772, top images and m/z 826, bottom images. 
Images representing the automated TM-sprayer are displayed on the left, and images for 
the manual airbrush deposition method are displayed on the right. There is over a two-fold 
increase in signal intensity for the TM-sprayer compared to the airbrush.  
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It should be noted that images presented are the raw, unprocessed data, and many 
groups do apply normalisation and smoothing algorithms, that enhance the appearance of 
MALDI-MS images produced using airbrush deposition[155, 252, 253]. 
The commonly reported lipid species listed in table 3 of chapter 2 are all detected with 
both deposition methods; however the detection sensitivity was far superior with the TM-
sprayer, as shown by the spectra presented in figure 3.7. The TM-sprayer demonstrates a 
5-10 fold increase in sensitivity depending on which lipid species is observed from the 
analysis of single point spectra, both of which were taken from the cerebral cortex of the 
brain. The spectral quality is far superior for the TM-sprayer, showing higher S/N, and a 
much cleaner spectrum compared to airbrush deposition, the latter is thought to be 
predominantly due to the lower concentration of matrix used, resulting in less spectral 
interference from matrix peaks. 
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Figure 3.7. Single point MALDI mass spectra taken from the cerebral cortex of rat brain 
sections, for the TM-sprayer (top spectrum) and airbrush (bottom spectrum) deposition 
methods. The increased signal intensity, S/N, and detection sensitivity, along with 
decreased spectral complexity for the TM-sprayer is evident.  
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3.4 Conclusion 
 
The MALDI-MS analysis of brain homogenates for profiling studies and whole serial 
sagittal sections for imaging studies, proved the automated TM-sprayer to be superior 
across all experiments, when compared to the traditional airbrush method for matrix 
deposition. This deposition method demonstrated  small crystal size and a homogenous 
coverage, high analyte extraction and co-crystallisation, and no analyte delocalisation. 
This was evidenced throughout this chapter, initially with the investigation of tissue 
homogenates, in which the TM-sprayer showed over a five-fold increase in detection 
sensitivity, and far greater mass resolution compared to airbrush deposition, across all 
species analysed. The spectral profile for the analysis of tissue homogenates differed 
from those usually observed for the MALDI-MS analysis of rat brain material in positive 
ion mode[12, 41, 164-166, 171, 230]. The characteristic even numbered peaks, 
particularly those representing PC 32:0 and PC 34:1, usually the most abundant peaks, 
as shown in literature, chapter 2 and the spectrum presented in figure 6 of this chapter, 
where not the most abundant here. The most abundant peaks in the analysis of tissue 
homogenates were odd numbered, at m/z 713 and 739, PC 32:0 and 34:1 are the most 
abundant phospholipids in rat brain, and thus these peaks are attributed to fragment 
products of these lipids, resulting from the loss of trimethylamine from the phosphocholine 
head group. The nature of the tissue homogenates, or the way in which they were 
prepared is believed to have resulted in lipid degradation. This is further evidenced by the 
high abundance of peaks between m/z 350-550, peaks within this range result from the 
neutral losses of fatty acids and trimethylamine[114, 254].  MALDI-MSI investigations also 
demonstrated spectral quality, detection sensitivity, S/N and image resolution were all far 
superior with the samples prepared using the TM-sprayer for matrix deposition. There 
was also minimal interference from matrix clusters found within the same m/z range of 
lipids species of interest; this is a common occurrence with airbrush deposition.  The 
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difference in matrix concentration is thought to be attributed to the cleaner spectra 
observed after deposition by the TM-sprayer, as it uses a concentration five times less 
than airbrush methods. A concentration of 25 mg/mL αCHCA was found to be optimum 
for MALDI-MSI within this group, thus lowering the concentration would have resulted in 
lower analyte signals. The TM-sprayer is equipped with a number of adjustable 
parameters, which are all believed to contribute to the production of a finely dispersed 
mist of minute matrix-solvent droplets. These include the flow rate, line spacing between 
depositions, sample stage speed and particularly the heated nozzle/gas flow. The high 
temperature applied during deposition ensures the solvent evaporates rapidly, minimising 
analyte delocalisation, but resulting in a fine sheet of co-crystals, which improves image 
rsolution. The TM-sprayer showed over a two-fold reduction in variability compared to 
airbrush deposition, reproducibility is one of the biggest drawbacks for the latter method. 
A more reproducible deposition method, as presented here, will aid in minimising the 
problems associated with inter- and intr- laboratory variability, due to irreproducible matrix 
deposition methods.  
At the time of investigation (early 2008) the only literature available on the application of 
the TM-sprayer for MALDI-MSI was the technical note, which showed high resolution 
images for peptides and proteins in tissue. A study has been published more recently 
using the TM-sprayer for the MALDI-MSI investigation of a drug, results presented 
correspond well to those observed in this chapter. The study by Yamada et al. (2010), 
analysing chloroquine distribution in rat ocular tissue by MALDI-MSI, found the TM-
sprayer resulted in much improved sensitivity, showing a fourteen-fold increase in signal 
compared to the airbrush method[255]. Collectively these results have proven the TM-
sprayer can be applied to the MALDI-MSI of large (peptides and proteins), and small 
(drugs and lipids) molecules, enhancing the spectral and image quality, detection 
sensitivity, mass resolution and reproducibility. Once optimised for a solvent system this 
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method is both fast and efficient, and a much lower concentration and thus consumption 
of matrix material also make the TM Leap sprayer attractive tool for MALDI-MSI.  
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4. Imaging of Phospholipids in Formalin Fixed Rat Brain Sections 
by Matrix Assisted Laser Desorption/Ionisation Mass 
Spectrometry 
 
4.1 Introduction 
 
Traditional analysis of pathological specimens employs histological staining procedures to 
investigate tissue anatomy[256, 257]. Labelled antibodies are often used in conjunction 
with staining protocols for the visualisation of specific biomarkers that aid in the diagnosis 
and prognosis of diseases; this is a subset of histology known as immunohistochemistry 
(IHC)[256-259]. IHC, as with other molecular labelling methods, are often limited in their 
ability to yield information on multiple species in a single section. Mass spectrometry 
imaging offers simultaneous label free analysis of multiple species in a single experiment, 
providing significant insights into disease pathogenesis[4, 104, 176, 203, 219, 225, 260-
264]. Conventional methods for collection and storage of tissue for histological evaluation 
uses formalin fixation to chemically preserve the tissue by preventing proteolytic 
degradation[265]. Formalin fixation (FF) causes inter and intra cross-linking between 
proteins and proteins and nucleic acids, which presents issues for direct analysis of 
proteins by IHC and mass spectrometry[266-268]. This cross linking is thought to 
predominantly involve hydroxymethylene bridges, but it has also been suggested that 
formation of coordinate bonds for calcium ions may play a role[269]. The net result is the 
masking of epitopes (antibody binding sites).  There are several techniques for reversing 
this cross-linking, to ‘un-mask’ these epitopes, which are widely used in IHC and referred 
to as ’antigen retrieval methods’. These methods involve enzymatic digestion, protein 
denaturation, heat treatment and heat-induced antigen retrieval (HIAR)[267, 269, 270].  
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Investigators attempting to analyse proteins in fixed tissue via MALDI-MSI have explored 
the use of enzymatic digestion prior to analysis[162, 268, 271, 272]. Research has also 
involved development of MALDI compatible staining protocols[204] as well as performing 
MALDI prior to histological staining[273]. These studies have aimed to establish methods 
that would permit direct comparison and correlation of images from microscopy and mass 
spectrometry. Compatible protocols would facilitate full correlation of spectral data with 
areas of interest highlighted in high resolution microscopy and enable analysis of proteins 
in archival material by MALDI. Analysis and imaging of lipids from formalin fixed tissue 
sections would improve correlation of MS lipid data with histological findings, and permit 
MALDI analysis of sections prepared from organs stored in formalin. Lipid profiles have 
been investigated from formalin fixed bovine lens tissue[274], but imaging of 
phospholipids directly from formalin fixed tissue sections has not been presented. 
 
This chapter investigates the effects of formalin fixation on analysis and imaging of 
phospholipids in tissue sections. Several studies have already reported the distribution of 
the commonly known phospholipids within the anatomical regions of the brain in fresh 
tissue sections[10, 12, 14, 155, 165, 166, 172, 205, 230, 232, 233, 238, 275-278]. Results 
from these studies provide a useful basis for the assessment of new sample preparation 
methods for MALDI-MSI. MS images and spectral data obtained from analysis of formalin 
fixed tissue are compared directly to data from fresh tissue. The effects of formalin fixation 
are considered with respect to image quality, sensitivity and the localisation of selected 
species. Studies were also conducted to assess the differences in salt adduct formation of 
lipid species ionised from fresh and fixed tissue. Prolonged storage in formalin is also 
evaluated. 
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4.2. Experimental 
 
4.2.1 Materials 
Alpha-cyano-4-hydroxy cinnamic acid (α-CHCA) and trifluoracetic acid (TFA) were 
purchased from Sigma-Aldrich (Dorset, UK).  10% neutral buffered formalin (NBF) was 
supplied by the Histology Department of the Medical School at the Royal Hallamshire 
Hospital, (Sheffield, UK). Methanol was purchased from Fisher Scientific (Loughborough, 
UK). Whole control rat brains were supplied by Covance, (Harrogate, UK).  
 
Tissue Preparation for MALDI MSI of Phospholipids 
A whole rat brain was removed from the -80°C freezer and allowed to thaw at room 
temperature. Once thawed the brain was placed in 10% NBF and fixed for 48-72 h, 3 
weeks, 12 months and 18 months. Fixed and fresh brains were bisected and half of each 
was mounted onto a cryostat chuck, using water-ice slush. Serial sections of each brain 
were taken at 12 µm and thaw mounted onto stainless steel MALDI target plates for mass 
spectrometry and glass slides for histology. For formalin spiked tissue analysis, 12 µm 
serial sections of fresh brain were prepared as above and subsequently spiked with 0.1 µl 
of formalin in 9 locations.  
 
4.2.2 Matrix Deposition 
For the initial evaluation of formalin fixation, following standard histological processes of 
fixation for 48-72 h, and for MS/MS analysis, tissue samples were coated in 5 mg ml-1 
αCHCA matrix material, prepared in 80% methanol (0.1% TFA) using the automated TM-
sprayer (HTX Technologies, LLC, North Carolina, USA). Plates were sprayed at 150°C, 
10 psi, a flow rate of 0.25 ml/min with a stage velocity of 500 mm/min. Each target insert 
was sprayed with 8 cycles, as optimised in Chapter 3. 
115 
 
Matrix deposition for the analysis of formalin spiked tissue samples, and the investigation 
into the effects of prolonged storage in formalin fixative, was carried out via airbrush 
deposition (Badger Airbrush Ltd, UK), the MALDI target insert was held in a fume hood 
using a clamp, 25 mg/mL αCHCA matrix material solution, (prepared in 80% methanol 
(0.1% TFA)) was deposited over each plate in cycles, allowing time to dry between each 
cycle. Deposition was carried out from a distance of 15-20 cm, the plate was rotated 90° 
between each cycle to ensure an even distribution, deposition was deemed optimal when 
9 mL had been deposited. 
 
4.2.3 Mass Spectrometry 
Experiments were carried out on a QqTOF (Qstar Elite) mass spectrometer (Applied 
Biosystems, Foster City, USA), operated in positive ion reflectron mode. Instrument 
parameters had been previously optimised for the analysis of PCs from rat brain, data 
were acquired between the mass range m/z 50-1000. The Nd:YAG (355nm) laser was 
operated at 20 % available power (2.1 µJ), with a repetition rate of 500 Hz. The target 
plate stepping distance was set to 100 µm for both the x and y dimension using the 
imaging acquisition software. Data were acquired using the ‘dynamic pixel’ setting, which 
involves the laser being moved within the 100 µm2 pixel area and resultant data being 
summed to give an accumulated mass spectrum over one second for each pixel area. 
The resulting two-dimensional ion density maps were generated using the TissueView 
software, after conversion of the raw data into the format required using the ‘wiff to 
analyse’ script, provided by applied biosystems. 
For MS/MS analysis instrument parameters and laser power were as described above, 
the collision gas was argon, used at a collisional activation energy of 35 V, this was 
optimised from tandem profiling analysis of lipids directly from rat brain. Images were 
acquired at 50 µm for both the x and y dimension, using oversampling as previously 
described [247]. The number of data points within a data set for these imaging 
116 
 
experiments were too high to be converted using the ‘wiff to analyse’ script, the images 
from these investigation were processed using oMALDI 5.1 software (supplied by MDS 
Analytical Technologies, Ontario, Canada). 
 
For the investigation into the effects of prolonged storage in formalin, experiments were 
conducted on a QqTOF (Qstar XL, Applied Biosystems, Foster City, USA) mass 
spectrometer equipped with a nitrogen laser (337 nm), operated at 25 μJ with a repetition 
rate of 20 Hz. TOF-MS data were acquired in the positive ion reflectron mode, over the 
m/z range 50-1000. The spatial resolution was set to 200 μm in both the x and y 
dimensions and a summed spectrum from each area was collected using ‘dynamic pixel’ 
(oMALDI 5.1, MDS Sciex). Ion images where generated using BioMap (MALDI-MSI.org). 
 
 
4.3 Results and Discussion 
 
4.3.1 MALDI-MSI of Formalin Fixed Rat Brain Sections 
 
Analysis of formalin fixed rat brain sections, without any pre-treatment, yielded high 
quality molecular images for several phosphatidylcholine (PC) and sphingomyelin (SM) 
species. MALDI-MS images of selected lipid species clearly highlight the specific 
anatomical regions of the brain, as illustrated by comparing the labelled H&E stained 
section in figure 4.1 with MALDI-MS images (figure 4.1). For example, PC 36:4, m/z 804, 
is highly localised within the hippocampus, as shown by the ion intensity within this 
region. Lower ion counts for this species are observed in the cerebral cortex, striatum and 
molecular/granular layer of the cerebellum. The corpus callosum, thalamus, midbrain, 
pons, and medulla regions are outlined by very low or zero intensity regions. Conversely 
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PC 38:/40:4 (m/z 838), was not detected or displayed very low counts in the 
hippocampus, molecular and granular layers of the cerebellum, cerebral cortex and 
striatum regions (grey matter regions). High ion counts for this lipid were observed within 
the corpus callosum, optic chiasm and arbour vitae area of the cerebellum (white matter 
regions of the brain).  
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Figure 4.1. MALDI-MS images of PC and SM species from formalin fixed sagittal rat brain 
sections with a haematoxylin and eosin (H&E) stained sagittal section. Regions of 
anatomical interest are labelled. Image intensity ranges from 500-10,000. 
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CTX=cerebral cortex, CC=corpus callosum, 
HP=hippocampus, S=Septum, TH=thalamus, MD=mid 
brain, CB=cerebellum, M=medulla, P=pons, PG=pituitary 
gland, HY=hypothalamus and OC=optic chiasm. 
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The lipid images presented in figure 4.1, from formalin fixed tissue, correspond well with 
previously published data[10, 12, 14, 155, 165, 166, 172, 205, 230, 232, 233, 238, 275-
278] and unpublished data obtained in this laboratory, for the analysis of lipid species 
directly from fresh rat brain sections. The three most commonly imaged lipid species 
within the rat brain to date, PC 32:0, PC 34:1, and PC 36:1, all display similar distributions 
to data published by Wang and co-workers (2008) [165]. The MALDI image of m/z 760 
[PC 34:1+H]+ shows an omnipresent distribution in the brain (data not shown), however 
images of m/z 782 and 798, which represent the sodium and potassium adduct 
respectively, show decreased ion counts within the corpus callosum and arbour vitae 
region of the cerebellum. These results indicate that multiple species are detected within 
this spectral region. Similar results for freshly prepared sagittal sections have been 
obtained within our laboratory. The sodium adduct for PC 34:1, m/z 782 shares the same 
m/z as the protonated species of PC 36:4 and with the growing number of lipid species 
being identified it is highly possible that numerous other lipid species share this mass 
range. 
The image of PC 32:0 (m/z 756) displays high ion counts outlining the grey matter regions 
of the brain. This is one of the most predominant PC species ionised in positive ion mode 
and all adducts of this lipid share the same lateral distribution. In contrast to Wang et al 
(2008) [165], data presented here for the distribution of PC 36:1 (m/z 810) show this lipid 
is not confined mainly within white matter regions of the brain. An even distribution of PC 
36:1 across most areas of the brain is presented in figure 4.1, but lower intensity counts 
are seen within the hippocampus and the cerebellar cortex. It should be noted that this 
study used sagittal rat brain sections whereas Wang and co-workers (2008) [165] 
analysed coronal sections. In addition, we have employed a different matrix system which 
may account for the differences seen. The sodium adduct for PC 36:1 is detected at the 
same m/z as the protonated species of PC 38:4. The occurrence of overlapping species 
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in the spectral region of interest highlights that care must be taken in the interpretation of 
MS images. 
The images presented show some evidence of laser ‘oversampling’[247], which results in 
areas of lower ion intensity, in a geometric arrangement across the image area. This is 
often seen in high resolution MALDI-MS images. 
A list of the lipid species ionised from both fixed and fresh tissue preparation is shown in 
table 4.  
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Peak Assignments for Fixed and Fresh 
Tissue 
m/z Assignment 
725.50 SM 16:0 + Na 
734.57 PC 32:0 + H 
741.50 SM 16:0 + K 
753.50 SM 18:0 + Na 
754.58 PC 32:1 + Na 
760.59 PC 34:1 + H 
769.50 SM 18:0 + K 
770.57 PC 32:1 + K 
781.60 SM 20:0 + Na 
782.56 PC 34:1 + Na 
784.57 PC 34:0 + Na 
786.58 PC 36:2 + H 
788.61 PC 36:1 + H 
798.55 PC 34:1 + K 
800.55 PC 34:0 + K 
804.55 PC 36:4 + Na 
808.59 PC 36:2 + Na 
810.60 PC 36:1 + Na 
820.54 PC 36:4 + K 
824.62 PC 36:2 + K 
826.58 PC 36:1 + K 
828.56 PC 38:6 + Na 
832.61 PC 38:4 + Na 
835.60 SM 24:1 + Na 
838.63 PC 38:1 + Na 
844.52 PC 38:6 + K 
848.60 PC 38:4 + K 
851.60 SM 24:1 + K 
856.58 PC 40:6 + Na 
 
Table 4. Tentative assignment of lipid species detected in both fresh and fixed tissue with 
their respective m/z values. 
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The images presented in figure 4.2 along with spectral examination of these samples 
(figure 4.3) revealed different ionisation pathways are favoured with FF tissue compared 
to fresh. The sodium adduct is the most abundant species in the former compared to the 
potassium adduct in the latter. This was observed for all lipids that have previously been 
reported by MALDI-MSI. There are also clear differences in the spectra obtained for the 
fixed and the fresh sections, as demonstrated by the spectral overlay presented in figure 
4.3. The [M+Na]+ is the most abundant  ion in fixed tissue as shown by the red peaks in 
the spectra, whereas the [M+K]+ ion is the predominant in fresh tissue as shown by the 
blue peaks in the spectra. The mass shift of 16 mass units (u) is clearly visible for each 
lipid species detected, particularly in the enlarged spectral region, in which the [M+Na]+ 
and [M+K]+ adducts  of PC 32:0 and PC34:1 are labelled. This was further investigated by 
comparing single point spectra obtained from eight different anatomical regions of the 
brain, for fixed and fresh tissue (data not included). The ion counts for the [M+H]+, 
[M+Na]+ and [M+K]+ ions of PC 32:0, PC 36:1, and SM 18:0 for fixed and fresh were 
compared. For all species and every location investigated the [M+Na]+ ion is the 
dominating species for fixed tissue and the [M+K]+ ion was found to be the most abundant 
ion detected  in fresh tissue. The salt content in brain is high, which could be why sodium 
and potassium adducts are often seen when analysing brain tissue. The sodium content 
of the buffered formalin may be responsible for the increase in sodium adduct formation 
seen. This would explain the difference observed in the ionisation pathways for the 
respective sample preparation methods. A recent report published by Sugiura and co-
workers (2009)[171] shows selective ionisation pathways are observed with the addition 
of alkali metals to the matrix solution. This supports the theory of the sodium in the 
buffered formalin being responsible for the change in ion species seen for the fixed tissue 
analysis. 
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Figure 4.2. MALDI-MS images of PC 32:0 in sagittal rat brains sections of fixed and fresh 
tissue, for the automated matrix deposition method. Images on the left represent the 
[M+K]+ against the [M+Na]+ in fresh sections, whilst images on the right represent the 
[M+K]+ against the [M+Na]+ in fixed sections. 
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Figure 4.3. MALDI-MS single point spectra taken from the cerebral cortex area of fresh 
(blue) and fixed (red) tissue. An enlarged spectral region of interest (m/z) is presented 
(bottom), ions relating to PC32:0 and PC 34:1 are labelled. 
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4.3.2 Analysis of Formalin Spiked Tissue  
 
The increase in sodium adduct formation in fixed tissue was further shown in the analysis 
of formalin spiked fresh tissue samples (top sections, figure 4.4). The image of [PC 32:0 + 
Na]+ has a much greater ion intensity within the spiked areas compared to the 
surrounding tissue, as shown by the pixel intensity. This appears to directly correlate with 
ion suppression of [PC 32:0 + K]+ within the formalin spiked areas, as shown by the 
change in ion intensity presented in figure 4.4. The difference in the intensity charts next 
to each image is due to the potassium adduct being predominantly formed in fresh tissue 
analysis, as previously discussed. Results from this spiking experiment indicate that 
formalin fixation does not causes migration or delocalisation of imaged lipids. This is 
illustrated by examining the formalin spike that covers part of the corpus callosum (top left 
spot of spiked section, [M+Na]+), an area where PC 32:0 is less abundant. The spike also 
straddles part of the neighbouring cerebral cortex. It is postulated that if analyte migration 
occurred as a result of formalin spiking (and hence fixation) then lipids from the cerebral 
cortex may have been detected within the corpus callosum. Low ion counts within the 
corpus callosum indicate that no migration of PC 32:0 from the cerbebral cortex has 
occurred.  
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Figure 4.4. MALDI-MS images of PC 32:0 taken from formalin spiked sagittal rat brain 
section, top images, and fresh control section, bottom images. The [M+K]+ species is 
represented on the left and the [M+Na]+ species on the right. 
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4.3.3 Tandem Analysis 
 
High resolution (50 µm) MS/MS imaging analysis of the ion at m/z 756, [PC 32:0 + Na]+, 
and 772, [PC 32:0 + K]+,  was carried out for fixed and fresh tissue respectively.  Images 
produced from the fragment ions for each analysis displayed the same distribution over 
the tissue sections; an example of the high resolution image achieved is presented in 
figure 4.5 for fixed tissue analysis. The analysis of single point CID spectra taken from the 
cerebral cortex for fixed and fresh tissue, demonstrated a more enriched fragment spectra 
for the dissociation of the sodium adduct, compared to the potassium adduct, as present 
in figure 4.6. Peaks common to both spectra are head group related peaks and are 
observed at m/z 86 representing choline, N(CH3)3(CH2)2, m/z 184 for the phosphocholine 
head group, m/z 146 and 162 corresponds to the five-membered cyclophosphane ring  
(C2H504P) with the addition of a sodium adduct for fixed tissue, and potassium adduct for 
fresh respectively. A peak corresponding to the neutral loss (NL) of trimethylamine, 
N(CH3)3, can also be observed in both spectra at m/z 697 for fixed tissue and m/z 713 for 
fresh. The difference in mass between the same fragment peaks in each spectrum is 
attributed to the mass difference between sodium and potassium. These peaks are 
common in CID spectra of phospholipids and sphingomyelins and agree with those 
previously reported[10, 105, 114, 172, 279]. There is a large difference in intensity for 
peaks representing the NL of the head group with and without the alkali adduct. This is 
evident when comparing the peaks at m/z 573 and 589 for the sodium (top spectrum) and 
potassium (bottom spectrum) adducts, which correspond to the NL of the head group, and 
the peak at m/z 551 which corresponds to the NL of the head group with the alkali adduct. 
As mentioned, these peaks in the CID spectrum from fresh tissue show incredibly low 
intensity, they are not considered to be above an acceptable S/N ratio. The peak at m/z 
441, which is present in the CID spectrum from fixed tissue, but absent from the fresh 
tissue spectrum, represents a NL of 325 u, corresponding to the NL of trimethylamine and 
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palmitic acid (hexadecanoic acid) from the head group and glycerol backbone 
respectively, and thus represents [PC 32:0 + Na- C16H32O2- N(CH3)3]+, this is in 
agreement with literature[10, 105, 114, 172, 279]. Peaks representing fatty acid molecules 
or their NLs are not usually detectable above an acceptable S/N ratio in MALDI CID 
spectra of [M+H]+, [M+Na]+ and [M+K]+, as demonstrated by the absence of a acceptable 
peak at m/z 500 (fixed tissue), which would represent the NL of palmitic acid. Cation 
adducts are known to induce greater fragmentation compared to the protonated molecule, 
which, when dissociated by low-energy CID, as is commonly used, results in a CID 
spectrum containing minimal peaks, the most intense signal is the  phosphocholine head 
group peak at m/z 184[13, 114, 279].  The degree of fragmentation of selected adducts 
appears to be proportional to the arrangement in the periodic table, as can be observed 
when comparing the CID spectra of PC 32:0 obtained from the sodium adduct, to the 
potassium adduct. This is further evidenced in literature and by results obtained from this 
group. The addition of lithium to the matrix solvent system, in the case of MALDI, or to the 
electrospray solvent solution, in the case of ESI, has shown the dissociation of the lithium 
cation of PLs causes greater fragmentation, resulting in peaks representative of the fatty 
acid side chains, enabling structural identification[10, 13, 105, 114].  
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Figure 4.5. High resolution MALDI-MS/MS image of m/z 756, [PC 32:0+Na]+ from formalin 
fixed tissue. The image is of the fragment ion at m/z 573. The image clearly outlines the 
anatomical regions of the brain where this ion is and is not present, due to the change in 
pixel intensity.  
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Figure 4.6. MALDI MS/MS mass spectra showing the fragment ions produced from the 
dissociation of [PC 32:0+Na]+, m/z 756 from fixed tissue, top spectrum, and [PC 32:0+K]+, 
m/z 772 from fresh tissue, bottom spectrum.  There is a significant increase in the 
intensity of peaks associated with the NL of the phospholipid head group, m/z 551, 573 
for [PC 32:0+Na]+ compared to m/z 551 and 589 for [PC 32:0+K]+. There is also a peak at 
m/z 441 in the spectrum from fixed tissue with is not present in fresh, A schematic of PC 
32:0 is shown in the top spectrum, with labelled fragmentation pathways. 
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4.3.4 Prolonged Storage in Formalin 
 
The MALDI-MSI investigation of tissue stored in formalin for prolonged periods showed 
such procedures to be unsuitable for MS, or MSI analysis, as shown by the spectra and 
corresponding images presented in figure 4.7. The image of PC 32:0 in fresh tissue and 
tissue fixed for 3 weeks display a defined distribution that correspond to those reported 
throughout this thesis, and in literature[10, 12, 14, 155, 165, 166, 172, 205, 230, 232, 233, 
238, 275-278], as shown by the images presented within the top and middle spectra in 
figure 4.7, for fresh and fixed respectively. The distribution of PC 32:0 in the section of 
brain fixed for one year appears to show signs of analyte delocalisation. This is evident by 
the increase in signal intensity for this lipid within the white matter regions of the brain, 
such as the corpus callosum and arbour vitae of the cerebellum. The anatomical features 
of this section are also no longer clearly defined, the hippocampus and corpus callosum 
are just recognisable, and the granular layer of the cerebellar cortex appears defocused. 
This may be due to analyte delocalisation; however it could also be due to the 
accumulation of high concentrations of salt within the tissue. The analysis of single point 
spectra taken from the cerebral cortex of tissue fixed for three weeks, middle spectrum in 
figure 4.7, shows reduced spectral complexity within the region of interest, m/z 700-900, 
compared to fresh tissue, top spectrum in figure 4.7. This is thought to be due to the high 
concentration of sodium in this sample, and thus a shift to the sodium adduct for PL 
species, as previously demonstrated in this chapter. The most abundant peak within this 
spectrum can be seen at m/z 656, this is believed to be a matrix associated cluster, the 
high abundant matrix associated peaks at m/z 265 and 221, observed in fresh tissue 
analysis, are not observed with high abundance in fixed tissue, thus different matrix 
adducts are also believed to be formed. The single point spectrum from the analysis of 
tissue stored in formalin for twelve months is rather complex, as demonstrated by the 
bottom spectrum in figure 4.7. This may be caused by an increase in the formation of salt 
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adducts, however this is highly unlikely, it is believed to be primarily due to lipid 
fragmentation, either in source or prior to ionisation, as a result of lipid degradation within 
the tissue. The analysis of tissue stored in formalin for eighteen months was not possible 
as the integrity of the tissue was extremely poor, upon sectioning the tissue crumbled and 
fell apart, thus it was not possible to obtain a section.  
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Figure 4.7. MALDI single point spectra taken from the cerebral cortex of fresh tissue (top 
spectrum), tissue fixed for three weeks (middle spectrum) and tissue fixed for twelve 
months (bottom spectrum), the corresponding MALDI-MS images for PC 32:0 are also 
presented. 
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4.5 Conclusion 
Lipid species have been successfully ionised directly from formalin fixed tissue without 
any pre-treatment that could interfere with the distribution of these molecules. High quality 
molecular lipid images were obtained, showing mutual distribution to fresh tissue 
preparation [10, 12, 14, 155, 165, 166, 172, 205, 230, 232, 233, 238, 275-278], indicating 
no signs of analyte delocalisation, or interference from the formalin itself.  Sodium buffers 
associated with the formalin fixation protocol caused a change in previously reported 
ionisation pathways [10, 12, 14, 155, 165, 166, 172, 205, 230, 232, 233, 238, 275-278], 
and the [M+Na]+ was found to be the most readily detected ion for each lipid species 
investigated.  This was evidenced in the images and spectra presented in this chapter, 
and by the investigation of formalin spiked tissue, which showed an increase sodium 
adduct formation directly correlated to a decrease in potassium adduct formation, within 
the spiked areas.  
As the sodium adducts in fixed tissue were detected with the highest abundance, this ion 
was selected for tandem MS analysis. Dissociation of m/z 756, [M+Na]+ in fixed tissue 
produced a more enriched CID mass spectrum, compared to those obtained from fresh 
tissue for the analysis of m/z 772, [M+K]+. The peak at m/z 441 in the CID spectrum from 
fixed tissue, although present with low abundance, corresponds to the NL of palmitic acid 
and trimethylamine [10, 105, 114, 172, 279], thus aiding in structural identification of this 
ion.  
Results presented in this chapter show tissues stored for prolonged periods in formalin 
fixative are not suitable for MALDI-MS investigations. MALDI-MSI images of PL 
distribution in brains stored for up to a year were poorly resolved, showing signs of 
analyte delocalisation and/or high accumulation of salt within the tissue. The mass 
spectra from these sections showed signs of lipid degradation, indicated by a highly 
complex spectrum. As lipids are not directly affected by formalin, they are not ‘fixed’, it is 
believed that over time they degrade.  
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As the involvement of lipids has now been proven in numerous physiological and 
pathological processes, the ability to analyse these species directly from and compare to, 
clinical histological specimens could provide a plethora of additional information.  
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5. Steps Towards MALDI-MS Analysis of Cell Envelope 
Components of Mycobacterium Bovis Extracted from Infected 
Cattle. 
 
5.1 Introduction 
 
The Mycobacterium tuberculosis complex includes the slow-growing pathogenic species 
M. bovis, the causative agent for tuberculosis in cattle. In addition to being a zoonotic 
pathogen, M. bovis is also known to be the causative agent of TB in a large spectrum of 
mammals, including, goats, seals, llama and oryx[280-282]. Human outbreaks of 
tuberculosis caused by M. bovis (bTB) have been attributed to infected dairy produce, 
direct transmission from cattle to dairy farm/abattoir workers, and as opportunistic 
pathogens in immunocompromised individuals [281]. In addition to the health risks 
associated with this bacterium, the economic cost as a result of infected cattle is 
incredibly high[283]. The Department for Environment Food and Rural Affairs placed this 
cost at £108.4 million in 2008/2009, compared to £8.2 million for 1998/99, the cost over 
the decade totalling at a staggering £603.3 million [284] 
M. bovis BCG, an attenuated version of M. bovis is also the only licensed TB vaccine that 
is currently used in immunisation projects globally, according to the World Health 
Organisation (WHO) programme of immunisation [285]. The efficacy of the BGC vaccine 
is, however, uncertain, investigations have shown different subcultures used for 
vaccination show large variations in their immunoprotective capabilities[285]. 
Immunisation does not necessarily confer immunity to pulmonary TB.  Mycobacterium 
bovis and Mycobacterium tuberculosis share 99.95 % genomic identity at the nucleotide 
level, and a cell wall composition that is common among all slow-growing pathogenic 
Mycobacterium.[280, 286] Although phenotypes and virulence are clearly different 
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between the two strains, demonstrated by different host infections, the similarities in the 
genome and cell wall composition undoubtedly indicate that the investigation of one 
species will provide a wealth of information on the other. The importance of the unique 
lipids that constitute mycobacterial cell wall were discussed in chapter 1. They are key to 
the intracellular survival, and contribute hugely to their virulence; they provide potential 
targets for pharmaceuticals, as well as being possible vaccine candidates. Investigations 
of mycobacterial lipids are either carried out on purified lipids from bacterial extracts, or by 
evaluating their contribution to growth and virulence by monitoring animal models infected 
with strains carrying specific mutations for the biosynthesis one or more of these lipids.  
MALDI-MS investigations of cell wall associated lipid species to date have been for the 
investigation of the effects of mutant models, and structural identification/mass 
determination of lipids purified from bacterial cell extracts. Research presented in this 
chapter investigates the feasibility of MALDI-MS detections of cell wall lipids, including 
mycolic acids, PDIMS, PGLs and MMGs, directly from lymph and blood extract taken from 
cattle infected with M. bovis. This may offer a more rapid first stage diagnostic tool, as the 
need for the growth stages that are necessary to identify many slow-growing pathogenic 
Mycobacterium are not needed for the analysis here. 
 
 
5.2 Experimental 
 
5.2.1 Materials 
Alpha-cyano-4-hydroxy cinnamic acid (α-CHCA), 2,5-dihydroxybenzoic acid (DHB), 
2’,4’,6’- trihydroxyacetophenone monohydrate (THAP) and trifluoroacetic acid (TFA) were 
purchased from Sigma-Aldrich (Dorset, UK). Methanol, chloroform and acetonitrile were 
purchased from Fisher Scientific (Loughborough, UK). Standards of free mycolic acids, 
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mycolic acid methyl esters and the lipids, phthiolcerol dimycocerosatic (PDIMs), phenolic 
glycolipid (PGLs) plus mono mycoloyl glycerol (MMG) were supplied by Professor D. 
Minnikin, Department of Biosciences, University of Birmingham. 
 
5.2.2 Lipid Extracts from Infected Cattle 
The following samples were supplied by Professor D. Minnikin, Department of 
Biosciences, University of Birmingham, as dry samples; cattle lymph extracts 4469 and 
4465 A (PDIMs) and B (PGLs/MMG); cattle blood extracts 5005 A (PDIMs) and B 
(PGLs/MMG); and cattle lymph non-polar extracts, PDIMs samples A1 (4465), 2 (4472) 
and 3 (4479), MAMEs samples B1 (4465), 2 (4472) and 3 (4479), and PGL + MMG 
samples C1 (4465), 2 (4472) and 3 (4479). TLC plates, designated control plates 1 and 2, 
and sample plates A, B and C, contained species specific lipid extracts and blood and 
lymph extracts.  
 
5.2.3 Lipid Standards and Lipid Sample Extract Preparation 
Standards were prepared at a concentration 2 mg mL-1 in chloroform and mixed 1:1 (v/v) 
with the matrix solution.  Lymph and blood extracts were re-suspended in 10, 50, 100, 
200 and 400 µL of chloroform and either mixed 1:1 (v/v) with the matrix solution or applied 
to the target plate using the overlay method. 
 
5.2.4 Matrix Compounds and Solvent Systems 
A number of different matrix solutions were evaluated for the analysis of the mycolic acid 
and lipid standards, they were as follows; αCHCA at a concentration of 25 mg mL-1 in 80 
% MeOH (0.1 %TFA); DHB at a concentration of 25 mg mL-1 in 80 % MeOH (0.1 %TFA); 
THAP at a concentration of 20 mg mL-1  in 80 % MeOH (0.1 %TFA) and DHB at a 
concentration of 12 and 25 mg mL-1 in 1:1 (v/v) MeOH:CHCl3 (v/v),  (0.1 %TFA). 
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5.2.5 Tissue Preparation 
Lymph nodes were excised from infected cattle and autoclaved (sterilised) to remove the 
risk of infection. These were then frozen to -80 and stored until analysis. Upon analysis 
the lymph nodes were transferred to a cryostat chamber and left for 30 min to allow 
temperature equilibration. The lymph node was then embedded on a cryostat chuck using 
water-ice-slush and sectioned. A range of thicknesses were evaluated. The sections used 
for MALDI-MSI analysis were sectioned at 5 µm and transferred to a stainless steel 
MALDI target plate.  
 
5.2.6 Matrix Deposition 
Matrix deposition was carried out in a fume hood using an artistic airbrush as previously 
described.  For lymph node analysis, DHB at 12.5 mg mL-1 (100 %  acetonitrile (1 % 
TFA)), was deposited over the target insert using an artistic airbrush,  from a distance of 
15-20 cm in repeated cycles. Deposition was deemed optimal when a dense coating of 
white crystals covered the target plate and tissue area. A larger amount was used for the 
preparation of TLC control plates and sample plate C, 15-20 mL-1 of DHB at 12.5 mg mL-1 
(100 % acetonitrile (1 % TFA)) was deposited in repeated cycles from a distance of 
around 20 cm. Sample plates A and B were sprayed from a distance of roughly 15 cm 
with a much wetter deposition achieved than the previous plates.  
 
5.2.7 Mass Spectrometry 
Lipid standards and extracts were analysed using an Applied Biosystems (Toronto, 
Canada) hybrid quadrupole time-of-flight (QqTOF) instrument (Qstar XL). The instrument 
was fitted with an orthogonal MALDI ion source and a nitrogen laser (337nm), operated at 
25 µJ, unless otherwise stated, with a repetition rate of 20Hz. The instrument was 
operated in the positive ion reflectron mode, recording all signals either between m/z 200-
2000 or m/z 1000-2000. Data were acquired using a Q1 scan time of 1 second, summing 
140 
 
30 scans per spectra obtained. Mass spectral data were analysed using the Analyst 
software supplied by Applied Biosystems. 
For TLC analysis, the plates were analysed as an ‘imaging experiment’, with a target plate 
stepping distance set to 1 mm for both the x and y dimension. Acquisition was carried out 
using the dynamic pixel setting; this moves the laser within the 1 mm2 area, summing the 
data to give an accumulated mass spectrum for each pixel area. The nitrogen laser 
(337nm) was operated at 50 µJ, unless otherwise stated, with a repetition rate of 20Hz. 
Data were acquired using a dwell time of 2 or 4 seconds, over a mass range of m/z 1000-
2000, to enhance detection over this m/z range. The resulting two-dimensional ion density 
maps were generated using TissueView software, after conversion of the raw data into 
the format required using the ‘wiff to analyse’ script, provided by Applied Biosystems. 
For MALDI-MS imaging analysis of cattle lymph node, the nitrogen laser (337nm) was 
operated at 30 µJ, with a repetition rate of 20Hz. Data were acquired using a dwell time of 
1 second, over a mass range of m/z 700-2000. The target plate stepping distance was set 
to 100 µm for both the x and y dimension using the imaging acquisition software. Data 
were acquired using the ‘dynamic pixel’ setting, which involves the laser being moved 
within the 100 µm2 pixel area and resultant data being summed to give an accumulated 
mass spectrum over one second for each pixel area. The resulting two-dimensional ion 
density maps were generated using the TissueView software, after conversion of the raw 
data into the format required using the ‘wiff to analyse’ script, provided by applied 
biosystems. 
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5.3 Results and Discussion 
 
5.3.1 Matrix Evaluation for the Analysis of Mycolic Acids and Lipid Standards 
 
The initial evaluation of matrix compounds suitable for MALDI-MS analysis of 
Mycobacterium cell wall associated lipids involved the screening of DHB, αCHCA and 
THAP, in 80 % MeOH (0.1 % TFA). The mass spectra acquired from the analysis of the 
lipid standards when using THAP as the matrix did not contain any peaks (results not 
shown), thus no further studies were carried out with this matrix. The mass spectra 
acquired using αCHCA as the matrix system did not reveal peaks within the desired m/z 
range that differed by multiples of 14 mass units. MAs and other cell wall associated lipids 
from these species occur in nature as structurally related molecules that differ from one 
another by one or two methylene groups; hence a difference of 14 or 28 m/z should be 
present in the spectra. These results indicated αCHCA is not a suitable matrix for the 
analysis of these lipids, thus no further studies were carried out with this matrix. The 
MALDI-MS analysis of the standard of mycolic acid methyl esters using DHB at 25 mg 
mL-1 (80 % MeOH, 0.1 TFA), was successful in the detection of alpha-, methoxy-, and 
keto-MAMEs, shown by the spectrum presented in figure 5.1.  Peaks representing the 
major homologues for the alpha-, methoxy-, and keto-MAMEs can be observed at m/z 
1173, 1289, and 1317 respectively,  these results correspond well with those previously 
reported for the MALDI-MS analysis of these lipids[193-197]. Ion counts for these species 
were found to be low, with relatively high background noise. Free MA standards were not 
desorbed, ionised and detected efficiently using this system as demonstrated by the mass 
spectrum presented in figure 5.2, the spectrum is predominantly noise with ion counts 
only reaching 16.  Free mycolates are particularly difficult to ionise due to their non-polar 
nature, especially the alpha-mycolic acids which are the least polar of the species, this is 
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possibly why most literature to date reports the MALDI-MS analysis of MAMEs, as these 
derivatives are more readily ionisable.    
 
 
 
 
 
 
 
Figure 5.1. MALDI mass spectrum of mycolic acid methyl esters using DHB 25 mg mL-1 
(80 % MeOH (0.1 %TFA)). Peaks representing the major homologues of the alpha-, 
methoxy-, and keto-MAMEs along with their carbon chain lengths are labelled. All peaks 
are believed to be [M+Na]+ ions.  
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a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
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Figure 5.2. MALDI mass spectrum of free mycolic acids using DHB 25 mg mL-1 (80 % 
MeOH (0.1 %TFA)). The ion counts are extremely low and the S/N ratio is poor.  
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The spectrum recorded from analysis of the extract containing PDIMs using DHB at 25 
mg mL-1 (80 % MeOH, 0.1 TFA), shows a clear pattern of peaks that differ from one 
another by 14 u, from m/z 1306 to 1460, as shown in figure 5.3. The masses detected 
here correspond to those previously published for PDIM type A,  for carbon chain lengths 
C87 to C97, in MALDI-MS analysis of extracts purified from M. bovis BCG wild type, and 
M.tb H37Rv (wild type) and Beijing strains [132, 200, 201]. The mass spectrum acquired 
from the analysis of PGLs and MMGs using this matrix system show relatively low ion 
counts for these species, as presented in figure 5.4. Major homologues of MMGs can be 
observed in the spectrum at m/z 1333 and 1362, which correspond to the previously 
reported masses of keto-MMGs as [M+Na]+ [287].  Peaks representing PGLs can be 
observed in this spectrum centring around the major homologue at m/z 1530, and agree 
with those in literature [201], however, the quality of the spectrum is rather poor, showing 
low ion counts and low signal-to-noise ratio (S/N). 
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Figure 5.3. MALDI mass spectrum of PDIMs using DHB 25 mg mL-1 in 80 % MeOH (0.1 % 
TFA) as the matrix.  Peaks present differ from one another by 14 u, which is characteristic 
of mycobacterial cell wall lipids; peaks from m/z 1306-1460 represent PDIM A, C87-C97. All 
peaks are believed to be [M+Na]+ ions.  
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Figure 5.4. MALDI mass spectrum of PGL/MMG lipids using DHB 25 mg mL-1 in 80 % 
MeOH (0.1 %TFA). Peaks representing MMGs are observed at m/z 1333 and 1361; the 
ions ranging from m/z 1487-1571 represent PGLs. All peaks are believed to be [M+Na]+ 
ions.  
 
 
 
 +TOF MS: 30 MCA scans from Sample 10 (Sample4_DHB) of D_M_Lipids.wiff
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
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 Previously published MALDI-MS data for the analysis of MAMEs, PDIMs and PGLs has 
shown DHB at 10 mg mL-1 in a solvent system of MeOH:CHCl3 1:1 (v/v) (0.1 TFA) to be 
suitable for the analysis of these species[132, 134, 193, 195, 200, 201, 287]. This solvent 
system was then applied to the analysis of free MAs to assess whether this enabled 
detection of these species. Free MAs were successfully desorbed, ionised and detected 
using this matrix and solvent system, as shown by the spectrum presented in figure 5.5. 
Peaks representing alpha-mycolates can be observed at m/z 1159 and 1187, the major 
homologue for the methoxy-mycolate can be seen at m/z 1275, and peaks representing 
keto-mycolates are observed at m/z 1302 and 1318. There is a substantial amount of 
background noise in this spectrum, however, the S/N for the alpha-, methoxy- and keto 
mycolates are improved. The ion counts for the MAME standard showed a five-fold 
increase when using MeOH:CHCl3 1:1 (v/v) (0.1 TFA) as the solvent system compared to 
the previously applied system, as demonstrated by comparing figure 5.6 to figure 5.1. 
This increase in sensitivity had enabled the detection of more species, as evidenced by 
the enriched spectrum in figure 5.6. The increased sensitivity observed with this system is 
thought to be attributed to the solubility of these analytes in CHCl3, whereby a greater 
incorporation of the analytes into the matrix crystals is believed to be achieved. This 
matrix system was used for the analysis of the cattle extracts. 
 
 
 
 
 
 
 
 
 
148 
 
 
 
 
 
 
 
 
Figure 5.5. MALDI mass spectrum of free mycolic acids, using DHB 12.5 mg mL-1 in 
MeOH:CHCl3 1:1 (v/v), 0.1 TFA as the matrix.. The key peaks representing the alpha-, 
methoxy- and keto- MAs are labelled and are observed at m/z 1159 and 1187 (alpha), 
1275 (methoxy) and 1303 (keto). All peaks are believed to be [M+Na]+ ions.  
 
 
 
 
 +TOF MS: 30 MCA scans from Sample 1 (Mycolic_acid_FA_sample1) of MA_standards_DHB12.5_50_50_CHCL3Me...
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
Max. 104.0 counts.
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Figure 5.6. MALDI mass spectrum of mycolic acid methyl esters using DHB 12.5 mg mL-1 
in MeOH:CHCl3 1:1 (v/v), 0.1 TFA as the matrix. The peaks representing the alpha-
MAMEs are labelled at m/z 1173 and 1201, methoxy-MAMEs centre around the major 
homologue at m/z 1289, and the major homologue for keto-MAMEs can be seen at m/z 
1317. All peaks are believed to be [M+Na]+ ions.  
 
 
 
 +TOF MS: 30 MCA scans from Sample 2 (Mycolic_acid_methyl_sample2) of MA_standards_DHB12.5_50_50_CHCL...
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
Max. 434.0 counts.
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5.3.2 Lymph and Blood Samples 
 
Extracts of lymph samples 4465 A and B, representing PDIMs and PGLs/MMG 
respectively, were re-suspended in 200 µL of CHCl3. Initially samples were mixed 1:1 (v/v) 
with the matrix solution and 1 µL were spotted onto the target plate for MALDI-MS 
analysis. The MALDI mass spectra acquired from analysis of these samples did not 
contain any peaks representing PDIMs, PGLs or MMGs within the m/z range of interest. 
Sample application to the target plate was then varied to assess whether this enabled 
detection of the lipids of interest. This involved 1 µL (2 x 0.5 µL) of each sample being 
spotted onto the target plate, followed by 0.5 µL of the matrix solution (the overlay 
method), using both 25 mg mL-1 and 12.5 mg mL-1 DHB concentrations.  A varying laser 
power (25, 30 and 35 µJ) was also evaluated as the samples had a very different 
consistency to the standards, when deposited on the target plate, sample A was found to 
dry as a thick white crust/film. Detection of PDIMs and PGLs/MMGs from these samples 
was unsuccessful.  
Lymph extract 4469 A and B, and blood extract 5005 A and B, representing PDIMs (A) 
and PGLs/MMG (B), were re-suspended in 50 µL of CHCl3 to give more concentrated 
samples than those previously analysed. Samples were again applied to the plate as 
“overlays”, this time with an equal concentration of analyte:matrix, analysis was carried 
out at  3 different laser powers, 25, 30 and 35 µJ.  The MALDI mass spectrum acquired 
from the analysis of lymph sample A contained peaks that differed from one another by 14 
mass units. These were observed within the m/z region 1151-1257, which is indicative of 
α-MAs. This sample, however, represents extracts of PDIMs which are observed within 
the mass range m/z 1306-1516 [132, 200, 201], no ions characteristic of these species 
were observed within this region, as shown in figure 5.7. It is also again worth noting that 
the alpha-MAs are the least polar of the mycolates, thus one would expect to see peaks 
representing the methoxy- and keto- MAs along with the alpha species, and showing 
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higher ion counts. These were not observed in this mass spectrum, thus care needs to be 
taken with the interpretation of these results, the peaks present are not believed to 
represent alpha-MAs.  
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Figure 5.7. MALDI mass spectrum of lymph sample 4469 A, representing PDIMs. A 
characteristic peak pattern and mass range for mycolic acids are present at m/z 1151-
1257. There are peaks present within the mass range for PDIMs, m/z 1306-1460; 
however the S/N ratio is extremely poor. 
 
 
 
 
 +TOF MS: 30 MCA scans from Sample 1 (LymphA_DHB_2ul) of Mycolic_12_3_10.wiff
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
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Lymph and blood extract samples were then dried down under a constant flow of nitrogen 
gas and re-suspended in 10 µL of CHCl3. The purpose of this was to produce even more 
concentrated samples, in a hope this enabled detection of these lipids. Samples were 
applied to the MALDI target plate as 4 x 2.5 µL spots, followed by the same amount of 
matrix. MALDI mass spectra obtained from the more concentrated samples did not 
contain any peaks in the m/z region of interest. Increasing the amount applied the plate 
up to 12 x 2.5 µL drops, did not improve the detection of these species. For the entire set 
of samples representing PDIMs, depositing sample amounts over 1 µL inhibited the 
ionisation of any molecules in the sample, including matrix species. This is thought to be 
due to the sample drying as a thick white crust on the plate, resulting in poor co-
crystallisation. The laser was also not able to penetrate the sample efficiently.  A typical 
mass spectrum of these samples is shown in figure 5.8. 
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Figure 5.8. MALDI mass spectrum of lymph sample 4465 A, representing PDIMs. The ion 
counts are low and the background noise is quite high giving a low S/N ratio, resulting in a 
spectrum of very poor quality. Peaks representing the characteristic pattern of PDIMs are 
not present in this spectrum. 
 
 
 
 
 +TOF MS: 30 MCA scans from Sample 19 (LymphLaser30_Overlay12mg_sample.A2.4465_10...
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
Max. 55.0 counts.
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Samples of cattle lymph extracts labelled A1, B1 and C1, representing PDIMs, MAMEs 
and PGLs/MMGs respectively,  were re-suspended in 50 µL of CHCl3. Samples were 
applied to the target plate as either 2 x 2.5 µL or 4 x 2.5 µL, followed by either 0.5 or 1 µL 
of DHB. Sample A1 (PDIMs), when deposited onto the plate, the solvent evaporated 
leaving a thick white coating, and when initially analysed minimal ion counts were 
observed. Sample B1 (MAMEs) had the appearance of an oil slick on the plate, and also 
showed low to no ion counts. Sample C1 (PGLs/MMGs), when deposited onto the plate, 
the solvent evaporated leaving a yellow glossy film, resembling a thin plastic sheet, again 
low to no ion counts were observed for this sample. These more concentrated samples 
did not ionise well, even when 60 scans were summed per spectrum. Samples were 
diluted with a further 100 µL of CHCl3, this resulted in an increase in ion counts for peaks 
in the m/z range 740-960, however peaks in the region of interest remained in the 
background noise. Samples A-C2 were re-suspended in 200 µL of CHCl3 and applied to 
the plate as 2, 4, 6, 8 and 10 x 0.25 µL aliquots, followed by either 0.5 µL of the matrix 
solution, or the same volume of the matrix solution as the samples. MALDI mass spectra 
obtained from these preparation procedures again showed no ions were detected within 
the region of interest. 
Although no ion counts were seen within the m/z range of interest for the selected cell 
wall associated lipid species, high ion counts were observed in the m/z range 800-930 
and 760-960, for lymph and blood samples A and B respectively. An example spectrum 
for each type of extract, PDIMs (A) and PGLs/MMGs (B) is presented for lymph sample 
4469 in figures 5.9 and 5.10 respectively. The peaks observed within this mass range 
differ by 14 mass units, which would correspond to one methlyene group (CH2).  These 
species could be associated with the mycobacterium lipids of interest, however due to 
their lower mass range it is thought they are mammalian or bacterial lipids that are 
present within this mass window. All MALDI-MS spectra acquired from the analysis of 
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lymph and blood extracts taken from cattle, contained the same peak profiles as those 
presented in figures 5.9 and 5.10.  
 
 
 
 
 
 
 
Figure 5.9. MALDI mass spectrum of lymph sample 4469 A, representing PDIMs. Peaks 
presented differ by 14 mass units which is characteristic of mycobacterium species, 
however due to their lower masses they are believed to be mammalian or bacterial lipid 
species that fall within this mass range and also differ from one another by a CH2 group. 
 
 
 
 +TOF MS: 30 MCA scans from Sample 2 (SampleA_12.5mgDHB) of Lymph_sample4469_1...
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
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Figure 5.10. MALDI mass spectrum of lymph sample 4469 B, representing PGLs/MMGs. 
Peaks presented differ by 14 mass units which is characteristic of mycobacterium 
species, however due to their lower masses they are believed to be mammalian or 
bacterial lipid species that fall within this mass range and also differ from one another by a 
CH2 group. 
 
 
 +TOF MS: 30 MCA scans from Sample 4 (SampleB_12_5mgDHB) of Lymph_sample4469_11...
a=3.56606634321894690e-004, t0=-3.53887937949439220e+001
Max. 773.0 counts.
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5.3.3 MALDI-MSI of TLC Plates 
 
The analysis of the TLC plates proved rather problematic for a number of reasons. The 
matrix system used for the analysis of the standards and samples could not be used here 
as chloroform is toxic, and is a potent anaesthesia, thus spray deposition was not 
possible. DHB in 100 % MeCN (1% TFA) was used instead of chloroform; this solvent 
system had been successful in the detection of the PGL and PDIM standards (results not 
shown). The MALDI-MSI investigation of TLC plates also proved difficult due to each plate 
being prepared differently, regarding the number of lanes on each plate, the amount 
loaded onto each plate and the concentration of the amounts being loaded.  These 
variations made it rather difficult to optimise matrix deposition and instrument parameters 
for analysis.  Hence analysis of the first three plates, 2 controls and one sample plate 
(plate C), proved unsuccessful as the sample preparation and acquisition parameters had 
not been optimised, matrix ions were low and background noise high in all cases. In 
addition to this, at the time of analysis there were problems with the motor that controls 
the sample plate stepping distance in the oMALDI source; this resulted in laser 
oversampling, which may have completely ablated the matrix crystals, leading to no or 
low ion transmission. 
Once matrix deposition and instrument parameters had been further optimised, evidenced 
by high TIC and matrix ion counts, several Mycobacterium cell wall associated lipid 
species of interest were detected. Ions at m/z 1333 and 1360 corresponding to keto-
mycolate MMGs and ions between m/z 1494-1524, possible PGLs, were detected directly 
from TLC plate B. The MALDI-MS image presented in figure 5.11 shows these species at 
different migratory points along the plate, single point spectra were taken from the centre 
of these areas. This plate contained 5 control lanes, representing cholesterol, PDIMs, 
PGLs/MMGs, MAs, MAMEs and a non-polar blood extract lane. The images produced 
from this plate show different lipid species at different migratory points along the plate; 
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however these species were only detected in the lane representing the non-polar blood 
extract. Upon visualising the stained plate it is clear to see that a much larger amount or 
higher concentration of the sample had been added to this lane compared to the control 
lanes. As this is a sample extract and the visualisation for TLC is non-specific, this does 
not necessarily mean there is a greater amount or concentration of the lipids of interest 
within this lane. This could merely be a complex mixture containing many lipid species, 
some evidence for this was observed when analysing the images and spectra obtained 
within the mass region m/z 760-900 (data not shown). The ions previously observed in the 
blood extract samples were also detected from this lane. The detection of these lipids in 
the sample lane, and not the standard lanes, however, collectively indicates a higher 
concentration of these lipids were present within this sample compared to the controls. 
The detection of bacterial lipid species from TLC plates has been shown; these results 
indicate that a matrix solution of MeCN may not be suitable for the analysis of all species 
of interest, as MAs and MAMEs are not being detected. This is primarily thought to be due 
to them being insoluble in this solvent system. A suitable solvent matrix needs to be 
optimised for the ionisation of all species from TLC plates. 
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Figure 5.11. MALDI-MS image of m/z 1333 and 1360 representing MMGs (top images) 
and m/z 1494 and 1522, possible PGLs (bottom images) at different migrating points 
along the TLC plate. A single point spectrum taken from each specific migrating area is 
shown.  
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5.3.4 MALDI-MSI of Infected Lymph Node 
 
The MALDI-MSI analysis of the lymph node excised from infected cattle was 
unsuccessful. Minimal ion counts were observed over the whole tissue section. Usually 
when analysing mammalian tissue sections high ion counts are observed for highly 
abundant lipid species that constitute cell membranes. The lymph node was classed as 
biohazard material, and following safety procedure was autoclaved to prevent potential 
infection.  Autoclaving is carried out at high temperatures (typically 121 °C and above) to 
ensure all Mycobacterium are destroyed. These high temperatures will have also 
denatured or destroyed all heat sensitive peptides, proteins and lipids, the whole organ in 
essence. The heating also removes water from the tissue, which is why sections above 5 
µm in thickness dried and crumbled off of the MALDI target plates. This process is 
believed to be the why extremely low ion counts were observed over the tissue area. 
Tissue that has been autoclaved does not suitable for MALDI-MS analysis. 
 
5.4 Conclusion 
 
The results presented in this chapter demonstrated two matrices, THAP and αCHCA to be 
unsuitable for the analysis of non-polar cell wall associated lipid species from 
mycobacterium. The MALDI-MS analysis of lipid standards using DHB in 80 % MeOH, 
proved successful in the detection of alpha-, methoxy-, and keto-MAMEs, PDIMs and 
PGLs/MMGs from lipid standards as [M+Na]+, results corresponded well to those 
previously published for these lipids [132, 134, 193-197, 200, 201, 287]. The spectral 
quality and ion counts for PGLs/MMGs were rather poor however, and the detection of 
free MAs was unsuccessful. This lead to the application of a previously reported solvent 
system for the MALDI-MS analysis of MAMEs and other non-polar lipids[132-134, 193-
197, 200, 201, 287]. This solvent system successfully detected free MA species, 
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evidenced by the presence of peaks representing alpha-mycolates, at m/z 1159 and 
1187, methoxy-mycolate, at m/z 1275, and keto-mycolate at m/z 1302. There was also a 
five-fold increase in the detection of the major homologues for the alpha-, methoxy-, and 
keto-MAMEs using this solvent system compared to DHB in 80 % MeOH. The application 
of this system to more complex samples, however, proved unsuccessful, as demonstrated 
throughout this chapter. The MALDI-MS detection of MAs, PDIMs, PGLs and MMGs from 
lymph and blood extracts taken from infected cattle, was not possible with this method. 
Variation of extract concentration, amounts applied to the MALDI target plate, changing 
the matrix:analyte ratio, and altering the laser power, all had no effect on the outcome of 
the results. The MALDI mass spectrum of lymph extract 4469 A, presented in figure 5.7 
does contain a cluster of peaks with a characteristic profile between m/z 1151 and 1257, 
which resembles those observed for these lipid species. These peaks could not be 
assigned to any of the lipids of interest, this is because they were detected in the sample 
representing PDIMs, and all data published to date for these lipids are at a higher m/z 
range, m/z 1306-1516[132, 200, 201]. These could be lipids with a similar polarity to 
PDIMs, and thus migrate with them along the TLC plate. They may be fragments or by-
products of PDIMs, there is little to no literature on the analysis of MAs, PDIMs and PGLs 
directly from infected lymph extracts, thus building a lipid profile is difficult. Consistent 
findings with the analysis of these samples were the highly abundant peaks observed in 
the mass range m/z 740-960, the difficulty here is they may be attributed to either 
mammalian[288] or bacterial lipids[289]. The presence of these species indicate the 
extracts are quite complex and contain many species, this may be why no ions 
corresponding to Mycobacterium lipids were detected. The mixture may be too complex 
for efficient desorption and ionisation, especially when compared to the purer standards 
which were all sufficiently ionised and detected using this method. 
A protocol has been optimised for the analysis of lipids directly from thin layer 
chromatography plates by MALDI-MSI. The detection of MMGs and possible PGLs 
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directly from TLC plates indicates this technique for analysis is useful for the MALDI-MSI 
analysis of complex mixtures, they are simplified as they are separated along the plate, 
thus providing a less complex sample mixture, however, at present it is still not well suited 
to the analysis of all Mycobacterium lipids of interest. This is thought to be primarily due to 
the insolubility of these molecules in the solvent system used. These structures are 
known for their insoluble nature, thus further optimisation is necessary to find a more 
sensitive solvent system.  
MALDI-MSI investigation of a lymph node excised from infected cattle produced spectra 
and images with minimal to no ion counts. This result is attributed to the process of 
autoclaving the tissue, which is believed to have destroyed all lipid species and 
dehydrated the organ; making it unsuitable for MALDI-MS investigations. Future analysis 
of infected organs should be carried out on tissue fixed for a minimum of 24-48 h (size 
dependant) in formalin. This is the standard safety procedure applied in clinical 
histopathology laboratories for biohazard material, and tissue prepared this way is 
suitable for MALDI-MS analysis of phospholipids, as shown in chapter 3 of this thesis. 
There still remains a void in techniques that can rapidly diagnose infections caused by the 
Mycobacterium tuberculosis complex. MALDI-MS offers the speed of analysis, with further 
optimisation of matrix compounds and solvent systems the analysis of these lipids 
species, which play key roles in virulence, could be possible from highly complex 
solutions.  
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6. Solvent Optimisation for the MALDI-MS analysis of Cell 
Envelope Components of Mycobacterium  
 
6.1 Introduction 
 
Several research articles have been published evaluating MALDI matrix solvent systems, 
and how optimising such parameters can have dramatic effects on the acquired MALDI 
mass spectrum. Cohen and Chait (1996)[207] carried out an evaluation of 17 different 
matrix solvent systems, for the MALDI-MS analysis of peptides and proteins. The group 
showed matrix solvent composition greatly influenced the quality of the MALDI mass 
spectra, in addition to observing mass discriminatory effects. From this study the group 
were able to advise on suitable matrix solvent solutions for the analysis of higher mass, 
lower mass and complex mixtures of peptides. A study by Hattan et al. (2004)[290] 
demonstrated solvent composition significantly influenced the size, distribution, density 
and morphology of matrix crystals, which in turn greatly affected the signal intensity and 
quality of the MALDI mass spectra acquired from the analysis of peptides and proteins. A 
binary MALDI matrix solvent system has been optimised for the analysis of lipids from 
complex extracts[291].  Through the analysis of multiple combinations of matrices and 
solvents, Sun et al. (2008)[291], demonstrated a set of solvent conditions that increased 
S/N, and decreased spectral complexity in MALDI-MS analysis of complex lipids. 
 
The matrix solvent system of choice for all MALDI-MS analysis of MAMEs, PGLs, and 
PDIMs, as is with other non-polar lipids, such as cholesterol and triacylglycerides, is 
chloroform:methanol at a ratio of either 1:1(v/v)[132, 134, 192, 193, 199-201] or 
2:1(v/v)[133, 194, 196, 197]. In most instances the matrix selected is DHB, and as with 
other non-polar lipids, the lipids are observed in the mass spectrum as sodium adducts 
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[M+Na]+. While this solvent system enables the ionisation and detection of these and 
other non-polar lipid species, a more sensitive solvent system is required for the analysis 
of free MAs from complex mixtures, and without the need for prior derivatisation. Results 
presented in Chapter 5 of this thesis showed MALDI-MS detection of specific 
mycobacterial cell wall lipids from purified lipid standards, using the previously published 
solvent system.  The attempts made to detect these species from lymph and blood 
extracts proved unsuccessful. Addition issues were highlighted due to the solvent system 
of choice being unsuitable for airbrush deposition, thus it could not be used in MALDI-MSI 
investigations. Collectively these results highlighted the need for an optimised matrix 
solvent system that enhances sensitivity and could be used in MALDI-MSI investigations. 
In addition to this, a more sensitive solvent system could enable the analysis of MAs and 
related Mycobacterium lipids directly from complex mixtures, such a blood and sputum, 
thereby omitting the need to analyse bacterial cell extracts and the timely growth stage 
that accompanies such procedures. Such approaches would lead to faster and more rapid 
analysis times and would aid in a greater understanding of the lipids involved in growth 
and virulence.  
 
Research presented in this chapter evaluates a number of matrix solvent systems and 
presents optimised routes for the analysis and detection of crude fatty acid mixtures of 
free MAs and their corresponding MAMEs. The optimised system was then used in 
MALDI-QqTOF analysis of complex bacterial extracts. 
 
 
 
 
 
 
166 
 
6.2 Experimental 
 
6.2.1 Materials 
2,5-dihydroxybenzoic acid (DHB) and trifluoracetic acid (TFA) were purchased from 
Sigma-Aldrich (Dorset, UK). Ethyl acetate (EA), 2-propanol (IPA), tetrahydrofuran (THF) 
and dichloromethane (DCM) were purchased from Fisher Scientific (Loughborough, UK). 
Free mycolic acids, mycolic acid methyl esters, BCG and strain C extracts were supplied 
by Professor D. Minnikin, Department of Biosciences, University of Birmingham. 
 
6.2.2 Preparation of Lipid Standards and Bacterial Cell Extracts 
Mycolic acids (4.2 mg) and mycolic acid methyl esters (7.2 mg) were re-suspended in 2 
mL of chloroform, giving a concentration of 2.1 mg ml-1 and 3.6 mg ml-1respectively. Strain 
C (7 mg) and BCG (22.9 mg) cell extracts were re-suspended in 1, 2, 3 and 4 mL of 
chloroform.  
 
6.2.3 Matrix Preparation 
DHB was prepared at 10 mg/mL in a range of solvents: EA,  IPA, THF and DCM (0.1% 
TFA) and solvent mixtures of EA:THF (1:1 v/v), 0.1% TFA; EA:DCM (1:1 v/v), 0.1% TFA; 
IPA:THF (1:1 v/v), 0.1%TFA; IPA:DCM (1:1 v/v), 0.1% TFA and chloroform:methanol (1:1 
and 2:1 v/v), 0.1% TFA.  
 
6.2.4 Mass Spectrometry 
MALDI mass spectrometric analysis was carried out using a QqTOF (Qstar XL – Applied 
Biosystems, Foster City, CA) mass spectrometer fitted with an orthogonal MALDI ion 
source. The nitrogen laser (337nm) has a band width of 3 ns and was operated at 35 µJ, 
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with a repetition rate of 20 Hz. Analysis was carried out in the positive ion reflectron 
mode. The mass range m/z 1000-2000 was used to avoid analyte suppression from 
highly abundant matrix ions and lipid species found in the lower mass range. Data were 
acquired using a Q1 scan time of 1 second, summing 30 scans per spectrum obtained. 
For the initial solvent evaluation 2.5 µL of the sample was applied to the plate and allowed 
to dry, followed by 2.5 µL of the matrix solution. For the comparison to the previously 
published matrix systems, 1 µL of the sample was applied to the plate and allowed to dry, 
followed by 0.5 µL of the matrix solution. 
 
 
6.3 Results and Discussion 
 
6.3.1 Crystal Formation for each Solvent System 
 
Initially the optimisation of solvent systems for the analysis of free MA and MAME 
samples involved the single solvent systems of EA, IPA, THF and DCM, according to 
sample and matrix solubility. The alpha-, methoxy- and keto-MA and MAME subclasses 
were all present in the spectra obtained using these matrix solvent systems. The spectral 
quality and S/N was rather low (this will be discussed in detail in the following section), 
especially for the free MA and alpha subclasses, which are the least polar and thus most 
difficult to ionise. On observation it was noted that the crystal formation of DHB within 
these solvent systems varied quite significantly. This led to the inclusion of combinations 
of all four solvents into the analysis. The combination of EA:IPA and THF:DCM will not be 
discussed as the results produced from these combinations were extremely poor, with 
respect to crystal formation, ion counts, species present and spectral quality. The images 
presented in figure 6.1 show IPA alone produced a very fine coating of crystals; EA 
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produced slightly larger, more rounded crystals; DCM produced quite large needle-like 
crystals and THF produced large needle-like crystals that aggregated into a needle-like 
film. The combination of IPA with DCM and THF resulted in the increased crystal size 
compared to the former and greatly reduced crystal size compared to the latter two. The 
crystals for IPA:DCM appeared small, with slight aggregations, whereas the crystals 
produced using IPA:THF appeared small with a more homogenous distribution. The 
combination of EA:DCM produced an extremely fine coating of crystals, finer than those 
observed with IPA. Conversely EA:THF produced needle-like crystals, smaller than those 
observed with THF, but significantly larger than those seen with EA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
169 
 
 
Figure 6.1. Optical images of DHB crystal formation within each solvent system.  Images 
show crystal size growing from the finely dispersed coating observed with IPA, to a thick 
film of needle-like structures with THF, for the single solvents (top images). The 
combination of IPA with both THF and DCM greatly reduced the crystal size previously 
observed with the latter two solvents on their own. The combination of EA with DCM 
reduced the crystal size to an extremely fine coating, whereas EA with THF reduced the 
crystal size of those observed with THF (bottom images). 
 
 
6.3.2 Matrix Solvent Evaluation for Analysis of Crude Fatty Acid Mixtures of Free Mycolic 
Acids and Mycolic Acid Methyl Esters 
 
All of the matrix single solvent systems successfully incorporated the analytes into the 
matrix crystals to enable desorption/ionisation and detection of these molecules, 
evidenced by the presence of the alpha-, methoxy- and keto-MAs and MAMEs in the 
acquired spectra. The S/N was rather low however, especially for the MA and alpha 
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species which are the least polar and most difficult to ionise, which is a reason these 
molecules are usually derivatised prior to analysis. Analysis of the free MAs using the 
single solvent systems showed IPA resulted in the lowest ion counts and S/N for all 
mycolates detected, followed by THF, with EA and DCM producing similar results, as 
detailed in table 5.  The spectral quality for IPA was also extremely poor compared to the 
other single solvents used, with respect to peak shape and the ‘grassroots’ appearance of 
the spectra acquired. The highest obtainable ion counts for IPA was 217 counts (mean 
193, n=3) for the major homologue of the keto-mycolates, m/z 1302, which is the most 
polar of the mycolates and thus more readily ionised compared to the alpha-mycolates. 
Peak shape was poor, with peak shouldering present for the major homologues of the 
methoxy- and keto-mycolate peaks, m/z 1276 and 1302 respectively, and a ‘split’ in the 
peak representing the most abundant alpha-mycolate, m/z 1160, indicating poor resolving 
power. The ‘grassroots’ signal observed was above 20 % of the relative intensity of the 
base peak for all spectra acquired using IPA as the matrix solvent.  The poor results 
observed for the analysis of free mycolic acids using IPA as the matrix solvent system are 
thought to be both due to the extremely non-polar nature of these molecules, along with 
the inefficient incorporation of the analytes into the matrix crystal, and the final crystal 
formation. As displayed in figure 6.1, IPA crystal formation was rather poor, which would 
lead to reduced desorption/ionisation. The spectral quality observed using THF as the 
matrix solvent system was greatly improved compared to IPA, with the S/N doubling, 
however the peak shape for the major homologue of the alpha-mycolate, m/z 1160 was 
still of rather low quality, demonstrating relatively poor mass resolution.  As already 
mentioned, EA and DCM produced relatively similar results and produced the best overall 
results for the single solvents evaluated, achieving greater ion counts, higher S/N and 
improved peak/mass resolution.  
The analysis of MAs using the mixed solvent systems showed EA combined with THF 
and DCM produced similar results to those achieved with the use of EA or DCM alone. 
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This is regarding ion counts, S/N and spectral quality. IPA, the least suitable solvent when 
used alone, in combination with DCM produced a two-fold increase in ion counts and S/N, 
and an increase in the resolution for the major homologue of the alpha- and methoxy-
mycolates, m/z 1160 and 1276 respectively, compared to the latter used alone. There 
was also a three-fold increase in ion counts and S/N for the major homologue of the keto-
mycolate, m/z 1302, compared to the latter used alone. IPA in combination with THF 
showed over a three-fold increase in ion counts and S/N for the major homologue of the 
alpha- and methoxy-mycolates, m/z 1160 and 1276 respectively, compared to the latter 
used alone. There was also over a five-fold increase in ion counts and S/N for the major 
homologue of the keto-mycolate, m/z 1302.  The spectral quality was significantly 
improved for these solvent systems, the spectra are much clearer, and the peak shapes 
are uniform. Table 5 shows the mean ions counts, resolution and S/N for the major 
homologues of the alpha-, methoxy- and keto- mycolates obtained using each matrix 
solvent system. Figure 6.2a clearly highlights the far superior S/N achieved using IPA 
combined with either THF or DCM when compared to the other solvent systems 
evaluated.  Figure 6.3 compares the mass spectra acquired from the two single solvents 
(EA and DCM) with the two mixed solvents (IPA:THF and IPA:DCM) that produced the 
best overall results. The improved ion counts, S/N and spectral quality for the latter two is 
evident.  
The results for the analysis of the MAMEs showed similar results to those previously 
observed with the analysis of the free MAs, in which IPA combined with either THF or 
DCM produced far superior results compared to the other solvent systems evaluated, 
figure 6.2b this is again with respect to ion counts, S/N, resolution and spectral quality 
across all three major homologues, representing the alpha-, methoxy- and keto-
mycolates, m/z 1174, 1290 and 1316 respectively. As these species are more readily 
ionised compared to free MAs, ion counts and spectral quality was greatly improved 
across all solvents used, however, the single solvents and combinations of EA with THF 
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and DCM all showed similar results for all MAME analysed and detected. The S/N again 
doubled for the combination of IPA with THF and DCM compared to all other solvents and 
combination of solvents evaluated, figure 6.2B. The standard deviation is shown in all 
cases for the analysis of the free MAs and their methyl esters, (n=3), and is quite large 
and often overlaps for most solvent systems, this is thought to be due to the ‘overlay’ 
method used for the application of the sample and matrix solutions to the MALDI target 
plate. This method, as with other dried droplet methods, is known to have poor spot-to-
spot reproducibility, thus a large SD is observed. The SD is nearly always lower for 
analysis using DCM within the matrix solvent system. This is believed to be due to the 
crystal size and nature of the crystals produced with this solvent; they are quite robust 
and thus reduce the effect of the laser, never being fully ablated.  
The superior results observed with the combination of IPA with either THF or DCM for 
both the analysis of free mycolic acids and mycolic acid methyl esters is thought to be due 
to the nature and speed in which these solvents dry, and thus the type of crystals formed 
from this. As previously discussed, the crystals formed from these solvents were quite 
small and rounded with quite a dense coverage, and in the case of IPA:THF a near 
homogenous distribution is achieved. These solvents are believed to induce a greater 
incorporation of the analytes into the matrix crystals, leading to greater 
desorption/ionisation and thus detection of the analytes. 
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Solvent m/z  
Centroid 
Mass  
 Ion 
Counts Resolution S/N 
Ethyl Acetate 1160.3842 1160.3575 225 ± 37 6678 ± 381 32 ± 5 
2-propanol 1160.3458 1160.3572 113 ± 17 6363 ± 1321 19 ± 3 
Tetrahydrofuran 1160.397 1160.3692 157 ± 29 6269 ± 840 26 ± 5 
Dichloromethane 1160.3714 1160.3657 266 ± 108 6602 ± 286 44 ± 18 
IPA:THF 1160.2947 1160.3149 505 ± 309 7904 ± 68 126 ± 77 
EA:THF 1160.3075 1160.3192 275 ± 85 6666 ± 462 31 ± 9 
IPA:DCM 1160.3203 1160.323 527 ± 91 7289 ± 37 88 ± 15 
EA:DCM 1160.2819 1160.3205 268 ± 58 6128 ± 77 34 ± 17 
            
Ethyl Acetate 1276.4913 1276.4875 449 ± 109 6961 ± 305 64 ± 16 
2-propanol 1276.4913 1276.4878 175 ± 28 7047 ± 337 29 ± 5 
Tetrahydrofuran 1276.4645 1276.4853 298 ± 76 7189 ± 373 50 ± 13 
Dichloromethane 1276.5047 1276.4901 524 ± 269 7279 ± 570 87 ± 45 
IPA:THF 1276.4377 1276.4424 1261 ± 873 8278 ± 350 
315 ± 
218 
EA:THF 1276.4511 1276.4439 556 ± 182 7072 ± 502 62 ± 20 
IPA:DCM 1276.4511 1276.4463 1312 ± 135 7670 ± 174 219 ± 22 
EA:DCM 1276.4645 1276.4404 582 ± 142 6825 ± 119 73 ± 18 
            
Ethyl Acetate 1302.5239 1302.5174 538 ± 119 7217 ± 212 77 ± 17 
2-propanol 1302.4968 1302.5169 193 ± 48 7581 ± 434 32 ± 8 
Tetrahydrofuran 1302.5103 1302.5146 365 ± 99 7176 ± 37 61 ± 17 
Dichloromethane 1302.5103 1302.5096 648 ± 346 7022 ± 189 108 ± 58 
IPA:THF 1302.4697 1302.4719 
2063 ± 
1514 8934 ± 163 
516 ± 
378 
EA:THF 1302.4562 1302.4711 665 ± 280.7 7201 ± 331 74 ± 31 
IPA:DCM 1302.4697 1302.4741 2021 ± 282 8333 ± 180 337 ± 47 
EA:DCM 1302.4562 1302.4739 755 ± 174 7136 ± 117 94 ± 22 
 
Table 5. Average ion counts, resolution and signal-to-noise (± SD, n=3) for each of the 
major homologues of the mycolic acids analysed and detected using DHB in each solvent 
system.  m/z 1160, 1276 and 1302 represents the alpha-, methoxy- and keto-mycolates of 
the free mycolic acids respectively.  IPA combined with THF or DCM gave the best results 
across all MAs detected, with respect to ion counts, resolution and S/N. 
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Figure 6.2. The analysis of MALDI mass spectra for the S/N for each solvent system 
based on the alpha-, methoxy- and Keto-mycolates of the free MA (A) and MAME (B) 
standards. Figure A m/z 1160, 1276 and 1302 represents the alpha, methoxy and keto- 
mycolic acids respectively. Figure B m/z 1174, 1290 and 1316 represents the alpha, 
methoxy and keto- mycolic acid methyl esters respectively. All peaks represent the 
[M+Na]+ ion. IPA combined with THF and DCM produced far better S/N across both 
samples. 
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Figure 6.3. MALDI-MS spectra of free mycolic acids using the matrix solvent systems EA 
(A), DCM (B), IPA:THF (C) and IPA:DCM (D). The most abundant peaks for the alpha-, 
methoxy- and keto-mycolates are present at m/z 1160, 1276 and 1302 respectively.  All 
peaks represent the [M+Na]+ ion. The figure shows the ion counts, S/N and spectral 
quality is greatly improved using IPA combined with either THF or DCM compared to the 
single solvents of EA and DCM.  EA, DCM, IPA:THF and IPA:DCM represent the solvent 
system that produced the best overall results for the single and mixed matrix solvent 
systems evaluated. 
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6.3.3 Subclasses Detected for Free MA and MAME Samples 
 
Example spectra for the analysis of free MAs and their methyl ester derivatives (MAMEs) 
using 10 mg/ml DHB in IPA:THF 1:1 (v/v) as the matrix solvent system is shown in figure 
6.4. A clear envelope of peaks is present that differ from one another by 14 or 28 mass 
units from m/z 1132 to 1374 for MAs and m/z 1134 to 1388 for MAMEs. The MALDI mass 
spectrum of the free mycolic acids shows two abundant alpha-mycolate peaks at m/z 
1160 and 1188, representing C78 and C80 respectively, followed by slightly less abundant 
peaks at m/z 1174, 1202, 1216 and 1230, representing C79, C81, C82 and C83 respectively. 
Less abundant but significant peaks for this mycolate are also observed in this spectrum 
at m/z 1132, 1146 1244, 1258, 1272 and 1286 representing alpha mycolates with carbon 
chain lengths C76, C77, C84, C85, C86 and C87 respectively. The most abundant peak for the 
methoxy-mycolate is observed at m/z 1304 for C87. At nearly 50% less relative intensity 
the next abundant peak for this subclass can be observed at m/z 1276, representing C85, 
followed by peaks at m/z 1248, 1262, 1290, and 1318 representing C83, C84, C86, and C88 
respectively. Less abundant but significant peaks for this mycolate are present at m/z 
1220, 1234, 1332, 1346, 1360 and 1374, representing C81 through to C92. The detection of 
keto-mycolates within this sample showed the most abundant peaks to be at m/z 1274 
and 1302 for C85 and C87 respectively, followed by less abundant peaks at m/z 1260, 1288 
and 1316 for C84, C86 and C88 respectively. Less abundant but significant peaks for this 
mycolate were also observed at m/z 1218, 1232, 1246, 1330, 1344 and 1358 
representing C81 through to C91. A characteristic MA profile can also be observed for m/z 
1224, 1238, 1252, 1266, 1280, 1294, 1308, 1322, 1336 and 1340, due to their size these 
could possibly be assigned to methoxy- or keto-MAs, however structural characterisation 
is needed for full identification. A smaller cluster of peaks are also present at m/z 1010 to 
1052 that have the characteristic mycolic acid pattern, these are yet to be identified but 
could  be  smaller  alpha  or  the  shorter  chain  alpha’ mycolates.  The  same  characteristic 
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peak profile was observed for the mycolic acid methyl esters, as was for the mycolic 
acids, a shift of 14 mass units was observed for each assignable mycolate, representing 
methylation. The relative intensity for almost all peaks has increased next to the base 
peak, when compared to the analysis of free MAs. This is thought to be due to the 
increased polarity of these species and thus an increase in desorption/ionisation, 
evidenced by the relative intensity of the alpha-mycolate methyl esters, m/z 1174 and 
1202, compared to the relative intensity of the free alpha-mycolates, m/z 1160 and 1188, 
figure 6.4 top and bottom spectra respectively.  Results found here correspond to those 
previously published for the MALDI-MS analysis of MAMEs from slow growing pathogenic 
mycobacterium, including M.tb and M. bovis BCG[193-198]. Table 6 lists assignable 
mycolates according to literature, along with the number of carbons for each, for the 
analysis of free MAs and MAMEs. 
 
 
 
Table 6. Masses and carbon lengths of α-, methoxy- and keto-mycolates for free acids 
(top table) and their methyl esters (bottom table), values represent the [M+Na]+ ions. The 
mass values for the major homologues are italicised in bold. 
Free mycolic acids
Mycolic  Total number of carbons in mycolic acid
acid type 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92
Alpha 1132 1146 1160 1174 1188 1202 1216 1230 1244 1258 1272 1286
Methoxy 1220 1234 1248 1262 1276 1290 1304 1318 1332 1346 1360 1374
Keto 1218 1232 1246 1260 1274 1288 1302 1316 1330 1344 1358
Mycolic acid methyl etsers
Mycolic  Total number of carbons in mycolic acid
acid type 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92
Alpha 1132 1146 1160 1174 1188 1202 1216 1230 1244 1258 1272 1286
Methoxy 1220 1234 1248 1262 1276 1290 1304 1318 1332 1346 1360 1374 1388
Keto 1218 1232 1246 1260 1274 1288 1302 1316 1330 1344 1358 1372
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Figure 6.4. MALDI-TOF mass spectra of free mycolic acids (top spectrum) and mycolic 
acid methyl esters (bottom spectrum) using DHB 10 mg ml-1 IPA:THF 1:1 (v/v) 0.1 % TFA. 
The major homologues representing the alpha-, methoxy- and keto-mycolates can be 
observed at m/z 1160, 1303 and 1302 respectively. The major homologues representing 
the alpha-, methoxy- and keto-mycolic acid methyl esters can be observed at m/z 1174, 
1290 and 1316 respectively. All peaks represent the [M+Na]+ ion. The most abundant 
peak for the methoxy subclass has switched from C87 for the free MA sample to C85 in the 
MAME sample; however, there is only a slight difference in the relative intensity for these 
two peaks in the MAME sample. 
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6.3.4 Matrix Solvent System – Comparison to Published Literature 
 
A comparison of MALDI-QqTOF-MS using the optimised solvent systems vs. previously 
published solvent systems[132-134, 193-201] shows the improved sensitivity of the new 
system: IPA:THF and IPA:DCM compared to CHCl3:MeOH 1:1 and 2:1 (v/v). The ion 
counts for IPA:THF and IPA:DCM are again similar, however,  IPA:THF produced slightly 
higher ion counts for all subclasses (alpha-, methoxy- and keto-) for both the free MA and 
the MAME samples, with less variance between analysis. For the analysis of the free 
mycolic acid sample, IPA:THF produced over a two-fold increase in ion counts for the 
major homologue of the alpha-MA at m/z 1160, compared to CHCl3: MeOH 1:1 (v/v). 
Higher ion counts were also observed for this mycolate and solvent system compared to 
CHCL: MeOH 2:1 (v/v). As the polarity increases slightly with the methoxy- and keto- 
mycolates, the gap in ion counts also increases when comparing the optimised systems 
of,  IPA:THF and IPA:DCM with CHCl3:MeOH 1:1 and 2:1 (v/v). There is over a two-fold 
increase in ion counts for IPA:DCM and over a three-fold increase in ion counts for 
IPA:THF when compared to CHCl3:MeOH 1:1 (v/v), the latter produced the poorest results 
over all mycolates for both samples, with respect to ion counts, resolution and S/N. 
IPA:DCM and CHCL3:MeOH 2:1 (v/v) resulted in comparable findings with respect to ion 
counts and S/N. IPA:THF produced far superior results compared to both the optimised 
solvent system of IPA:DCM and the most useful of the previously published systems, 
which was CHCl3:MeOH 2:1 (v/v), for both the purified MA and MAME samples. The S/N 
ratio shows over a ten-fold increase for the major homologues of the alpha-, methoxy- 
and keto-MAs, at m/z 1160, 1276 and 1302 respectively, when comparing, IPA:THF with 
CHCl3:MeOH 1:1 (v/v), and over a three-fold increase when comparing IPA:THF with 
CHCl3:MeOH 2:1 (v/v) or IPA:DCM, as shown in table 7. A similar trend is observed when 
analysing the S/N ratio acquired for the MAME sample. There is again a ten-fold increase 
for the alpha-MAME, m/z 1174, when comparing IPA:THF with CHCl3:MeOH 1:1 (v/v) and 
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over a ten-fold increase for the methoxy- and keto-MAME, m/z 1290 and 1316 
respectively. IPA:THF also yielded a four-fold increase in S/N for the alpha-MAME and 
over six-fold increase in S/N for the methoxy- and keto-MAME when compared to the 
previously published CHCl3:MeOH 2:1 (v/v), as shown in the graphs presented in figure 
6.5. Results presented here also show that an increase in the amount of sample applied 
to the plate compared to the amount of matrix, i.e 1 µL followed by 0.5 µL respectively, 
greatly increases the spot-to-spot reproducibility achieved, as shown by the reduction in 
error bars in figure 6.5 compared to those presented in figure 6.2. The effect of sample 
preparation on reproducibility in a MALDI experiment has long been known and greatly 
investigated [35, 206, 207, 209]. 
 
Solvent m/z  
Ion 
Counts Resolution S/N 
CHCl3:MeOH 1:1 1160 107 ± 19 6788 ± 209 54 ± 10 
CHCl3:MeOH 2:1 1160 201 ± 27 6660 ± 312 201 ± 27 
IPA:THF 1160 314 ± 26 6874 ± 688 627 ± 52 
IPA:DCM 1160 291 ± 88 6689 ± 316 146 ± 44 
          
CHCl3:MeOH 1:1 1276 203 ± 61 6415 ± 542 101 ± 31 
CHCl3:MeOH 2:1 1276 383 ± 38 6584 ± 446 383 ± 38 
IPA:THF 1276 725 ± 45 7093 ± 238 1451 ± 90 
IPA:DCM 1276 522 ± 123 6538 ± 146 261 ± 61 
          
CHCl3:MeOH 1:1 1302 280 ± 67 6915 ± 597 140 ± 34 
CHCl3:MeOH 2:1 1302 582 ± 107 6866 ± 120 582 ± 107 
IPA:THF 1302 1015 ± 34 7407 ± 145 2031 ± 68 
IPA:DCM 1302 852 ± 145 7515 ± 221 426 ± 72 
 
Table 7. Average ion counts, resolution and signal-to-noise (± SD, n=3) for each of the 
major homologues of the mycolic acids analysed and detected using DHB in each solvent 
system.  m/z 1160, 1276 and 1302 represents the alpha-, methoxy- and keto-mycolates of 
the free mycolic acids respectively.  IPA:THF gave the best results across all MAs 
detected, with respect to ion counts, resolution and S/N. 
181 
 
 
 
 
Figure 6.5. The analysis of MALDI mass spectra from each solvent system, for the S/N of 
the alpha-, methoxy- and Keto- mycolates of the free MA (A) and MAME (B) standards.  
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6.3.5 Analysis of Strain C Extracts 
 
The analysis of the Strain C extract showed a clear characteristic peak pattern previously 
reported for the analysis of purified PDIMs from bacterial extracts[132, 200, 201]. The 
mass spectrum presented in figure 6.6 shows the major homologues of PDIMs are 
present at m/z 1474 and 1502 representing C98 and C100  respectively, but a characteristic 
peak pattern can be observed at m/z 1376, 1390, 1404, 1418, 1432, 1446, 1460, 1474, 
1488, 1502 and 1516, representing C91 to C101. This peak pattern, with respect to the 
masses present, corresponds to those previously published for the MALDI-TOF analysis 
of purified PDIM type A, also known as DIM A[132, 200, 201] and the MALDI-MS analysis 
of the standards of PDIMs analysed in Chapter 4 of this thesis. Peaks representing the 
major homologues of the methoxy- and keto-mycolic acids are also present in the mass 
spectrum acquired from this sample, and can be observed at m/z 1276 (C85) and  m/z 
1302 (C87) respectively. There are slightly lower abundant methoxy-mycolate peaks 
present at m/z 1304 and 1318. All masses correspond to those detected from the MA 
standards (figure 64 and table 5) and those previously published. Whilst the peak for the 
methoxy-MA is clearly visible above the background noise, the peak representing keto-
MA is only just visible above this region of the spectrum.  The peak shape is rather poor 
for both of these species, with peak broadening; this is thought to be due to the 
complexity of the sample. The alpha-mycolates were not detected from this sample, these 
are the least polar and thus most difficult to ionise of the MAs, it is thought the sample is 
too complex and the more polar lipids species are favourably ionised. 
A number of possible cell wall associated lipid species were also detected in this sample, 
observed as peaks within the MALDI mass spectrum at m/z 1542 and 1556. In addition to 
these, a characteristic lipid profile can be observed at the higher mass range of the 
spectrum, m/z 1676-1768, these species are yet to be identified. The masses fall within 
the mass range of TMMs, however they do not correspond to any published masses of 
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these species to date. Structural characterisation will need to be carried out for full 
identification.  m/z 1199 is a peak associated with the fractionation of solutions on Florisil 
columns. All significant peaks are listed in table 8, all masses are believed to be [M+Na]+.  
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Figure 6.6. MALDI mass spectrum of bacterial extracts from Strain C using DHB 10 mg 
ml-1 IPA:THF (1:1, v/v). The peak for the major homologue of the methoxy-MA is present 
at m/z 1276. The main cluster of peaks m/z 1376-1516 represent PDIMs C92-C101, the 
maximum ion counts given is for the base peak which is m/z 1474 and represents the 
major homologue of PDIM A, C98. The cluster of peaks seen at the higher mass range m/z 
1677-1756 are believed to be cell envelope associated lipids with a similar structure, 
these are yet to be identified. The peak at m/z 1199 is a molecule associated with 
samples fractionated on Florisil columns. 
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m/z Lipid Reference 
1276 Methoxy-MA [193-195, 197]  
1302.4605 Keto-MA [193, 194, 197]  
1304.09 Methoxy-MA [193-195, 197]  
1318.0576 Methoxy-MA [193-195, 197]  
      
1376.53 PDIM A [132, 200, 201]  
1390.55 PDIM A 
[132, 200, 
201]   
1404.56 PDIM A [132, 200, 201]  
1418.58 PDIM A [132, 200, 201]  
1432.61 PDIM A [132, 200, 201]  
1446.63 PDIM A [132, 200, 201]  
1460.64 PDIM A [132, 200, 201]  
1474.66 PDIM A [132, 200, 201]  
1488.67 PDIM A [132, 200, 201]  
1502.69 PDIM A [132, 200, 201]  
1516.7 PDIM A [132, 200, 201]  
      
1542.29 Unidentified   
1556.3 Unidentified   
      
1676.32 Unidentified   
1698.31 Unidentified   
1712.33 Unidentified   
1714.31 Unidentified   
1726.34 Unidentified   
1740.37 Unidentified   
1754.39 Unidentified   
1768.37 Unidentified   
 
Table 8. MALDI-MS data of methoxy-, keto-MAs and PDIMs type A detected from the 
analysis of the Strain C extract, the references for all previously published masses are 
shown. The m/z of previously unpublished masses is listed as unidentified. All masses 
are the [M+Na]+. 
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6.3.6 Analysis of BCG Extracts 
 
The spectrum acquired from the analysis of the BCG extract is quite complex due to the 
number of lipids in the sample, as shown in figure 6.7. As the lipids within this sample are 
quite similar structurally and fall within the same mass range, leading to increased 
isobaric species, care must be taken with the interpretation of the spectrum. 
At the lower mass range of the spectrum presented in figure 6.7 a cluster of peaks are 
present at m/z 1010-1084, these masses and characteristic peak pattern correspond to 
those observed in this region of the spectrum for the standard of free MAs (figure 6.4, top 
spectrum), indicating the presence of mycolic acids. As M. bovis BCG reportedly do not 
synthesise the shorter chain α’-MAs[292], these peaks could represent shorter chain α-
MAs, which, to the best of the authors knowledge, have not previously been reported, 
structural characterisation is needed. The more polar methoxy-MAs were detected in this 
sample and can be observed in the mass spectrum at m/z 1234, 1248, 1262, 1276, 1290, 
1304, 1318, 1332 and 1346, representing C81-C89. Keto-MAs were also detected from this 
sample and are observed in the mass spectrum at m/z1246, 1260, 1274 and 1288, 
representing C81-84. All masses correspond to those detected from the MA standards 
(figure 6. 4) and those previously published[193-195, 197]. 
Peaks representing PDIM A are again present at m/z 1306-1516, representing C87 to C101 
and correspond to those previously published for the MALDI-TOF analysis of these 
species from purified M. bovis BCG wild type and M.tb H37Rv (wild type) and Beijing 
extracts[132, 200, 201], and the MALDI-MS analysis of the standards of PDIMs analysed 
in Chapter 4 of this thesis. The characteristic peak pattern of these species is less evident 
in the spectrum due to the presence of PGLs in the sample, which shares the same mass 
range. The peak at m/z 1488 could be attributed to PDIM A C99 or PGL, however due the 
accuracy and resolution afforded by the TOF analyser, and as the peak is at m/z 1488.48 
it is believed this is PGL. This corresponds to the m/z previously reported for this 
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species[201], whereas PDIM A C99 have been reported at m/z 1488.60 and 1488.67 in 
literature and the strain C sample (see previous section) respectively, both of which did 
not contain PGLs. m/z 1460 and 1502 are also isobars, according to literature they could 
be PDIMs or PGLs. The peak representing the major homologue for PGL is present at 
m/z 1530, with a series of less abundant peaks at m/z 1488, 1502, 1544, 1558, 1572 and 
1586. Masses of PGLs detected from this sample correspond to those previously reported 
for the MALDI-MS analysis of M. bovis BCG extracts [201], and those detected from the 
standards in Chapter 4 of this thesis. The m/z represented in italics correspond to isobaric 
species, thus these are tentative assignments.  There are also two high abundant peaks 
within this mass spectrum at m/z 1334 and 1362 that correspond to the previously 
reported masses of the major homologues of a class of cell wall associated lipids known 
as monomycoloyl glycerol (MMG)[183]. MMGs are mycolate containing lipids often 
observed along with PGLs and it is believed these masses correspond to two keto-
mycolate MMGs.  Again a number of possible cell wall associated lipid species are also 
present in these mass spectra, observed within the higher mass range m/z 1677-1762; 
these peaks have the same masses and characteristic pattern as those observed in the 
Strain C extract and are yet to be identified. As mention for the analysis of the Strain C 
extract, the masses fall within the mass range of TMMs; however they do not correspond 
to any published masses of these species to date. Structural characterisation will need to 
be carried out for full identification.  . All significant peaks are listed in table 9, all masses 
are believed to be [M+Na]+. 
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Figure 6.7. MALDI mass spectrum of bacterial extracts from M. Bovis BCG using DHB 10 
mg ml-1 IPA:THF (1:1, v/v). The peak for the major homologue of the methoxy-MA is 
thought to be present at m/z 1275.98. The two high abundant peaks observed at m/z 
1334 and 1362 represent the major homologue of MMG. Peaks from m/z 1306-1516 
represent PDIM As C87-C101, whilst the peaks ranging from m/z 1446-1572 represent 
PGLs. The maximum ion count given is for the base peak which is at m/z 1530 and 
represents the major homologue of PGL. The cluster of peaks seen at the higher mass 
range m/z 1677-1756 are believed to be cell envelope associated lipids with a similar 
structure, but are yet to be identified. 
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Table 9. MALDI-MS data of m/z of interest detected from the BCG extract. 
m/z Lipid Reference 
1012 Unidentified   
1026.04 Unidentified   
1040.01 Unidentified   
1054.05 Unidentified   
1070.05 Unidentified   
1084.06 Unidentified   
      
1234.31 Methoxy-MA [193-195, 197]  
1246.26 Keto-MA [193, 194, 197]  
1248.31 Methoxy-MA  [193-195, 197]  
1260.31 Keto-MA  [193, 194, 197] 
1262.34 Methoxy-MA [193-195, 197]   
1274.32 Keto-MA  [193, 194, 197] 
1275.98 Methoxy-MA [193-195, 197]   
1288.33 Keto-MA  [193, 194, 197] 
1290.37 Methoxy-MA  [193-195, 197]   
1304 Methoxy-MA  [193-195, 197]   
1318.39 Methoxy-MA  [193-195, 197]  
1332.44 Methoxy-MA  [193-195, 197]  
1346.46 Methoxy-MA  [193-195, 197]  
      
1306.41 PDIM A [132, 200, 201]   
1320.43 PDIM A [132, 200, 201]   
1334.44 PDIM A/ MMG [132, 200, 201] [183] 
1348.47 PDIM A [132, 200, 201]   
1362.48 PDIM A/ MMG [132, 200, 201]  [183] 
1376.5 PDIM A [132, 200, 201]   
1390.52 PDIM A [132, 200, 201]   
1404.5 PDIM A [132, 200, 201]   
1418.53 PDIM A [132, 200, 201]   
1446.43 PDIM A [132, 200, 201]   
1460.06 PDIM A  [132, 200, 201]  
1474.47 PDIM A [132, 200, 201]   
1488.48 PDIM A/PGL [132, 200, 201]   
1502.49 PDIM A/PGL [132, 200, 201]   
1516.51 PDIM A [132, 200, 201]   
      
1530.26 PGL  [201] 
1544.54 PGL  [201] 
1558.55 PGL [201]  
1572.58 PGL [201]  
      
1676.32 Unidentified   
1690.16 Unidentified   
1698.3 Unidentified   
1714.27 Unidentified   
1718.35 Unidentified   
1726.33 Unidentified   
1734.32 Unidentified   
1740.34 Unidentified   
1742.35 Unidentified   
1756.32 Unidentified   
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6.4 Conclusion  
 
The evaluation of numerous solvents that could be applied to the analysis of mycolic 
acids, without the need for prior derivatisation, led to the optimised combination of 
IPA:THF 1:1 (v/v).  Whilst all of the solvent systems evaluated proved successful with 
respect to the detection of free MAs and their methyl esters, the spectral quality was 
rather poor for six of the eight systems. The experimental data for the initial solvent 
optimisation experiments showed IPA:THF, and IPA:DCM were the most sensitive 
systems to take forward for further experimentation. When analysing the spectra for both 
free MAs and MAMEs the quality was drastically improved compared to the other 
systems. Ion counts, S/N and resolving power was far greater with these solvents, 
particularly when analysing the extremely non-polar alpha-mycolates as free acids. All 
alpha-, methoxy- and keto-mycolates previously reported in literature were detected using 
IPA:THF as the matrix solvent system, with the addition of peaks that may be attributed to 
smaller chain alpha-MAs at the lower mass range of m/z 1012-1084, and possible 
methoxy- or keto-MAs at m/z 1224-1340, that, to the best of the authors knowledge, have 
not been previously reported. These molecules need further investigation to enable 
proper identification. In addition to this, most literature to date analyses MAMEs[193-195, 
197, 198], as these are more readily ionised and thus increase sensitivity and detection of 
mycolates. The matrix solvent system presented here has proven sensitive enough to 
detect free MAs, including numerous alpha-MAs which are extremely non-polar by nature 
and thus difficult to ionise, thereby omitting the need for the derivatisation step. Most 
studies to date have also analysed individual mycolate subclasses after separation on 
TLC plates[193-195, 197, 198], whereas all data presented here is from complex lipid 
mixtures.  
Numerous studies to date have shown the composition of the MALDI matrix solvent 
system greatly influences the resulting mass spectra and thus analysis[207, 209, 290, 
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293]. This is with respect to detection sensitivity and the relative intensities of the 
species/molecules detected[207, 209, 290]. In addition to this the matrix-sample solvent 
system has been shown to have mass discriminatory effects in the resulting MALDI-MS 
signal[293]; however most of the studies to date have been carried out for the analysis of 
peptides and proteins. The greater sensitivity achieved using IPA:THF as the solvent 
system is thought to be due to greater extraction and incorporation of the analytes into the 
matrix crystals, together with the size, shape and distribution of these crystals on the 
target plate, as presented in this chapter.  
The comparison of IPA:THF and IPA:DCM to the matrix solvent systems currently used in 
literature, based around varying ratios of chloroform:methanol for the analysis of non-
polar lipids, including MAMEs, TAGS and cholesterol[132-134, 192-201], showed 
IPA:THF to be a far more sensitive matrix solvent system. IPA:THF showed the greatest 
overall results for both the free MA and MAME samples. When analysing the major 
homologues of the alpha-, methoxy- and keto-mycolates at m/z 1160, 1276 and 1302 
respectively IPA:THF showed a 3-4 times increase in S/N compared to those used in 
literature. By changing the ratio of analyte to matrix applied to the MALDI target plate the 
reproducibility also greatly increased for this solvent system. In addition to this, the 
change in sample preparation resulted in IPA:THF producing far greater results with 
respect to ion counts, S/N and thus spectral quality when compared to the other optimised 
solvent system of IPA:DCM. With these results in mind IPA:THF was applied to the 
analysis of whole mycobacterial lipid extracts from two bacterial species know as Strain C 
and M. bovis BGC. 
The analysis of the Strain C extract using DHB in the optimised solvent system IPA:THF 
(v/v) was successful for the detection of numerous cell wall associated lipid species, 
known to be involved in virulence. The main cluster of peaks present in the MALDI mass 
spectrum correlate well with those previously published for the analysis of purified PDIMs 
type A analysed from, M. tb H37Rv (wild type)[200], M. tb Beijing strain (HN878)[132], M. 
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bovis BCG (PMM137:PM261) and M. bovis BCG wild type[201]. PDIMs are key virulence 
factors involved in both the replication of mycobacterium within the host, and the 
modulation of the host immune response[132, 199-201, 294]. In addition to the detection 
of PDIMs, methoxy- and keto-mycolic acids were also present within this mass spectrum, 
the sample proved too complex for the analysis of the extremely non-polar alpha-MAs. 
Whilst the analysis of the alpha-MAs is desirable from complex mixtures, it should be 
noted that these are the most widely distributed of the mycolate subclasses and are 
present in every species examined to date, followed by the least polar keto-MAs, it is the 
methoxy-MAs that are predominantly (not exclusively) found in slow-growing pathogenic 
species[292], and should thus possibly be the key species of interest. There is also a 
cluster of peaks present at the higher mass range of this mass spectrum that have the 
characteristic lipid profile, these could possibly be TMM, however, they do not correspond 
to any masses published in literature to date for these molecules. Structural 
characterisation is needed for full identification, as these lipids could prove to be important 
virulence factors that correspond to known lipids but have different chain lengths to those 
previously analysed. Strain C is believed to be a complimentary M. tb strain, this is due to 
the presence of mycolic acids and PDIMs, but a lack of PGLs, which are absent from 
most commonly used laboratory and clinical strains of M. tb due to a frame-shift mutation, 
as previously discussed[132, 136]. 
The MALDI-MS analysis of the M. bovis BCG extract produced a highly complex mass 
spectrum due to the number of lipid species detected from this sample. Several methoxy- 
and keto-MAs were detected from this sample that corresponds well to those previously 
published for the analysis of MAs from slow-growing pathogenic mycobacterium[193-198]. 
PDIMs type A was again present within this mass spectrum and again the masses 
correspond well with those previously published for this type of lipid for C87 to C101[132, 
200, 201]. In addition to those lipids detected from the Strain C extract, PGLs were 
detected from this sample and their masses correspond to those previously published for 
193 
 
the MALDI-MS analysis of purified lipid extracts from M. bovis BCG wild-type[201]. The 
peaks at m/z 1334 and 1362, although isobaric, are believed to be two species of keto-
mycolate monomycoloyl glycerol (MMG) that are often found in association with or are 
separated with PGLs via TLC analysis[295]. These masses correspond to those reported 
for the [M+Na]+ ions for C86 and C88 respectively from M. bovis BCG Danish 1331 
strain[183]. MMGs have been shown to have potent immunostimulatory activity[183, 295]. 
There were also a number of unidentified peaks within this mass spectrum, that again, 
once identified could add the knowledge that already exists for mycobacterial lipid species 
involved in virulence. At the lower mass range m/z 1012-1084, a cluster of peaks are 
present that display the characteristic mycobacterium lipid profile, in that they differ from 
one another my 14 mass units. These share the same masses and profile as those 
observed in the mass spectrum of the free mycolic acid standards (figure 4) indicating the 
presence of shorter chain MAs. At the higher mass range, m/z 1676-1756 a cluster of 
peaks are present that also differ from one another by 14 mass units, these could possibly 
be TMM, but they are yet to be identified, they do share the same masses as the 
unidentified lipids detected from the Strain C sample. M. bovis BCG is an attenuated 
strain derived from the virulent M. bovis for use in vaccination against TB. The original 
vaccine strain has been subcultured and distributed to so many laboratories world-wide 
that today many substrains of the original exist, each with varying lipid profiles that are 
thought to have effects on attenuation, and thus have varying protective immunity[294]. 
Although the BCG strain supplied here is unknown, several substrains can be excluded 
due to the lipid profiles present. It is known that M. bovis BCG-Moreau, -Japan, and –
Glaxo are deficient in PDIM and PGL biosynthesis, as these lipids are present these 
strains can be excluded[285]. Many BCG strains, those distributed from the Pasteur 
Institute after 1927, are deficient in the biosynthesis of methoxy-MAs due to a point 
mutation in the mmA3 gene; these include Prague, Pasteur, Connaught, Denmark, Glaxo, 
Tice, Phipps and Frappier[296]. With the knowledge of the combined lipid profiles there 
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are only four remaining possibilities for this strain, they are Birkhaug, Japan, Russia and 
Sweden. 
Mycolic acids and other cell envelope non-polar lipids including, PDIMs, PGLs and MMGs 
are important molecules as they play a central role in the pathogenicity of M. tb and M. 
bovis, thus methods that can rapidly analysis these species for aiding in diagnosis, 
identification of growth and virulence through the analysis of mutant models, and the 
identification of therapeutic targets/affects of pharmaceuticals is greatly needed. The 
application of MALDI-MS, using this solvent system could greatly contribute to such 
investigations. Work presented in this chapter has proven MALDI-MS as a viable tool for 
the investigation of lipids involved in the virulence of mycobacterium from highly complex 
mixtures. Several key lipids were detected along with numerous unknown species. In 
addition to this, this solvent system could be applied to MALDI-MS imaging studies, which 
was not previously possible using chloroform as part of the matrix solvent system, due to 
its toxicity and anaesthetic properties. The analysis of these lipids from formalin fixed 
samples could also be a possibility, lipid analysis from FF tissue was shown in chapter 3, 
and the analysis of fixed tissue would reduced the biohazard risk, as is common practice 
in histopathology laboratories. This solvent system may also be of more use when 
analysing other non-polar lipids including TAGs and cholesterol. 
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7.1 Conclusions and Future Work 
 
MALDI-MSI is proven as a viable tool for the analysis of lipids in both normal and disease 
states, however, method development and sample preparation protocols can still be 
improved. This thesis reports the significant impact sample preparation has on MALDI-MS 
analysis, and further demonstrates the potential of this highly versatile technique in 
analysis of lipids in complex samples.  
 
MALDI-MSI results demonstrated tissue sections that had been dehydrated resulted in 
much lower signal intensities compared to those that had not. The significant difference in 
signal intensity and spectral quality observed is thought to be due to alterations in 
surface/tissue properties, with ‘dryer’ sections resulting in reduced analyte extraction and 
co-crystallisation compared to the ‘wetter’ sections. Alternatively, the deposition of matrix 
onto the ‘wetter’ samples may decrease the solvent evaporation time, which in turn would 
decrease the crystal drying process, allowing more time for the analyte/s to be 
incorporated into the matrix crystals[206, 239]. It is unknown how these effects would 
translate to the analysis of larger molecules such as peptides and proteins. This would be 
an interesting investigation to carry out, as sample desiccation prior to matrix deposition is 
still a protocol in many MALDI-MSI investigations.  Researchers do not really explain why 
samples are desiccated, other than to dehydrate the tissue, nor has anyone commented 
on the effects of such procedures. Many investigators have commented on the changes 
that occur within tissue immediately after death/during excision, prior to flash-freezing, 
even if this time period is minutes, it is still thought to affect the biological profiles in 
tissue. Investigators have attempted to minimise this by using processes such as rapid 
heating of the organs immediately after excision. Investigators also try to minimise the 
time tissue is out of the freezer, between storage periods and sectioning in the cryostat 
chamber, constant transfer between the two affects protein signal over time. With all this 
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knowledge in mind, it is postulated that sample desiccation or tissue ‘dehydration’ for time 
periods after sectioning will reduce the obtainable signal in MALDI-MSI, as demonstrated 
in chapter 2. Investigations should be carried out assessing time verses signal quality for 
a number of molecules, with an aim to provide a protocol or guidelines for analysts. 
Results presented also indicated matrix application and not sample thickness greatly 
affects the sensitivity and quality of a MALDI-MSI study.  
 
The automated TM-sprayer was introduced at ASMS in 2007, there was little to no 
literature available on the application of this in MALDI-MS investigations, other than the 
technical note supplied by Leap Technologies. This deposition method demonstrated 
small crystal size and a homogenous coverage, high analyte extraction and co-
crystallisation, and no analyte delocalisation, demonstrated by enhanced detection 
sensitivity and thus S/N, and high resolution images. The TM-sprayer showed over a two-
fold reduction in variability compared to airbrush deposition, reproducibility is a key issue 
for the latter method. A more reproducible deposition method, as presented here, will aid 
in minimising the problems associated with inter- and intra- laboratory variability, due to 
irreproducible matrix deposition. Once optimised for a solvent system this method is both 
fast and efficient, and a much lower concentration and thus consumption of matrix 
material also make the TM Leap sprayer attractive tool for MALDI-MSI. The only problem 
with this instrument is its cost; at $50,000 it is beyond what is affordable by many 
research groups.  
 
The MALDI-MSI analysis of phospholipids directly from formalin fixed tissue was 
presented for the first time in this thesis. High quality molecular lipid images were 
obtained, showing mutual distribution to fresh tissue preparation [10, 12, 14, 155, 165, 
166, 172, 205, 230, 232, 233, 238, 275-278]. Sodium buffers associated with the formalin 
fixation protocol caused a change in previously reported ionisation pathways [10, 12, 14, 
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155, 165, 166, 172, 205, 230, 232, 233, 238, 275-278], and the [M+Na]+ was found to be 
the most readily detected ion for each lipid species investigated. Dissociation of m/z 756, 
[M+Na]+ in fixed tissue produced a more enriched CID mass spectrum, compared to those 
obtained from fresh tissue for the analysis of m/z 772, [M+K]+. MALDI-MSI investigations 
were carried out on soft sarcoma sections that had been fixed in formalin, numerous 
suspected lipid species were detected, however, due to the absence of normal tissue 
architecture, and minimal pathological information, this investigation could not continue. 
Working alongside pathologists in the future would enable thorough MALDI-MSI 
investigations into the differential expression and distribution of PLs in disease states.  
There are a number of concerns regarding the interpretation of results obtained from 
MALDI-MSI investigations of PLs, as highlighted in chapter 1 of this thesis. Authors report 
results based on a single ion form for a given species, when the mass spectrum acquired 
is complex, containing protonated, cationised and fragment peaks of a single lipid. There 
are also discrepancies in the reported distribution of some PLs across tissue areas. It is 
postulated in this thesis that the method of sample preparation not only affects the quality 
of results, but may also result the discrepancies reported for the distribution of lipid 
species. This could be due to the use of different matrices, solvent systems, and matrix 
deposition methods across laboratories. The future analysis of these molecules should 
involve multi-laboratory efforts to build a database, not only of results acquired, but also of 
the experimental data used to obtain each result. This could be similar to the imzML 
initiative, which was set up to facilitate the exchange and processing of MALDI-MS 
imaging data, but with the addition of sample preparation and acquisition parameters. 
This would build a library of changes observed with each preparation, such as the use of 
methanol compared to acetonitrile. This would also help build a database of optimised 
strategies for lipid analysis. The importance of monitoring all ions for a given lipid species 
when discussing a difference in distribution, signal intensity and ratios needs to be 
recognised, as is reported in this thesis.  
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The MALDI-MS detection of MAs, PDIMs, PGLs and MMGs from lymph and blood 
extracts taken from infected cattle, was not possible with the method commonly used in 
literature. Variation of extract concentration, amounts applied to the MALDI target plate, 
changing the matrix:analyte ratio, and altering the laser power, all had no effect on the 
outcome of the results. A protocol has been optimised for the analysis of lipids directly 
from thin layer chromatography plates by MALDI-MSI; however, at present it is still not 
well suited to the analysis of all Mycobacterium lipids of interest. Analysis of tissue that 
had been autoclaved to remove biohazard risks proved this procedure to be unsuitable for 
MALDI-MSI investigations. Future analysis of infected organs should be carried out on 
tissue fixed for a minimum of 24-48hrs (size dependant) in formalin. This is the standard 
safety procedure applied in clinical histopathology laboratories for biohazard material, and 
tissue prepared this way is suitable for MALDI-MS analysis of phospholipids, as shown in 
chapter 3 of this thesis. 
 
Solvent optimisation for MALDI-MS investigations of complex Mycobacterium cell wall 
lipids proved the binary matrix IPA:THF was far more sensitive than those used in 
literature, IPA:THF demonstrated a 3-4 times increase in S/N compared to those 
previously reported. The application of this solvent system to the analysis of complex 
bacterial extracts was successful in the detection of several key lipids known to be 
involved in virulence, including MAs, PDIMs, PGLs and MMGs, numerous unknown 
species were also detected. Further optimisation varying the ratios of these solvents may 
enhance detection sensitivity further. Protocols also need to be developed that enable 
low-energy CID of the unknown species, and thus aid in structurally elucidating these 
molecules. This solvent system could be applied to MALDI-MS imaging studies. The 
analysis of fixed organs taken from infected animals may provide distribution information 
of these lipids within organ systems, information that, to the best of the author’s 
knowledge, has never been acquired before. Such studies may be able to complement 
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current MALDI-MSI investigations into the distribution of anti-mycobacterial drugs in lung 
tissue. The type and amount of MAs biosynthesised by Mycobacterium are affected by 
growth stages, temperature and growth medium, as analysis is nearly always carried out 
on bacteria grown in media it is unknown how these change in a host environment. Future 
work should aim to establish such information. 
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